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ABSTRACT

Breast cancer research aims to develop a detailed understanding of the underlying
mechanisms of disease progression and to generate approaches to improve early
detection, monitoring, and treatment of breast cancerous lesions. The success of current
standardized breast cancer therapies varies as each breast cancer patient and tumor is
different and unique whereas the standard of care is based on specific breast cancer
patient cohorts. To further current clinical success, the characteristics of each tumor mass
must be considered. Such an individualized or personalized approach is incompatible
with current understanding of “average” breast cancer tumors and responses to
treatments. Thus, the long-term objective of the present research is to develop modular
breast tissue models to (1) further our understanding of individual breast cancer tumors
and (2) monitor and develop customized treatment plans, thus contributing to breast
tissue and breast cancer research.
The main goal of this project was to develop a three-dimensional (3D) breast
tissue in vitro test system using tissue-engineering concepts. The model is uniquely
different from existing models in that it accounted for extracellular matrix (ECM)
heterogeneity through use of an ECM hydrogel embedded with polylactide beads.
Furthermore, the 3D model was used to specifically investigate the effect of
heterogeneity of the mammary microenvironment on normal human mammary epithelial
cells (MCF10A) and human breast cancer cells (MCF7). Specifically, (1) polylactide
beads with various physicochemical features were produced and characterized, (2) an
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ECM hydrogel representing the stromal component was evaluated and selected, and (3) a
3D tissue engineered composite system with and without polylactide beads containing
either MCF10A or MCF7 cells was used to investigate the effects of microenvironment
heterogeneity. Development of a benchmark 3D breast tissue model, where cellular
interaction can be studied in an environment that is more representative of the native
tissue, helps researchers better understand cell reactions and behaviors in breast cancer.
This model allows the rapid assessment of therapies as well as controlled studies of basic
breast cancer processes and mechanisms. The outcome of this research was the
generation of a 3D in vitro breast tissue model that better mimics specific influences of
the ECM in breast tissue and breast cancer progression.
While the scientific merit of the proposed work was to advance the understanding
of breast tissue development and early breast cancer stages, the goal was to reach outside
the breast cancer community to share the work and progress. Further, the second
objective of this research was to reach out to young scientists and engineers through an
undergraduate introductory research program, highlighting interdisciplinary approaches
in scientific endeavors. This initiative broadened the intellectual merit of the project and
introduced ideas related to breast cancer research in other related fields of research,
thereby generating additional in-depth research opportunities and advancements in the
field of breast cancer research.
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PREFACE
Breast cancer is the most prevalent malignant disease of women in the developed
world, apart from skin cancer, with approximately 1 in 8 women in the United States
being diagnosed with breast cancer during their life times [1]. Breast cancer begins when
normal mammary epithelial cells grow, divide and form a cell mass, which then invades
surrounding tissue and eventually leads to metastasis. Much research using breast tissue
models has been conducted to understand how cells become cancerous in the mammary
gland, propagate, and eventually metastasize in the body. While this research has
provided a better understanding of the underlying mechanisms associated with normal
mammary gland function and breast cancer, our understanding of the extracellular matrix
(ECM)-cell interactions during normal breast tissue and malignant development remains
unclear. Model systems currently in use include clinical and in vivo models, twodimensional (2D) in vitro models, and three-dimensional (3D) in vitro culture models. In
recent years, 3D model systems have been developed for numerous normal tissues and
pathologic conditions. Ranging from the use of tissue tumor explants to cell lines in
homo or heterotypic cultures, 3D in vitro culture systems provide information on the role
of mesenchymal cells, the matrix composition, and density in the formation of acinusand duct-like structures. However, the need for reliable, versatile, and reproducible 3D in
vitro model systems that allow the modulation of the ECM properties remains. Therefore,
3D in vitro mammary culture may provide further understanding of breast tissue growth
and malignant development. Furthermore, standardization of such culture systems may
generate a reliable and reproducible model to test and monitor breast cancer treatments.

xi

To understand how this disease develops and how normal mammary epithelial cells
transform into cancerous cells, the development of a modular breast tissue model system
was used to study the cellular interactions and the mammary microenvironment.
This research focuses on the development of a new 3D heterogeneous in vitro
breast tissue model. The model was engineered as a complex tissue, with normal and
cancerous mammary epithelial cells embedded within a 3D matrix. Acinus- and duct-like
mammary structure formation within the 3D system was assessed to determine how ECM
heterogeneity affects structure formation. The matrix structure in vitro was controlled
using combinations of natural and synthetic biomaterial substrates to mimic the
heterogeneous stiffness of the normal mammary tissue. In these conditions, the behavior
of the normal and cancerous mammary epithelial cells in response to heterogeneity
changes was monitored. The ability to control the phenotypic changes of normal and
cancerous mammary epithelial cells provided a means for improved understanding of in
vivo conditions and the effect heterogeneity plays during breast formation. As the cellcell and cell-ECM interactions [2] play a large part in breast formation and mammary
tumor progression, developing a benchmark 3D breast cancer model to study these
interactions provides a new research tool to further our understanding of breast
development and mammary malignant growth. Such a model may also be relevant in
clinical diagnostic, therapeutic, and monitoring applications. This model is not meant to
replace existing models, but to radically enhance our understanding of the normal breast
and breast cancer microenvironment, thereby allowing development of more efficient
tools for diagnosing and treating breast cancer.
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The next chapters cover the research conducted, which includes two components:
development of a 3D in vitro breast tissue model and understanding how involvement of
undergraduate students in Science, Technology, Engineering, and Mathematics (STEM)
disciplines in research helps them develop a research identity. The overall research
objective is to establish a new 3D breast tissue model composed of polylactide (PL)
beads embedded in a hydrogel and to determine behavior of normal and cancerous
mammary epithelial cells in the presence of increased microenvironment heterogeneity.
Chapter 2 discusses polylactide bead fabrication and characterized. In Chapter 3, the
hydrogel matrix material, representative of the stromal component of the breast, for the
3D in vitro breast tissue model was determined. The stromal component was selected
based on cell viability and acinar-like structure formation. Portions of results in Chapter 3
were generated by an Institute for Biological Interfaces of Engineering interdisciplinary
team, including Clemson University undergraduate student Devleena Kole, and were
presented at the 2013 Annual Meeting and Exposition of the Society For Biomaterials:
McCave EJ, Kole D, Burg KJL: Development of a Heterogeneous In Vitro ThreeDimensional Breast Tissue Model. In: Society For Biomaterials 2014 Annual Meeting
& Exposition: 2014 (Denver, CO; 2014) [3]. The laboratory research concluded in
Chapter 4 where the composite 3D model system was generated and evaluated to
determine effects of heterogeneity on cells. Mechanical properties of the 3D breast tissue
model, composed of hydrogel matrix material alone or hydrogel containing PL beads,
were characterized. Further, normal human mammary epithelial (MCF10A) or human
breast cancer (MCF7) cells were added to the model system and changes in cell viability,
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proliferation, protein expression, and function determined. This 3D model will enhance
understanding of the role of mammary microenvironment in the function of normal
mammary epithelial cells and in early stages of mammary cancer progression.
The educational portion of this project, Chapter 5, focuses on research identity
development through participation in research programs. Minority undergraduate
students from Clemson University and the University of North Carolina Charlotte
participated in one semester of the National Science Foundation: Emerging Frontiers in
Research and Innovation (NSF:EFRI) – Research Experience and Mentoring (REM)
program. Students were introduced to research focused on developing different 3D
culture methods for normal and breast cancer research. The REM program was students’
first exposure to research and focuses on developing necessary skills for students to
succeed in future research within their own majors. Students were paired with a mentor
on the mentor’s project. Beyond the laboratory skills gained through the experience,
different professional development topics, such as “introduction to research”, “how to
conduct research”, “how to read scientific articles”, “how to produce a standard operating
procedure”, and “exploration of career paths”, were discussed with the students. A joint
10-week summer Research Experience for Undergraduates (REU) was offered to four of
the participating REM students and helped the students further develop their research
identity by building their research skills and providing them with the opportunity to
develop an independent research project. Results in Chapter 5 were generated by an
Institute for Biological Interfaces of Engineering interdisciplinary team and co-written
with Clemson University doctoral student Jordon Gilmore, and were presented at the
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2014 Northeastern Biomedical Engineering Conference McCave EJ, Gilmore JA, Burg
TC, Burg KJL: Evaluation of an Introductory Research Program for Minority
Student in an Interdisciplinary Tissue Engineering Lab. In: 40th Annual Northeast
Bioengienering Conference (NEBEC): 2014; Boston, MA: IEEE; 2014 [4] and the 2014
American Society for Engineering Education Annual Meeting and Exposition McCave
EJ, Gilmore JA, Burg KJL: Engineering and Science Student Preparedness for
Research: Exploring the Connections Between Student Identity and Readiness for
Research. In: 121st American Society for Engineering Education Annual Conference &
Exposition. Indianapolis, IN; 2014 [5].
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CHAPTER ONE
Portions of this chapter were published in the following review article: McCave EJ, Cass
CA, Burg KJ, Booth BW: The Normal Microenvironment Directs Mammary Gland
Development. J Mammary Gland Biol Neoplasia 2010, 15(3):291-299 [6].
LITERATURE REVIEW

Anatomy of the Human Breast
The human breast is a complex tissue composed of a glandular structure (the
mammary gland) located on top of the pectoral muscles of the chest [7], consisting of a
nipple, lobes, and ducts, surrounded by stromal tissue, fibrous and fatty tissue. The
mammary gland is a dynamic structural tissue that changes with stages in life, beginning
with the formation of the lobule bud structure during neonatal development, continuing
with the development of alveoli or acini during adolescent puberty, then full lobuloalveolar development with child birth, followed by involution at the end of lactation [8].
Each breast contains 15-20 lobes of glandular tissue [7, 9] that branch into smaller
lobules which are subdivided into the secretory alveoli for milk production (Figure 1.1).
Each lobule has an excretory ductal system that converges to form the lactiferous ducts
which exit through the nipple; just behind the nipple the lactiferous ducts widen to create
reservoirs called lactiferous sinuses [7]. The stroma, i.e. the fatty and connective tissue,
surrounds the lobes of the glandular tissue and is connected to the chest wall by Cooper’s
ligaments which help shape the breast [7]. Lymph nodes, responsible for draining the
lymph fluids from the breast, are present in five major areas surrounding the breasts, and
play an important role in fighting infection by removal of bacteria, other disease-causing
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organisms, and abnormal cells [9, 10]. The breast contains very little muscle and is
mainly composed of stroma, which defines the shape and size of the breast [7, 9, 11].

Figure 1.1 A schematic of the anatomy of the female breast. The glandular structure is
surrounded by fatty connective tissue. The enlargement demonstrates the lobule structure
and the normal excretory ductal structure [12].

Ductal Tissue and Structure
The glandular ducts consist of luminal epithelial cells associated with myoepithelial cells and surrounded by a basement membrane (BM) that connects the
glandular tissue to the stroma of the breast [13]. In early mammary gland formation in
utero, the mammary placodes formed in the ventral skin of the embryo through epithelialmesenchyme interactions [14] create the rudimentary ductal structure of the mammary
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gland. The functional unit of the gland, the acinar shaped ducts [15, 16], are lined with a
single layer of luminal epithelial cells which are associated with a layer of alveolar myoepithelial cells, which are stellate shaped and form a basket-like structure around the
acinus [17]. Although approximately 20% of the luminal epithelial cells do directly
contact the BM, the remainder are adjacent to myo-epithelial cells [18]. Polarity is a
fundamental property of epithelium, allowing the surfaces of the cells and tissues to
divide into apical and baso-lateral areas, where cell-cell contact and cell-extracellular
matrix (ECM) interactions determine the asymmetric architecture and polarity, resulting
in directionality of protein localization and appropriate function of the organ during
lactation [19].
During adolescent puberty, the distal ends of the rudimentary ducts enlarge to
form club shaped lobular structures, called terminal end buds (TEB), which contain
highly proliferative cells [14]. The TEB (Figure 1.2) have a basally located monolayer of
cap cells at their tip that move to the proximal part of the duct and differentiate into myoepithelial cells [17], which act similarly to smooth muscle cells and aid in contraction
during lactation [15, 20, 21]. Breast epithelial stem cells, found throughout the ductal
structures, are thought to be responsible for continuous cell renewal, growth, and
branching throughout the reproductive period, as well as the massive epithelial expansion
seen during pregnancy [21]. As the ductal tree forms, repeated dichotomous branching
proceeds, creating the tubes that deliver milk to the nipple, while lateral buds develop
along mature ducts and are constrained by the lack of open territory of the surrounding
stroma [22]. Clusters of lobular alveoli and the ducts that drain them form into units
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called lobules [15], which continue to develop with new budding of structures with each
ovulatory cycle [23].

Figure 1.2 Cross-section through end bud with accompanying diagram. End buds are
bilayered structures; an outer layer of myo-epithelial progenitor cells (cap cells) overlays a
multilayered mass of luminal cells fated to form the walls of the ductal lumen (L). Stained
with hematoxylin and eosin. Original magnification approx. ×300 [22].

The breast tissue attains its maximum development during pregnancy and is
characterized by proliferation of the ductal tree and further development of the existing
lobules as a result of increased cell number due to cell division and in cell size due to
cytoplasmic enlargement. The second half of pregnancy is characterized by progressive
branching with less bud formation and the formation of true secretory acini
(differentiated structures) [23]. Even with creation of the lobulo-alveolar structures
during gestation, the onset of milk secretion by the alveolar cells does not occur without
progressive biochemical and structural differentiation [15]; thus, not all lobulo-alveolar
structures produce the same amount of milk during lactation.

4

Stromal Tissue
The stroma, composed of the fibrous connective tissue and adipose (fatty) tissue,
comprises approximately 80% of the resting breast volume and is composed of
fibroblasts, epithelial cells, adipocytes (fat cells), blood vessels, inflammatory cells, nerve
cells, and a macromolecular network of proteoglycans and glycoproteins, such as
laminin, fibronectin, elastin and collagen [13, 24], which contribute to the extracellular
matrix (ECM) [11]. The stroma is composed of two types of ECM. The first is the
basement membrane (BM), which consists primarily of collagen IV, laminins,
entactin/nidogen, and heparan sulfate proteoglycans; the second is the interstitial matrix,
which consists primarily of collagen I and III and fibronectin, which contribute to the
mechanical strength of the tissue [25]. The stroma is thought to be critical in the
characteristic shaping of the branching structure of the mammary gland [8] through
localized activity of transforming growth factor beta (TGFβ). In the branching area of the
ductal structure, TGFβ is absent, hence its inhibitory effects on epithelial cell
proliferation and production of ECM-degrading enzymes do not occur, which allows the
basement membrane to undergo remodeling and promoting cell proliferation and
branching morphogenesis [24]. As the gland continues to develop, the area occupied by
the epithelium increases at the expense of the surrounding stromal tissue, which does not
necessarily mean the loss of stromal cell numbers, but rather a rearrangement of the
existing stromal cells and tissue elements [15]. The mature mammary fat pad consists
primarily of adipocytes coupled with developing epithelium that is encased in fibrous
connective tissue, resulting in the specialized interlobular and intralobular stroma of the
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mature gland [8]. The BM and stroma influence the apoptotic (programmed cell death)
behavior of the epithelial cells during involution and during menopause, by producing
enzymes that degrade and rearrange the BM of the mammary gland resulting in a prepregnancy-like glandular structure [8, 15, 23, 26].

Breast Development
The development of the breast correlates to changes in size, shape, and function
which are associated with the stages of infantile growth, puberty, pregnancy, lactation,
and menopause [23].
Newborn
Female children are born with small breasts consisting of a nipple and an
undeveloped system of ducts which exit at the nipple [9]. Mammary gland parenchyma
arises from a single epithelial ectodermal bud [26] where the mammary placodes, which
are surrounded by a primary mesenchyme, give rise to the mammary nipple and the
underlying ductal tree [8]. The placodes elongate, then sprout into the underlying stroma
of preadipocytes (composing the mammary fat pad) to form the rudimentary ductal
system [8, 14]. The breast of a newborn is composed of 6-10 straight ductal structures
opening into the nipple; the ducts open into primitive lobules in the mammary fat pad
[26]. The mammary fat pad and ductal structure continue to grow isometrically, keeping
pace with the growth of the child until puberty [20, 26].
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Puberty
With the onset of puberty, the mammary ductal development accelerates, showing
growth in both the glandular tissue as well as the surrounding stroma [26]. The
reproductive hormones which aid in the glandular ductal structure formation are estrogen,
which promotes the growth of the gland and ducts, and progesterone, which stimulates
the development of the milk-producing cells [7]. The glandular tissue increases with the
growth and division of the ductal system through the TEB [8, 14, 17], or alveolar buds,
which advance through and to the edge of the fat pad by use of cap cells, i.e. myoepithelial cell precursors, which have the ability to clear a “path” through the stromal
tissue in order for the ducts to advance forward, by channeling the internal force of
dividing cells in a forward direction [22]. The ducts dichotomously divide as they
progress through the fat pad, leaving a full ductal tree system that continues to develop
with each menstrual cycle, until about the 35th year of age [26].
Pregnancy
During pregnancy, the breast attains its maximum development through two
distinct phases: an early phase of growth, characterized by proliferation of the distal
elements of the ductal tree that results in formation of new branches and new ductules,
and a late phase of lobular differentiation, which occurs in the last half of the pregnancy
where the lobules formed enlarge and increase in number in preparation of lactation [26].
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Lactation
Lactation starts after post-partum withdrawal of placental lactogen and sex
steroids, which appear to prevent the action of prolactin on the mammary epithelium
[26]. Prolactin, released from the anterior pituitary, stimulates milk production while
oxytocin, released from the posterior pituitary in response to suckling, causes milk
ejection from the lactating breast [7]. During lactation, no morphological changes occur
to the mammary gland, which consists of enlarged lobules and acini with dilated lumina
[26]. The varied size of the lobules throughout the gland suggests varied activity
throughout [26]. Milk is synthesized and stored in the lactiferous reservoirs until it is
needed, although if it is stored for longer than 48 hours, milk production and secretion
begins to decline [26]. Cessation of lactation following weaning is accompanied by
massive apoptosis and tissue remodeling, and the gland reverts to a structure resembling
that before pregnancy [15, 20].
Menopause
When a woman reaches menopause, usually in her 50’s, breasts undergo changes
related to the loss of the reproductive hormones, estrogen and progesterone, causing the
firm breast tissue to shrink and the amount of fat (adipose) tissue to increase [9]. The
breasts usually become larger and the connective tissue begins to lose strength, causing
the breasts to sag [10]. At this stage, it is easier for radiologists to detect breast cancer
because abnormalities are not hidden in dense breast tissue [10].
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Breast Cancer
Breast cancer is the second most prevalent malignant disease of women in the
developed world with approximately 1 in 8 women in the United States being diagnosed
with breast cancer at some point in their lives [1]. The National Cancer Institute
estimated in 2010 based on NCI’s SEER Cancer Statistics Review that 207,090 females
and 1,970 males in the United States would be newly diagnosed with breast cancer in
2010, while 39,840 and 390 deaths would occur in 2010 [27]. The development of the
breast and understanding of ductal growth is necessary because 90% or more of
mammary cancers are ductal in origin [22]. Breast tumors are caused by both genetic
alterations of the normal mammary epithelial cells and epigenetic factors, such as
interactions with the stromal tissue microenvironment, which play into the initiation,
progression, and metastasis of the disease [28-31].
All normal cells incur many continuous mutations over their lifetime (normal rate
of mutations); almost all of these mutations will have no functional effect on the cell;
however, tumor (cancer) cells are usually formed when “two hits” occur somatically in
the same gene [32]. Cancer stem cells have been identified, from a subset of cancer cells,
as key components in solid tumor growth as these cells are self-renewing cells
responsible for maintaining cancer growth and producing differentiated progeny that
form the bulk of the tumor [33]. However, the search for specific genetic causes of breast
cancer has elucidated important clues to how cells regulate and turn off specific genes to
promote proliferation, apoptosis, differentiation, adhesion, and maintain genomic
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stability, which are relevant to the initiation, progression, and potential metastasis of
tumors [34].
The stromal tissue microenvironment, a source of epigenetic factors, is
instrumental in tumor initiation and progression [25, 28, 30, 31, 35-37]. Changes in the
microenvironment, such as ECM remodeling, angiogenesis, lymphatic infiltration, and an
increase in the number of fibroblasts and myo-fibroblasts have been shown to influence
tumor progression [28], while cellular signaling proteins such as cytokines, growth
factors, and proteases secreted from the various cell types in the stroma affect tumor
invasion and later metastasis of breast cancer primary tumors [35]. Cellular behaviors are
regulated by complex molecular interactions that involve both positive and negative
feedback loops, as well as high levels of cellular cross-talk [30].
The breast changes with age and reproductive history; these changes are reflected
at the phenotypic level and at the genomic level [23]. This dynamic state provides a need
to further study the complexity of breast tissue and the cellular interactions that occur
during development as well as cancer initiation and progression and use this knowledge
to develop strategies for cancer prevention and cure.

Cell, Tissue, and Organ Culture
Cell and tissue culture began back in the 19th century with the works of Ringer
and Roux [38], while in 1907 Ross Harrison began by culturing frog neurons using the
“hanging-drop” method [38, 39]. In 1912, Alexis Carrel took a small fragment from the
heart of an 18-day-old chick embryo and explanted it on hypotonic plasma; passaging the
tissue 18 times over a period of 3 months and observing that it not only remained viable,
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but also continued its rhythmic beat [40]. In the 1950’s animal cell culture became
routine in the laboratory and lead to the development of the first human cell line, HeLa,
developed from a cancer patient [38, 41]. These early research endeavors have lead to the
cell and tissue culture techniques that remain a laboratory staple in biomedical and
biological research today.
Types of Culture
Tissue culture is a commonly used generic term for the in vitro cultivation of
cells, generally consisting of heterogeneous cultures of crudely disaggregated tissues;
terms such as organ culture, cell culture, primary explants, and ex vivo propagation all
concern the in vitro cultivation of cells or tissues [38]. Cell culture, on the other hand,
usually refers to the isolation and propagation of a homogeneous or heterogeneous
population of cells (e.g., epithelial cells, fibroblasts, etc.) that originate from either
primary cells, which have a finite lifespan, or cell lines, immortalized cells which are
normally derived from transformed or cancerous cells [38]. Primary cells are widely used
to examine the effects of toxins, infectious agents, and other cellular interactions that
would not otherwise be feasible in vivo [38]. Cell lines are often used to investigate
questions in biomedical research because of their immortality and because they are well
studied and characterized; however, they generally do not have the phenotypic
characteristics of the cell from which they originated [38]. Early cell lines were
established from tumor tissue and, as such, possess abnormal growth characteristics [38].
Organ culture involves ex vivo culture of the whole organ or a significant portion
of the organ which allows the retention and preservation of the original cell-cell
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interactions and three-dimensional (3D) extracellular architecture [38]. Organ culture is
important when an ex vivo system requires the original organ architecture; however,
organ cultures do not normally grow rapidly and are not suitable for studies where large
numbers of cells are required [38]. While tissue or organ culture have been used
previously to investigate cellular interactions and determine developmental biology
processes, two-dimensional cell culture is the prominent laboratory technique used, due
to the ease of cell propagation on tissue plastic surfaces, ability to produce large
populations of single cell cultures, and the ability to manipulate the microenvironment for
research purposes.

Cell Culture Materials
Three-dimensional cell culture matrices, also known as scaffolds, were introduced
to cell culture to overcome the 2D culture limitations [42]. These scaffolds are porous
substrates that can support cell growth, organization, and differentiation on or within their
structure [42] and are composed of either naturally derived materials (e.g., collagen type
I, rBM) or synthetic materials (e.g., polylactide). Such materials should provide a 3D
support to interact with cells to control their function, guiding the spatially and
temporally complex multicellular process of tissue formation and regeneration [43]. In
designing scaffolds, mimicking the natural ECM, an intricate interwoven fiber meshwork
of collagen and elastic fibers embedded in a highly hydrated gel-like material of
glycosaminoglycans, proteoglycans, and glycoproteins [42], is attractive, but other
chemical, physical, and mechanical properties of the scaffold material influence cellular
affinity and interactions. While all these properties must be taken into consideration,
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scaffold fabrication remains highly challenging as the natural in vivo remodeling process
that is part of the tissue formation process does not take place in vitro [44].
Natural Materials
There are many naturally derived materials that have been and are currently being
used in epithelial and breast cancer model systems. Some of the common materials used
are collagen (most often type I, III, and IV), rBM (e.g. Matrigel™), and decellularized
mammary gland ECM (MGEM). Emerman and colleagues used floating collagen
membranes as a substrate for culturing mammary epithelial cells in order to evaluate the
effects of substrate-induced cell shape on differentiation [45, 46]. Most of these materials
are naturally found in the ECM and are derived from animal ECM. While these materials
are natural, provide the necessary structure and properties for cells, and direct the
macroscopic process of tissue formation, they are not always preferred for tissue
engineering applications and 3D model systems due to their quick remodeling,
stimulation of inflammatory response, and high cost.
Synthetic Materials
Many different synthetic materials have been used as substrates for tissue
engineering applications and 3D models. Presently, materials such as poly(lactide-coglycolide) (PLG) [47, 48] as sintered microspheres [49, 50] and porous scaffolds [51, 52],
hyaluronic acid-based (HA) spongy scaffolds [53-56], gelatin sponges [57], polyethylene
terephthalate (PET) nonwoven fabrics [58], poly(ester amide) (PEA) nonwoven scaffolds
[59], poly(ethylene glycol) diacrylate hydrogels [60], collagen-chitosan hydrogels [61]
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and many other materials have been used as tissue engineering scaffolds. Each scaffold is
chosen based on certain criteria: rigid enough to structurally support the tissue, but not so
stiff that it causes differences in appearance, and biodegrades at a rate consistent with
tissue growth and proliferation.

Types of Culture Models
Numerous model systems have been developed in order to evaluate normal
mammary epithelial tissue formation and function as well as tumor formation and
progression. Normal human mammary epithelial cells have been cultured in order to
compare their behavior with that of breast cancer cells, to investigate molecular
mechanisms underlying any determined differences, and also to examine the effect of
manipulating the microenvironment on cellular behavior [62]. Currently, animal or
human in vitro models, in vitro cell culture systems, and animal genetic knockout mice
are used to investigate many different in vivo tissue processes [63].
2D vs. 3D
Two-dimensional models were first developed, but do not represent the threedimensional nature of tissues and organs; however, our ability to understand tissue
formation, function, and pathology has often depended on 2D monolayer culture, organ
culture, or animal model systems [64, 65]. Monolayer culture is normally performed on
2D surfaces such as micro-well plates, tissue culture flasks, Petri dishes, or glass slides
[42] and has been used to evaluate cell morphology, growth, differentiation, gene
expression, and toxicity [45, 46, 66-69].
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Even though monolayer culture has provided substantial understanding of normal
cell morphology and phenotypic expression and allowed evaluation of therapeutic cancer
drugs [70-72], there are limitations. Cells dissociated from their normal tissues and
maintained on tissue culture plastic or glass substrates rapidly lose their normal and
differentiated characteristics despite the presence of nutrients from medium and essential
hormones [45]. Another major limitation of 2D monolayer culture is the lack of stroma,
which is important when modeling breast cancer since stroma of the mammary gland
accounts for more than 80% of the resting breast volume [2]. The ECM and its
components are pivotal in determining cell phenotype and function, especially in the
mammary gland [73].
Three-dimensional cultures provide a well-defined geometry, which makes it
possible to directly relate structure to function, they can be composed of representative
cell combinations (for example, proliferating, non-proliferating, and necrotic cells), and
they can support co-cultivation of multiple cell types in order to study the interaction
between cell types and their surrounding matrix [2]. Overall, 3D models have emerged as
powerful tools to investigate fundamental cellular and biophysical mechanisms that have
not been readily amenable to traditional genetic or biochemical analysis [74].
Animal Models
A number of different approaches have been taken to model early breast cancer
progression though the use of murine models. Research methods include the induction of
premalignant lesions, the generation of genetically engineered mice that are susceptible to
neoplasia or preneoplasia, or the use of epithelial cells that have been spontaneously
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transformed, transduced with oncogenic viruses, or transfected with activated oncogenes
to derive altered cells that mimic premalignant lesions when tested in immune deficient
mice [75]. Smith and colleagues have used murine models to investigate DNA division in
label-retaining epithelial cells in the mouse mammary gland through transgenic
mammary implants [76-78]. Animal models frequently provide definitive tests of the
importance of specific molecules and processes; however, there can be discrepancies
between conclusions due to the distinct differences between human and animal tissues
and the chemicals that could interfere with the function of specific proteins [64].
Although animal models are able to provide us with relevant biological interactions and
help in the understanding of developmental biology, they are costly and complex with
problems of unpredictable characteristics and ethical approval, thus other physiological
3D model systems are more desirable [65].
Normal Mammary Epithelial and Tumor Models
Normal human and murine mammary epithelial cell culture models have been
established in order to uncover the key components of initiation and maintenance of cell
differentiation, which include both the cell and the surrounding microenvironment [69].
While these models have investigated the correlation between cell shape and growth and
differentiation [45, 46, 66], the role the ECM plays to influence cell phenotype [67, 69,
79, 80], and the epithelial-stromal interactions [13, 25, 81], natural materials (e.g.
collagen, rBM) are used in these culture models to maintain a morphology reminiscent of
the in vivo conditions [69]. The natural materials used in these culture conditions provide
the necessary structure to form polarized luminal ductal and acinar structures, but are
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limited by the components present in the model system; thus, interpretations of data from
these systems need to be weighed against the limitations of the particular system [74].
Cancer models have significantly enhanced our understanding of carcinoma
biology in four areas: the formation and maintenance of a hollow glandular lumen and its
disruption by cancer genes, the regulation of apicobasal polarity in normal and cancerous
epithelium, the discovery that cell-cell and cell-matrix adhesion pathways can interfere
with the phenotypic expression of the tumorigenic state, and the emerging importance for
tensional force in driving 3D tissue architecture and homeostasis [74]. While these four
areas are of great importance in understanding tumor formation and cancer progression,
others have used 3D models to evaluate the cytotoxicity and toxicology of cancer drugs
[82-84].
Overall, current 2D and 3D models have allowed insight into the development
and function of normal mammary epithelial tissue, tumor formation and cancer
progression, as well as evaluation of effective therapeutic agents in cancer treatment;
however, there are limitations as to what cellular and matrix components are used, what
these models can accomplish, and how well they represent the true in vivo breast
conditions.
Adipose Tissue Models
Engineered adipose tissue, composed of the patient’s own cells, a suitable
scaffold, and appropriate growth factors, was initially developed for use in breast and soft
tissue reconstruction after tumor resection [85-87]. Preadipocytes and mesenchymal stem
cells have been seeded on PLG scaffolds [47, 48, 51, 52], various hydrogel materials [61,
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87], and porous polymers [56-58, 88] in order to produce a defined volume of adipose
tissue for implantation into a defect site. While these tissue engineering strategies have
been used for reconstruction, they are inherently useful in breast tissue model systems as
the breast, in its entirety, is composed of the epithelial parenchyma surrounded by
intrastitial and interstitial ECM, all embedded in the mammary fat pad. Numerous
natural, synthetic, and hybrid materials have been used to act as adipose surrogates; they
have predominantly been used to replace adipose volume and not function [85]. To date,
epithelial culture systems have been used to recreate the cardinal features of glandular
epithelium in vivo and represent a valuable tool for modeling breast cancer initiation and
progression in a structurally appropriate context [74], but have not been used to
determine how adipose tissue influences mammary gland structure and development.
Improvement upon the current model systems is needed for translational results and
further understanding.

Tissue Test Systems
A three-dimensional model system that is used in applications where a whole
tissue is represented can also be referred to as a tissue test system. Tissue test systems are
developed to represent the in vivo conditions, provide a tunable system to investigate
certain aspects of the environment, and also allow precise data collection. In any 3D
model system, the specific cellular and matrix microenvironment provided to the cells
can substantially influence the experimental outcome [64]; thus, the model/tissue test
system should be designed to provide the necessary cellular and micro-environmental
components to best represent the natural in vivo conditions of the breast. Selection of the
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cell type(s), scaffold material or components, and micro-environmental cues, such as
hormones, growth factors, etc., all play a considerable role in the development of the
overall tissue test system. Current 3D model systems have limitations as to how they
perform and the data that can be obtained, therefore development of a tunable system
would be helpful to understand all aspects of the tissue and its function in vivo.

Normal Breast Tissue and Breast Cancer Models
Studying normal breast tissue biology, architecture, and development to
understand how human breast cells grow, interact, and undergo programmed cell death
began with 2D culture of cells [45, 46, 66-68, 89, 90] coupled with the development of
cell lines to be used for research purposes. Two-dimensional models have allowed a
better understanding of the effect of the surrounding environment on cell growth [66, 67],
proliferation, interaction [90], differentiation [45, 46, 67], and apoptosis. Further
investigation of human breast development, the pathological progression of breast cancer,
and therapeutic drug evaluation continued to be answered through use of 2D models such
as the NCI60 cell line assay [41, 70, 71]. Although these models were able to identify key
biological development processes and interactions of mammary epithelial cells, the 2D
models do not represent the complete in vivo conditions of the normal and cancerous
breast. The mammary gland is a complex tissue; thus, in order to evaluate the complex
phenotypic alterations of the mammary epithelial cells and the surrounding
microenvironment [91], 3D models have been developed. The advent of 3D cell culture
models has allowed investigators to make significant progress toward characterizing the
factors involved in the establishment and maintenance of epithelial architecture.
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The function of an organ relies upon the organ’s constituent cell types and overall
organization; i.e., the structure of a tissue or organ is critical for its function [92]. In
developing 3D models and tissue test systems, achieving and maintaining the remarkable
level of tissue organization, mammary epithelial cells (MECs) and their surrounding
ECM components must integrate their structure in a highly concentrated fashion [93].
Tissue engineering, i.e. the construction of tissues using cells and biomaterial “scaffolds”
or “matrices” as foundational building blocks, has been of interest for many years for
mammary reconstruction following mastectomy or lumpectomy, and has been
investigated more recently for use in building 3D mammary tissue models [6]. Many
different natural and synthetic materials, cell types (primary cells or cell lines), and
microenvironments have been used in order to engineer normal breast tissue and breast
tumor tissue. Many of the tailored models that have been use to investigate normal and
malignant breast tissues are outlined further in order to describe the specific niches
researchers have thoroughly explored in order to fully understand the biological
principles of the mammary gland tissue and the breast environment.
Ductal Structure Formation, Terminal End Bud Motility, and Epithelial Cell Polarity
Ductal structure formation, terminal end bud motility, and epithelial cell polarity
are all dependent on the microenvironment and interactions of the epithelial cells with
each other and the basement membrane. A great deal of breast biology and breast cancer
research on ductal structure formation has included mammary epithelial cells or breast
cancer cells embedded in natural materials such as collagen Type I, reconstituted
basement membrane products (rBM, e.g. Matrigel™), or a combination of the two, to
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represent the naturally-occurring ECM of the breast [79-81, 94]. Dhimolea and
colleagues found that flexible Type I collagen matrices supported polarized acini and
branching ducts when human breast epithelial (MCF10A) cells and human mammary
fibroblasts obtained from reduction mammoplasties (RMF) cells were suspended in the
gels in co-culture [79]. Krause and colleagues co-cultured MCF10A and RMF cells
embedded in a Type I collagen gel, which resulted in the development of branched ducts,
but when rBM was added to the collagen in a 1:1 ratio, branching ducts and alveoli were
produced [81]. Dréau and coworkers found that the behavior of 3D cultures of normal
murine mammary gland (NMuMG) cells, cultured either alone or in combination with
mouse mesenchymal stem cells (D1), were dependent on the “matrix” or surrounding
biomaterial environment consisting of agarose, collagen, or Matrigel™ alone or in
combination [95]. The number of acinar structures was significantly higher in cultures
grown in combination matrices of agarose with Matrigel™ or collagen I when compared
to cultures grown in Matrigel™ or collagen I alone. No tubular structures were formed
when agarose was included in the matrix, regardless of the combination. These works
highlight the process of ductal formation, demonstrating how epithelial cells react in
different gel environments, highlighting the fact that the surrounding microenvironment
plays a particular role in normal ductal formation and overall regulation of ductal
branching and lobular formation in the breast. The downfall of these studies is that the
researchers do not include all the components found in the normal and cancerous breast
environments. If researchers are to investigate the development of the normal breast, they
would need to include adipose tissue components which also influence the developing
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ductal tree. Without the adipose and stromal cell components and their signaling factors
and influence within the model system, the results from these tissue models do not fully
represent the native tissue. Model systems are just beginning to use all of these
components in one system, Wang and colleagues cultured human breast epithelial cells in
a tri-culture with stromal and adipose cells in a silk scaffold in which the cells displayed
more differentiated morphological phenotype and functional activity compared to monoor co-culture of the cells. [96] This study in fact demonstrates how current model systems
are deficient and what they should strive for in the future.
The TEB, at the tip of the ductal structure in the normal breast, initiates invasion
into the surrounding fat pad of the breast [97]. Proliferation of TEB cells results in ductal
elongation, while clefting results in bifurcation or branching of the ducts [97]. Ductal
formation and TEB motility is guided by changes in the surrounding ECM components,
specifically the fat pad and fibroblasts surrounding the epithelial cells [13]. The TEBs
include a cell population with high rates of mitosis which are known to include endocrine
and local growth-regulatory signals, stromal-epithelial interactions, ECM remodeling,
and dynamic adhesions within the end buds that maintain the bilayer structure [22]. As
TEBs advance through into the fat pad, remodeling of the surrounding ECM is necessary
for the ductal structure to advance, branch, and expand. Remodeling of the ECM usually
occurs through systematic crosstalk between the adipose cells, fibroblasts, and cap cells
of the TEB and includes signaling proteins such as BMP, Wnt, and EGF [97].
Metalloproteinases (MMPs) the principal matrix-degrading enzymes, are regulated by
tissue inhibitors of metalloproteinase (TIMPs) [13].
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Luminal epithelial cells are polarized glandular cells with specialized apical and
basolateral membrane domains [98]. The permanent loss of polarity in tumors disrupts
tissue structure, compromises the segregation of signaling effectors, and exacerbates the
increased cell proliferation that is induced by other oncogenic signals [19]. In normal
breast development, luminal epithelial cells orient themselves through cues from myoepithelial cells and the surrounding BM, although the exact signaling mechanisms are not
fully understood. Experiments have focused on polarity through the formation of the
mammary ductal structure and also how a lack of polarity and BM deposition is
characteristic of tumor cells [98]. Gudjonsson and colleagues used breast luminal
epithelial and myo-epithelial cells derived from reduction mammoplasty biopsies and
residual tissue from breast carcinoma mastectomy specimens to investigate the
differences in normal and myo-epithelial cells and their interactions with luminal
epithelial cells to recapitulate polarity [21]. Double-layered breast acini formed when
normal luminal and myo-epithelial cells were cultured together, but when normal luminal
and cancerous myo-epithelial cells were cultured together only some acini formed, due to
a lack of laminin-1 production from the cancerous myo-epithelial cells, demonstrating the
importance of laminin-1 production and the role of the myo-epithelial cells in
maintenance of polarity in normal breast and how myo-epithelial cells may function as
structural tumor suppressors [21]. In contrast, Liu and colleagues investigated the
potential connection of cellular proliferation and polarity to tumor expansion and
invasion; these researchers demonstrated that although cell proliferation and polarity
defects are separable states, both are required for the development of a malignant
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phenotype [19]. These studies highlight the importance of polarity in the normal breast as
well as in tumor initiation, progression, and metastasis. The models used here to
investigate polarity and the influence it has in the cancerous breast are lacking the cellular
and structural components that would be seen in the cancerous environment. Polarity
models should not only include the normal and cancerous epithelial cells, but fibroblasts,
macrophages, inflammatory cells, and endothelial cells. The tumor microenvironment is a
heterogeneous environment that is most notably characterized by an increase in fibroblast
and

myo-fibroblast

activity,

increased

angiogenesis,

increased

infiltration

of

inflammatory cells and remodeling of the extracellular matrix adjacent to the cancerous
cell. [28] Without the influence and inclusion of these cell types and structural
components within the current models, we will not be able to completely understand how
polarity affects tumor initiation, progression, and metastasis.
Overall, understanding the developmental biology of ductal structure formation,
terminal end bud motility, and polarity within the normal breast environment is crucial to
advancing technology for breast cancer detection, prevention, and cures.
Hormones, growth factors and signaling molecules
The development of the mammary ductal structures involves a complex interplay
between epithelium and mesenchyme; the branching of the mammary ducts is dependent
on circulating hormones for stimulation and synchronization with reproductive events,
but is also influenced by local factors to provide signals that influence glandular growth,
differentiation, and morphogenesis [99]. Extracellular signals are transmitted across the
cell membrane via the transmembrane receptors which recognize ECM molecules;
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changes in these receptors, triggered by ligand binding, in turn cause rearrangement of
the cytoskeletal network and intracellular cascade of signal transduction, leading to
changes in gene expression, and therefore the growth and differentiation state of the cells
[69].
During normal breast development, estrogen and progesterone are required for
proliferation and morphogenesis of the normal mammary gland; estrogen drives ductal
development during puberty, whereas estrogen plus progesterone mediate the
proliferative and morphological changes of ductal side-branching and alveologenesis that
occur at sexual maturity and during pregnancy [100]. Both epithelial and stromal cells
express the estrogen receptor (ER)-α [92], which is a crucial regulator of branching in the
virgin gland [101]. The hormone progesterone, in combination with the prolactin receptor
(PRL), promotes differentiation of the alveoli, which are the structures that synthesize
and secrete milk during lactation during pregnancy [101]. In vivo studies by Smith and
coworkers examined two populations of slowly dividing (label-retaining) cells, ER-αpositive and progesterone receptor (PR)-positive, which were equally represented among
the body cells of the TEBs and within the epithelial of the subtending ducts of the FVB/N
mice [77]. In the normal mammary glands of both mice and women, ER-α-positive cells
are not normally proliferative, but this association is lost in breast cancer [100, 101], thus
providing a breast cancer indicator for which one can test. Additionally, prolactin was
examined by Gill and colleagues using immunohistological processes to compare normal,
benign, and malignant breast tissues, where PRL was expressed at different sites within
normal, benign, and malignant breast epithelial cells, expressed in over two thirds of the
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breast carcinomas, and was correlated with strong staining for ER-α-positive but not
other prognostic factors [102]. These studies have all looked at the influence of hormones
within the glandular structure; however, most of these studies are conducted in animal
models or through histological evaluation of biopsied tissue. Animal models, while
useful, are not the best representation for extrapolation to human condition. Rodents
typically possess very little subcutaneous adipose tissue [51] and the mammary glands
are not structurally the same; in many rodents and other mammals the glands are
relatively thin and flat. [15] In summary, to advance the understanding of hormonal
influence and interactions within the normal and cancerous breast environments, use of
animal models that are better representative of the human condition and development of
in vitro models is crucial.
While estrogen and progesterone and their receptors are necessary in normal
mammary gland development, there are growth factors that are also important.
Hepatocyte growth factor (HGF) is a mesenchyme-derived growth factor that is
synthesized in the stroma in vivo and stimulates the proliferation, motility, and
morphogenesis of nearby epithelium [103]. Haslam and colleagues investigated cell
proliferation of luminal and myo-epithelial cells of the mammary gland in organoid
culture; cell proliferation did not increase with progestin (R5020) or 17β-estradiol (E2)
alone or R5020+E2, but did increase when HGF was added to E2 and further increased in
combination with R5020 forming tubules off the organoids [103]. There is also evidence
of bidirectional crosstalk between epidermal growth factor receptor (EGFR) and β1integrin in human mammary tumor cultures [65]. Wang and colleagues cultured human
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mammary epithelial cells (HMT-3522) and human mammary tumor cells (T4-2) in 3D
rBM in order to evaluate the bidirectional cross-modulation of β1-integrin and EGFR
signaling, which does not occur in 2D culture [94]. The group found that regulation of
EGFR (as well as β1-integrin) is linked to tissue morphogenesis, that EGFR and β1integrin pathways are coupled, and that as long as the pathways are not altered or deleted,
aberrant behavior can be corrected, thus restoring normal function to tumor cells in a 3D
BM. These studies demonstrate the importance that growth hormones and their receptors
play in the overall development of the normal mammary gland as well as tumor initiation
and progression.
Some of the most researched signaling molecules in the breast are the
transforming growth factor β (TGFβ) family, composed of three isoforms (1, 2, and 3),
which have been identified as multifunctional cytokines with pivotal roles in several
cellular functions including cell growth, differentiation, extracellular matrix production
and degradation, motility, and regulation of the immune system [24, 104]. Osin and
colleagues used histological staining to determine where TGFβ was found in fetal and
infant breasts; they found that TGFβ was localized to the ECM, suggesting that TGFβ
plays an important role in inhibiting epithelial proliferation at specific sites and thereby
influencing morphogenesis [105]. TGFβ inhibits branching morphogenesis during
puberty, blocks formation of alveoli and secretion of milk during pregnancy, and
promotes apoptosis during involution [92]. Beyond TGFβ and its effects in normal and
stromal microenvironments, there are many other growth factors, signaling molecules and
hormones that influence normal breast development and tumor formation.
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While these studies are great beginning points and have given us insight into the
crosstalk and signaling that occurs in the normal and tumor microenvironment, there is
still much technical insight to be gained. Further development is needed for model
systems to include the stromal components, i.e. fibroblasts, adipocytes, and other cell
types found within the microenvironment being studied in order for researchers to better
understand the underlying mechanisms influenced by hormones, growth factors, and
other signaling proteins.
Stroma
The stroma is composed of multiple cell types that co-exist within the ECM
network, where the cellular components evolve with the developmental stages of the
mammary gland [13, 24]. Therefore, it is expected that the variations seen in epithelialstromal interactions and ratios that occur during the different stages of breast
development will influence the components of cellular microenvironment (growth
factors, hormones, and ECM) and, in turn, influence gene expression that may account
for the susceptibility or risk to develop breast cancer [99, 106]. While research has
focused on epithelial-stroma interactions and how they influence the proliferation, the
differentiation, and, at times, the quiescence of the epithelial cells and their progenitors,
there is still information about the cellular interactions and their influence on cellular
behavior in the normal breast and breast cancer environment that is unknown.
In vitro model systems have been developed, through the use of tissue
engineering methods [107], in order to better understand the development and structure
of the gland parenchyma and how the stroma influences development as well as
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influences breast cancer initiation and progression. While normal formation of the
mammary gland depends on the coordination of physical and biochemical signals from
the normal microenvironment (defined by neighboring cells, surrounding ECM, and local
soluble factors) [93], tumor initiation and progression are marked by an imbalance in the
microenvironment. In normal mammary tissue, where multiple cell types co-exist,
homeostasis and involution are driven by programmed cell death (PCD, or apoptosis
regulation) through cell-cell and cell-ECM adhesion as well as the 3D tissue architecture
[108].
Stromal interactions
Normal growth, function, and homeostasis of breast epithelial cells depend on
intricate interactions between the numerous surrounding stromal cells within the
mammary gland [109]. These cells secrete multiple cellular products, such as growth
factors and ECM components, which influence normal epithelial cell behavior, while
alterations in regular communication between these cells, i.e. an abnormal stromal
environment, can lead to the progression or expansion of malignant growth [73, 109].
Within the stroma, fibroblasts and the molecular signals they produce seem to
play a critical role in normal and malignant epithelial cell behavior. Fleming and
colleagues demonstrated that fibroblasts in the surrounding intralobular and interlobular
do not show genetic differences, but they do influence the progression of malignant
growth [109]; therefore, these researchers suggested that co-culturing fibroblasts with
cancer cells would be necessary to examine tumor progression and metastasis. Recently,
Rodrigues-Lisoni and colleagues co-cultured Hep2 cancerous cells with fibroblasts in
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order to determine how cancer-stromal interactions influenced gene expression and found
that the molecular crosstalk between neoplastic and the surrounding tissue induced
several stromal changes, including neoangiogenesis and immune/inflammatory reaction,
as well as new ECM formation and the activation of fibroblast-like cells (i.e.
desmoplasia) [110]. Although fibroblasts seem to be important to stromal interactions
with mammary epithelial cells, ECM components also regulate epithelial cell behavior.
Cell adhesion plays an important role in a variety of basic biological processes,
including guiding cells into their appropriate locations in the body, providing cell
anchorage, and controlling cell proliferation, differentiation, and apoptosis [111]. The
identification of cellular transmembrane receptors for specific sequences present on ECM
molecules established that ECM molecules affect cellular behavior. These molecules
include integrins, cell-surface proteoglycans, and other receptors [24]. Integrins are a
family of heterodimeric transmembrane proteins composed of α and β subunits that
contribute to the ligand specificity and contain potential binding sites for ligands [111].
These ligands specifically bind to protein sequences, for example, the RGD sequence
found in many of the ECM components [24, 111], and regulate cell behavior through
signaling pathways. There is also evidence that in mammary epithelial cell cultures, ECM
must suppress growth before signals for differentiation can be received [24]. Bissell and
colleagues have conducted many studies to determine how these ligands and cell
adhesion receptors influence the luminal epithelial cell polarity and ductal formation and
development [80, 94, 98].
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ECM Architecture, Stiffness, and Mechanical Forces
The stroma and cellular architecture, stromal components, ECM stiffness, and
mechanical forces regulate the formation and branching of the mammary gland
parenchyma. Each of these influences epithelial and stromal cell phenotypes, thus
impacting the development, regulation, and function of the mammary gland and
surrounding stroma as well as tumor formation and metastasis.
The ECM architecture and epithelial cytoskeletal architecture are imperative in
normal cellular function, while loss of ECM architecture is inherent in involution of the
mammary gland and impacts cell migration. All cells contain a cytoskeleton which is
important

in

orchestrating

cellular

events

such

as

cell

motility,

protein

trafficking/secretion, and mitosis [112]; this cytoskeleton is composed of actin
microfilaments, microtubules, and intermediate filaments (IFs; see Figure 1.3), which
determine the mechanical properties of adherent cells [113]. Researchers have
investigated how the intermediate filaments, specifically vimentin in fibroblasts,
influence cell stiffness and migration [112-115]. While cellular stiffness and cell-cell
junctions (e.g. E-cadherin in adherens junctions, see Figure 1.3 [97]) increase the
stiffness of a given tissue, the ECM architecture of the BM and the supporting connective
tissue has been determined to influence cellular behavior as well. The ECM BM is
integral to the polarity of luminal epithelial cells [18] and maintaining tissue function of
the mammary gland [108], while collagen stiffness regulates cellular contraction, matrix
remodeling, and cellular migration [116, 117].
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Figure 1.3 Scheme of dynamic reciprocity between cells and their microenvironment. Cellcell and cell-ECM interactions cause a cascade of biochemical and mechanical signaling to
the nucleus, which in turn affects the cellular micro-architecture and gene expression
(adapted from [92] and [118]).
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Stiffness of the mammary gland parenchyma and surrounding stroma plays an
integral role in cell migration and gene expression. Hadjipanayi and colleagues
investigated the migration of cells over a collagen matrix with a graded directional
stiffness, where it was determined that cells migrate to stiffer surfaces and that the speed
of migration increases on softer matrices [116]. Karamichos and colleagues used collagen
matrix stiffness to assess the gene expression of matrix metalloproteinases (MMPs),
which are produced in order to degrade ECM proteins for cell migration, and found that
with an increase in stiffness there was an increase in MMP-2 production [117]. Research
conducted by Hadjipanayi and Karamichos involves the use of dermal fibroblasts in
collagen matrices and while it does not directly include breast cells, it is useful in
understanding how cells migrate. Improvements in these methods might include starting
with the replacement of dermal fibroblasts with epithelial cells and stromal cells within
the collagen matrix, but then progressing to use of a system that incorporates the entire
cancerous environment to better understand not only how tumors attract different cells,
but also how metastatic cancer cells migrate to other tissues. Research of normal and
tumor tissue requires the development of 3D models that reflect the tissue stiffness and
components in order to best represent the native tissue. Samani and colleagues have used
mechanical testing of normal breast tissue and breast tumor tissues in order to determine
the stiffnesses necessary for development of future 3D models [119]. While these
researchers have made progress toward understanding the processes involved in cell
migration and how matrix stiffness influences normal cells and tumor cells, there is still
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more to investigate and understand with the use of 3D model systems that can be tailored
to a specific research question.
When modeling epithelial-stromal interactions, it is important to recognize that
many studies exclusively employ epithelial cells and lack any stromal components [91].
While these studies have been able to give researchers insight into cellular behavior, the
mammary stroma comprises over 80% of the cellular population of the in vivo gland, thus
studies should use co-culture of epithelial cells and their stromal counterparts to
investigate the relationships and subsequent behaviors [91].
Tumor Microenvironment
Tumors persistently shape their microenvironment, thereby establishing an
abnormal ecosystem [120]. The tumor microenvironment is represented by an increase in
fibroblast and myofibroblast activity, an increase in angiogenesis, an infiltration of
inflammatory cells, and ECM remodeling adjacent to the cancerous cells [28]. While all
of these components contribute to tumor progression, macrophages, recruited to the
tumor by various signals, begin to release chemotactic factors that in turn recruit
monocytes to the area that mature into tumor-associated macrophages (TAMs) which in
turn promote neoplasia and angiogenesis [121]. In support of this theory, Robinson and
colleagues found that the macrophage density increased with the grade of the tumor (in
situ to invasive), that vessel density was higher in in situ and invasive tumors, and that
there was a lack of epithelial cells in any proximity to either tumor cells or macrophages
[1]. However, their results were not conclusive; thus, better understanding of the
macrophage and its influence in the tumor microenvironment is necessary and could be
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achieved through heterogeneous model systems. Further research studying the tumor
microenvironment by Rodrigues-Lisoni and colleagues focused on gene expression
influenced by the cancer-stroma interactions using conditioned medium (HCM – Hep2
Conditioned Medium, FCM – Fibroblast Conditioned Medium) from Hep2 cancer cells
and fibroblasts. These researchers measured the gene expression and its influence on
angiogenesis, the immune/inflammatory response, ECM formation, and fibroblast
activation in culture [110]. They found that FCM inhibited Hep2 cell line proliferation
and induced apoptosis, suggesting that factors secreted by fibroblasts include proteins
that interfere in cell growth and death of neoplastic cells, whereas fibroblasts treated with
HCM down-regulated genes corresponding to biological processes such as cell
proliferation, transport, transcription and translation, apoptosis, and protein and RNA
metabolism [110]. While this study shed light into gene expression of tumor cells and the
influence of soluble paracrine factors produced in vitro by stromal cells, the study lacked
the 3D nature of the body, as all culture was completed in well plates. Further studies
should be conducted in 3D to better understand gene expression and how it influences the
tumor microenvironment and progression of a tumor.
The tumor microenvironment is driven by the soluble factors and crosstalk
occurring between the multiple cell types present within and surrounding a tumor. While
studies have begun to address the individual interactions that occur between tumor cells
and the surrounding vasculature cells, inflammatory and immune cells, fibroblasts, and
macrophages, they have yet to piece this heterogeneous microenvironment together.
Also, a majority of these studies have been conducted on tissue biopsies. Modular model
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systems could be developed to further enhance the understanding of the tumor
microenvironment, especially for each pathological state, by seeding relative cell
densities of the representative cell populations within the model systems. By
incorporating the different types of cells beyond epithelial cells, researchers create a
microenvironment more representative of the pathological state.
Cytotoxicity and Toxicology
Cytotoxicity and toxicology models started in 2D using assays to determine how
cancerous cells reacted to drug therapies. The National Cancer Institute developed the
NCI60 cell line, which includes 60 different human tumor strains, for cancer cell
microarray testing to evaluate cellular behavior including early clinical trials of drugs
[72] and gene expression [71]. With the advent of 3D models and the better
representation of the normal tissue environment in 3D compared to 2D cell culture,
current toxicology models use tumor cells grown in natural and synthetic materials.
Research groups have used polymeric substrates, such as electrospun polycaprolactone,
poly(ethylene

glycol)

diacrylate

hydrogels,

and

polylactide-co-polyglycolide

microspheres or porous disks, to create 3D engineered models of adipose tissue to assess
the cytotoxicity of breast cancer drugs [47, 52, 56, 83, 87, 88]. Horning and colleagues
used polylactide microspheres seeded with MCF-7 cells in order to evaluate the efficacy
of cancer drugs in 3D and 2D in vitro models, determining that drug efficacy is
significantly lower in 3D compared to 2D culture and suggesting that the role of the
natural 3D cellular architecture affects drug uptake by the cells and lowers the
distribution throughout the tissue, thus lowering the efficacy of the drug response [83].
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Although this study demonstrated why a third dimension is necessary when evaluating
toxicity of cancer drugs, their study was not comprehensive and representative of the
natural environment, i.e. incorporating all the cellular components present in the body.
Other limitations of this study were that it not only used different substrates in their 2D
and 3D comparison, but they used a set cell concentration within the culture
environments instead of seeding for confluency (i.e. seeding based on surface area),
which could influence results as cells could be confluent in 2D culture, but may not be in
3D culture inhibiting a true comparison of results. Similarly, Dhiman and colleagues
evaluated the cytotoxicity of tamoxifen on 3D cultured MCF-7 cells on a chitosan matrix;
the 3D culture provided a better understanding of the carbohydrate metabolism, cytotoxic
effect of tamoxifen, and the kinetics and uptake of cathepsin D in breast cancer cells [82].
Limitations of this study by Dhiman were the use of cell lines instead of primary cells,
the fact that different substrates were used in 2D compared to 3D and that material
characterization was not conducted to determine if the substrate could influence results.
Such 3D cancer models can be used to evaluate new anticancer drugs and to provide
better understanding of the signaling factors that influence cancer cell growth, but 3D
models that address the above limitations need to be developed before in vitro
cytotoxicity and toxicology models will be comparative to human response in vivo.
Adipose Tissue Engineering
The majority of mammary gland and breast cancer research focuses on epithelial
cells and the surrounding ECM interactions, further, adipose tissue and its influence in
mammary gland development and tumor initiation and progression has rarely been
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investigated. Tissue engineering of adipose tissue using natural or synthetic scaffold
paired with stem cells or preadipocytes has been the focus of adipose research for soft
tissue defects of late [56, 122-124].
Stem cells or preadipocytes have previously been used to produce mature adipose
tissue for applications in replacing soft tissue due to trauma, diseases, or congenital
abnormalities [87, 124, 125]. For example, Halbieb and colleagues seeded preadipocytes
on a hyaluronic acid-based scaffold and found that hyaluronic acid-based scaffolds
appear to be suitable three-dimensional carriers for culture and in vitro differentiation of
preadipocytes [56], however, material characterization was not completed on the scaffold
material to determine the degradation rate, stiffness, or other material properties which
influence how cells react within the 3D system. Similarly, Patrick and colleagues seeded
PLG polymer disks with preadipocytes to demonstrate the potential of using
preadipocytes as a cell source in cell-seeded polymer scaffolds for tissue engineering
[52]. This study was further developed to investigate the long-term feasibility of these
cell-seeded scaffolds for clinically translatable, tissue engineered constructs for
reconstructive, correctional, and cosmetic indications by implanting the scaffolds
subcutaneously on the back of rats [51]. Although these preliminary studies were able to
prove that preadipocytes would proliferate and mature throughout the polymer scaffold,
in the long-term study the lack of vascularization and rat microenvironment around the
implants may have contributed to a decrease in adipose tissue after 2 months in vivo.
Reinforcing the limitations of rodent models in bioengineering research, where rodent
models typically have very little subcutaneous fat [51] which could be why the implanted
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constructs decreased in the amount of adipose tissue present after 2 months. Beyond
designing engineered adipose tissue for soft tissue defects and reconstruction application,
the ability to understand adipose differentiation is important. Kang and colleagues used
an adipose tissue model of preadipocytes seeded on fibrous polyethylene terephthalate
(PET) polymer matrices to understand the mechanisms behind adipose tissue
differentiation [58]. The researchers determined that the PET nanoscale fibers provided a
microenvironment for cell differentiation and spatial organization, thus mimicking the
morphology of ECM in adipose tissue. Preadipocytes have not been the only cell type
used in adipose tissue engineering; many studies have used mesenchymal or embryonic
stem cells in adipose tissue engineering applications [47, 48, 57, 87, 88]. Recently, Kang
and colleagues used murine embryonic stem cells seeded on an electrospun
polycaprolactone (PCL) matrix using an adipogenic cocktail to produce functional fat
cells [88]. The 3D geometry of the electrospun matrix provides environmental cues for
adipogenesis and 3D structural features and functionality that cannot be obtained in 2D
cell culture. Although all of these studies have focused on developing methods in which
to engineer adipose tissue for soft tissue defects and breast reconstruction and they do not
address the fact that the microenvironment of adipose tissue is highly vascularized and
contains much more than just adipose cells, they are still useful in helping to better
understand the adipose microenvironment and challenges of developing a comprehensive
model system for the normal breast and breast cancer. Some of the limitations of the
previously mentioned studies that need to be addressed are that the material needs to
allow for anchorage of the cells and provide support during tissue development, while
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upholding the mechanical properties of normal adipose tissue through material
characterization. The substrates used also have to allow for spatial organization of the
preadipocytes in order to fully differentiate into mature adipocytes. Hopefully, further
studies will expand on the knowledge gained from these adipose tissue engineering
studies in order to build thorough tissue models for use in normal breast and breast cancer
research in the future.
Whereas synthetic polymer substrates may fully represent the tissue ECM, the 3D
geometry provides environmental cues for adipogenesis that cannot be obtained in 2D
(monolayer) culture [88]. The substrates provide the necessary mechanical stability,
attachment capability, and biocompatibility to produce function-specific tissue [83].
Epithelial cells are anchorage-dependent cells that require a substrate to ensure proper
cell morphology and functionality. In fact, while synthetic polymeric materials with the
appropriate binding sites may be suitable for adipocytes, natural materials generally
facilitate polarity in epithelial cell cultures. However, use of synthetic polymeric matrices
seeded with preadipocytes, or stem cells, combined with epithelial cells and fibroblasts
(which would not normally be incorporated for tissue reconstruction following breast
cancer), and embedded in a collagen-rBM gel has the potential to produce engineered 3D
models that better represent the architecture and microenvironment of the breast [6].
Overall, the unique mammary gland microenvironment influences mammary
tissue homeostasis through cues from hormones, soluble factors, stroma, and physical
stress and strain [74]. Tissue engineering and model systems can help better represent the
in vivo conditions of the mammary gland and the surrounding stroma; indeed, the
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microenvironment and ECM are key components of 3D in vitro mammary systems that
can be tailored to study normal epithelial cell-stromal interactions, gland development,
and breast cancer initiation, progression, and metastasis

Epilogue
Approximately 1 in 8 women in the United States will be diagnosed with breast
cancer at some point in their lives [1]. Breast cancer begins when normal mammary
epithelial cells begin to grow and divide out of control, forming a cell mass which then
invades surrounding tissue and eventually, if not caught and diagnosed, leads to
metastasis. In an effort to understand normal mammary gland development and function
and how breast cancer begins, much research has been conducted to understand how cells
become cancerous in the mammary gland, how they propagate, and how they eventually
metastasize throughout the body. The complexity of the tumor microenvironment is
immense and much information is still necessary for better understanding how the
relationship between stroma and carcinoma cells can be used for diagnostic and
prognostic evaluation and a target for therapy [110]. While this research has helped us
understand some of the underlying mechanisms associated with normal mammary gland
function and breast cancer, there is still much we do not understand; the diagram below
(Figure 1.4) details the pros and cons of the current model systems and the needs to be
addressed in the future.

41

Figure 1.4 Types of models available for normal breast and cancer research. Pros and cons
are listed for each model, also included are a list of suggested 3D model improvements.

Normal breast and breast cancer models have been developed to investigate many
aspects of form, function, and interaction within the breast microenvironment, beginning
with 2D and animal models and progressing to 3D models. Two-dimensional cell culture
models are easy to generate and assess, but these models lack the realistic third
dimension of the body. While these models are able to provide a better understanding of
the normal interactions and development of the mammary gland, as well as tumor
formation, progression, and microenvironment, they are not able to mimic the cellular
conditions of the human body and do not normally include all the components (i.e.
multiple cell types, cellular and acellular ECM components, spatial architecture)
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representative of the normal breast or tumor environment. The ultimate goal is to develop
a culture system in which cells respond to various extracellular signals in a manner that is
physiologically relevant; the first step toward achieving this goal is to allow the cells to
maintain a morphology reminiscent of their counterparts in vivo [69]. Two-dimensional
models, while appropriate for pilot studies and initial investigative research, do not mimic
the 3D tissue microenvironment and provide different results compared to animal and 3D
models.
Animal models are used in research to provide an environment which is spatially
and biochemically more relevant to the human biology than the 2D in vitro models. In
cancer research, animal models have been and are used to investigate cell characteristics,
cellular components comprising the tumor microenvironment, and tumor formation.
While they provide insights and data that cannot be reproduced in 2D model systems,
they still have inherent limitations. For example, when tumors are grown in immune
deficient or compromised mice, there is an accelerated development of the mammary
gland structure which correlates with the development of the human mammary gland, but
the glandular components, development of the ductal structure, and percentage of fat in
the mammary pads is not representative of the human environment. Also, the absence of
a normal immune system in those mice prevents any analysis of the key role of the
immune system in both mammary gland physiology and mammary tumor progression.
Also, rodents have a much smaller percentage of fat compared to humans, thus the
influences that may be seen from the mammary fat pad of a human cannot be fully
represented in rats and mice. Further, animals may have other signaling molecules,

43

hormones, and other factors than humans. These may influence or conflict with the
signaling factors and biomaterials that are being studied in the experiments. Finally,
conduction of in vivo animal studies can be costly and limit time points investigated.
Beyond that, the animal model variabilities (e.g., genetic, experimental, methodological)
can also influence data obtained highlighting the need for 3D alternative models. In
contrast, 3D test systems can be precisely replicated for experiments,
While each of the above models is useful to better understand normal breast and
cancer development, each has a specific niche and limitations. Two-dimensional models
were first developed as rudimentary systems in which to investigate cell response. While
these models have been extensively used to date, one must be aware of the drawbacks.
Animal models, although used less frequently, have provided perspective and expanded
understanding of the mechanisms involved in breast and cancer development. Initial
experimentation will continue in 2D and animal models as proof of concept, to test
biocompatibility, or to benchmark against but 3D models must be developed to add
crucial missing information regarding normal and cancerous breast tissue.
In the past two decades, researchers have realized the importance of 3D model
systems especially, for cellular function and signaling. Even though the use of a 3D
model inherently adds complexity to the culture system, a 3D system more closely
represents the tissue conditions. Currently, multiple 3D models are available including
using scaffold materials, either natural or synthetic, in or on which the cells are grown.
There is a range of materials that have chemical and structural properties that can be
tailored to the specific application. For example, most epithelial cell cultures are
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conducted in rBM, laminin, or collagen in order to mimic the ECM present in the breast.
Subsequently, many adipose tissue models have used synthetic materials (i.e.,
polylactide, PLG, PCL) in different forms to provide structural support for the stem cells
or preadipocytes. Cell type and selection is another key parameter to consider in 3D
models; while cell lines are great to study initially to determine how the cells react within
the modeled environment, these cells typically are transformed and have lost many of
their phenotypic characteristics, thus the 3D models using cell lines may only partially
mimic the tissue of interest. These multiple parameters of a 3D model system should be
critically considered when investigating biological responses within 3D models of the
mammary gland environment and of breast cancer progression.
Beyond epithelial cell and scaffold selection, 3D models currently are missing
other molecular, cellular, and structural components. Most 3D models still use a single
cell population and very few include multiple cell types. In order to encompass a more
relevant range of cellular components of the mammary gland or tumor, the 3D model
system must include epithelial and myo-epithelial cells, fibroblasts, adipose cells,
inflammatory cells, and vascular cells. All of these cells add to the overall
microenvironment of the breast, influencing gene expression, signaling, and even
apoptotic behavior of the cells, thus 3D models should strive to include multiple cell
types to better represent the heterotypic environment present in the normal mammary
gland as well as in tumors. Further, research is necessary to advance our knowledge of
the microenvironment in normal mammary gland and during breast tumor development.
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Development and use of 3D model systems has increased in the past decade.
However, there is still a need to further enhance established 3D model systems by
developing more modular model systems, reducing the production costs and the
utilization costs, and increasing their result productivity. Globally, tissue cultures
improved from cell culture conducted in petri dishes years ago to today’s state of cell
culture conducted within 3D model systems. The latter approach is currently used to
investigate the development of the normal and cancerous mammary gland, to understand
the interactions that occur through cell-cell and cell-ECM interactions, to improve
detection methods for cancer, and finally, to develop improved treatment methods for
breast cancer patients.
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CHAPTER TWO

DEVELOPMENT OF A TUNABLE POLYMERIC MATERIAL FOR A 3D BREAST
TISSUE MODEL
Introduction
Three-dimensional cell culture matrices, also known as scaffolds, were introduced
to cell culture to help overcome 2D culture limitations [42]. These scaffolds are
substrates that support cell growth, organization, and differentiation on or within their
structure [42] and are composed of either naturally derived materials (e.g. collagen type I,
rBM) or synthetic materials (e.g. polylactide). Such materials provide a 3D support to
interact with cells to control their function, guiding the spatially and temporally complex
multicellular process of tissue formation [43]. In designing scaffolds mimicking the
natural ECM, an intricate interwoven fiber meshwork of collagen and elastic fibers
embedded in a highly hydrated gel-like material of glycosaminoglycans, proteoglycans,
and glycoproteins [42] is attractive, but other chemical, physical, and mechanical
properties of the scaffold material influence cellular affinity and interactions. While all
these properties must be taken into consideration, scaffold fabrication remains highly
challenging as the in vivo remodeling process that is part of the tissue formation process
to a large extent not take place in vitro [44].
Synthetic absorbable polymers allow cells to attach, spread, proliferate, and
differentiate to form tissue [42]. As with all biomaterials, the nature of the scaffold itself
is of utmost importance in the design of tissue model systems. The physical and chemical
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properties of the material used in such a system affect its cellular affinity [126],
absorption or degradation characteristics, and mechanical stability; these characteristics
ultimately determine the suitability of a tissue engineering scaffold. Absorbable polymers
such as polylactide (PL), polyglycolide, polycaprolactone, and their copolymers have
been used over the past decades in medical applications, such as bone plates and screws
[127], films [128, 129], and biodegradable sutures, and have been investigated for uses in
tissue engineering. The word “polylactide” refers to a family of polymers that have
varying degradation profiles and characteristics, depending on the structure and
molecular weight of the polymer. Poly-L-lactide and poly-D-lactide are crystalline (i.e.
generally comprised of ordered, more densely packed molecular chains), while
copolymers of poly-D,L-lactide are normally amorphous (i.e. generally comprised of
disordered, less densely packed molecular chains) [44]. These synthetic, absorbable
polymers, typically characterized by their degradation profiles and initial molecular
weight, are selected for use based on their mechanical and chemical properties depending
on the target application.
Processing of degradable materials plays a large part in the initial physical and
chemical properties of these scaffolds and, accordingly, influences cell adhesion,
migration, and differentiation. Therefore, activities focused on developing processing
methodologies and techniques, understanding the relationships among device
composition, structure, and the resulting degradation properties are crucial to understand
and control cell–surface interactions in a 3D tissue engineering scaffold [130]. Beads
have been produced using phase separation, solvent evaporation, solvent extraction, spray
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drying, and cold precipitation techniques [131, 132]. Most commonly used are single or
double emulsion technique (also called “oil-in-water” and “water-in-oil-in-water”,
respectively) [131], which have been previously used to produce absorbable beads of
polylactide, polyglycolide, polycaprolactone, and their copolymers for drug delivery
applications. A single emulsion technique consists of dropping a solution of a hydrophilic
polymer dissolved in a solvent (oil phase) into an aqueous solution containing a hardener
such a polyvinyl alcohol (water phase) and stirring at a high rate to create hollow beads.
Double emulsion techniques can be employed to encapsulate drugs or proteins in the
polymer prior to bead formation; the beads can later be delivered in a controlled manner
upon polymer degradation/absorption in the body [132]. Beads of injectable diameter,
ranging from approximately 1 µm in diameter [133] to approximately 100 µm [134] have
been reported [135-139]. The bulk and surface properties that are influenced by the
processing variables impact cellular behavior. Some of the processing variables that
affect bead properties include solvent type, solution volumes, processing vessel size, stir
speed, and polymer composition [132]. Thus, when designing beads for tissue
engineering applications, modulating processing techniques and methodologies to tune
the scaffold is critical.
Although both single emulsion and double emulsion techniques have been used to
generate beads for drug delivery applications [131, 132, 140, 141], both techniques are
being explored to produce larger, tunable beads of suitable size for cell seeding [47, 48,
50, 126, 136, 142, 143]. With the prevalence of tissue engineering and the clinical
familiarity of degradable polymers, such as polylactides, understanding how polymer
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properties are influenced by processing is important in developing scaffolds that support
cells and maintain a microenvironment for viable tissue growth. To date, little work has
been conducted to address the impact of polymer processing and the resulting structural
changes on the performance of these materials with respect to cellular behavior [144]. In
fact, most work focuses on cell response to absorbable materials with little to no regard
for the dynamic material characteristics. Accordingly, this study was designed to assess
specific processing variables in the production of polylactide beads and how changes in
those variables affected bead formation and properties, specifically bead size,
degradation, molecular weight, and crystallinity. Understanding how processing affects
the material characteristics provides a way to produce polylactide beads that can be tuned
for specific needs within the 3D breast tissue model.

Materials and Methods
Polylactide (PL) beads were produced in separate batches using a single emulsion
technique. Three processing methods, Bead Fabrication Procedure 1, 2, and 3, were used
to produce polylactide (PL) beads (Table 2.1). Each fabrication method had four separate
conditions and within each condition four different batches of beads was produced. In
Bead Fabrication Procedure 1, the effect of processing tank size and stir paddle size was
observed. Processing tanks of 1L, 2L, and 6L volume were used with either a square stir
paddle measuring 6.9 cm x 6.9 cm (large, Figure 2.1B) or an oval swivel blade paddle
measuring 5.0 cm x 1.3 cm (small, Figure 2.1A). In Bead Fabrication Procedure 2, the
effect of varying PL solution amounts, ranging from 10 mL in the smallest tank to 60 mL
in the largest tank, was studied. Finally, in Bead Fabrication Procedure 3, the
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concentration of polyvinyl alcohol (PVA) was varied in the 2L tank using 20 mL of PL
solution and the swivel blade paddle, ranging from 0.05 to 0.50%.

Table 2.1 Specific parameters for Bead Fabrication Procedures. For every condition the stir
speed (300 RPMs), stir time (90 minutes), and rinse times (10 minutes) were similar. All
beads were washed in 2% Isopropanol solution over night on a shaker plate, placed on filter
paper within a buchner funnel, then rinsed 3x with dH20. The beads were dried using a
vacuum system for 24 hours and then stored in a desiccator.

Fabrication
Procedure

Vessel
Size
(L)

1

6
2
2
1

2

6
6
1
1

3

2
2
2
2

Paddle
Size
(cm)

PL Soln.
Volume
(mL)

PVA Soln.
Conc.
(%)

I. Varied by Vessel Size
6.9 x 6.9
20
0.05
6.9 x 6.9
20
0.05
5.0 x 1.3
20
0.05
5.0 x 1.3
20
0.05
II. Varied by PL Solution Amount
6.9 x 6.9
60
0.05
6.9 x 6.9
20
0.05
5.0 x 1.3
20
0.05
5.0 x 1.3
10
0.05
III. Varied by PVA Concentration
5.0 x 1.3
20
0.05%
5.0 x 1.3
20
0.10%
5.0 x 1.3
20
0.25%
5.0 x 1.3
20
0.50%

Rinse Soln.
Volume (mL)
2000
800
800
400
2000
800
800
400
800
800
800
800

As-received PL beads and post-processing beads were characterized using several
methods, including imaging, gel permeation chromatography (GPC), differential
scanning calorimetry (DSC), and lactic acid analysis. Degradation of produced beads was
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evaluated by immersing beads in phosphate buffered solution (PBS) while crystallinity
and thermal characterization properties were determined before immersion in PBS, and
throughout the 49-day study.
Polylactide Bead Processing
Bead Fabrication Procedure I
Polylactide (PL; NatureWorks LLC, Minnetonka, MN) pellets (2 g) were
dissolved in 20 mL of dichloromethane (10% w/v; Mallinckrodt Baker, Inc, Phillipsburg,
NJ) for 24 hours in scintillation vials (VWR International, West Chester, PA). A 0.3%
(w/v) aqueous PVA solution (weight average molecular weight 13,000-23,000 Daltons
(Da); Sigma-Aldrich, St. Louis, MO) and a 2% (v/v) isopropanol solution (Honeywell,
Morristown, NJ) were prepared in 1 L pyrex bottles (Corning, Corning, NY). To make a
0.05% PVA stir solution in the 6L tank, 1 L of aqueous PVA solution was added to the
tank, followed by 5 L of distilled H2O (dH2O), to achieve a final volume of 6 L. The
PVA solution was stirred at 300 RPM for 10 minutes using the square stir paddle. Using
a 20 mL Luer-Lok™ syringe (BD, Franklin Lakes, NJ) with an attached 16-gauge needle
(BD, Franklin Lakes, NJ), the polymer solution was injected into the PVA solution while
stirring at 300 RPM with the needle tip submerged in the liquid at a 45° angle. The beads
were stirred for 90 minutes at 300 RPM to ensure complete solvent extraction. The
stirring was halted and the PVA solution drained until 1 L remained in the 6L tank.
Subsequently, 2 L of 2% isopropanol solution was added and the beads were rinsed by
stirring for 10 minutes. The remaining solution was drained and the beads were removed
from the tank and deposited in a 250 mL glass bottle (Corning, Corning, NY) with 100
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mL fresh 2% isopropanol. The bottle with beads was placed on a shaker plate for 24
hours at 150 RPM, at which time the beads were placed on filter paper in a Buchner filter
funnel (VWR International, West Chester, PA), rinsed with dH2O three times, dried in
the chemical hood (Hamilton Concept from Fisher Hamilton LLC, Two Rivers, WI)
under constant air flow produced by the suction of the house vacuum for 24 hours, and
stored in a desiccator.

Figure 2.1 (A) Bead processing tank set-up with small paddle. (B) Large paddle.

Four batches of polylactide beads were produced consecutively on the same day
to ensure similar processing conditions. For the 1L and 2L tank set-ups the processing
was the same with the exception of solution volumes and paddle used (Table I). The
solution volumes used for the 1L and 2L tanks were 150 mL and 300 mL of PVA
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solution, 750 mL and 1500 mL of dH2O, and 400 mL and 600mL isopropanol,
respectively. The square stirrer paddle and the swivel blade paddle were used in the 2L
tank, while only the swivel blade paddle was used in the 1L tank.
Bead Fabrication Procedure II
The protocol for Bead Fabrication Procedure I was repeated using varying PL
solutions of 10, and 20 mL for the 1L tank and 20 and 60 mL for the 6L tank.
Bead Fabrication Procedure III
The protocol for Bead Fabrication Procedure I was repeated using varying PVA
solution concentrations of 0.05, 0.1, 0.25 and 0.50% for the 2L tank with the swivel blade
paddle.
Bead Diameter Measurements
A Lumenera 2-3C 3.3 MP camera (Lumenera Corp, Ottawa, ON, Canada)
mounted on a stand and MatLab 7 (MathWorks, Natick, MA) were used to capture
images of the PL bead batches produced by Fabrication Procedures I, II and III.
AxioVision 4.7 software (Carl Zeiss AG, Germany) was used to measure the average
diameter of 300 beads per batch. To account for different shapes and sizes, two
measurements in perpendicular directions were taken for each bead. The mean and
standard deviation of the bead diameters were calculated for all batches.
Acellular Degradation Study
The degradation properties of the beads produced by each of the processing
methods were studied by immersing beads produced in 2 mL Dulbecco’s Phosphate
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Buffered Saline (PBS; Sigma, Milwaukee, WI) solution in each well of a 24-well cell
culture plate. The well plates were stored in an incubator (37oC, 5% CO2). Throughout
the study, aliquots of the PBS solution were taken weekly and analyzed using an YSI
Biochemistry analyzer for lactic acid content; subsequently, the PBS solution was
replaced. At each time point, after aspiration of the PBS, beads were collected from the
well plates using a spatula and placed on filter paper in a Buchner filter funnel. The beads
were rinsed with dH2O three times, dried in the chemical hood under constant air flow
produced by the suction of the house vacuum for 24 hours, and stored in a desiccator
until characterization was completed. Beads were characterized through molecular weight
analysis, thermal analysis, and crystallinity determination.
Molecular Weight Analysis
Molecular weight was measured using gel permeation chromatography (GPC;
Waters, Milford, MA). A Waters Breeze (Milford, MA) system equipped with a
Refractive Index (RI) detector was used to assess PDL beads produced. The fluid pump
for each was set to a rate of 1 mL/min. Polystyrene standards (Polysciences, Inc.,
Warrington, PA) with narrow weight average molecular weights (Mw), including
1,000,000, 400,000, 233,000, 104,000, 50,000, 23,000, 4000, and 436 Da. were used.
Samples were prepared in high performance liquid chromatography grade chloroform
(Honeywell, Morristown, NJ) at a concentration of 1 mg/mL and filtered through a 0.2µμm
Teflon membrane filter (VWR International, West Chester, PA).
Number average (Mn) and weight average (Mw) molecular weights values were
determined from the retention curves using Breeze 2 Software. The polydispersity index

55

(PD), which is the molecular weight average to molecular number average ratio (Mw/Mn),
was calculated for each bead type produced.
Thermal Analysis and Crystallinity Determination
A TA Instruments DSC 2920 (New Castle, DE) differential scanning calorimeter
controlled by TA Instruments Thermal Advantage Software was used to thermally
analyze PDL beads prior to immersion in PBS as well as at time points of 21 and 49 days.
Beads were removed from the PBS at 21 and 49 days and placed on filter paper in a
Buchner funnel and dried in the chemical hood under constant air-flow for 24 hours.
Each sample (n=3), weighing approximately 5 mg, was heated from 0˚C to 200˚C in
nitrogen at a rate of 10˚C per minute. Thermal transitions were analyzed using TA
Instruments Universal Analysis 2000, and percent crystallinity was calculated using the
following equation:

ΔH f − ΔH c
l
ΔH theoretica
f

× 100 = %Crystallin ity

where ΔH f is the measured heat of fusion, ΔH c is the measured heat of crystallization,
l
and ΔH theoretica
is the theoretical value for the heat of fusion of polylactide (92.9 J/g)
f

[145]. Thermal glass transition temperatures (Tg) were taken at the onset, inflection, and
end points; the inflection values are reported.
Statistics
JMP software (SAS Institute Inc., Cary, NC) was used to run a one-way Analysis
of Variance (ANOVA, α=0.05) to analyze differences comparing all pairs using post-hoc
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Tukey-Kramer HSD for bead measurements, molecular weight analysis, and thermal
analysis of polylactide beads produced in Bead Fabrication Procedures I, II, and III.

Results
Bead Diameter Measurements
Bead Fabrication Procedure I determined how changes in the size of the vessel
and the type of paddle used affected PL bead size and shape. PL beads with average
diameters of 403±47, 544±96, 864±168, and 807±120 µm were produced in the 6L tank,
2L tank with large paddle, 2L tank with small paddle, and 1L tank (Figure 2.2A),
respectively. The shape of the beads changed depending on the vessel size and paddle
size used to produce beads. The 6L tank produced the smallest size beads and also the
beads that were most uniformly round (Figure 2.2D, 6L20). There was a significant size
difference (p<0.01) between beads produced using the large vs. small paddle in the 2L
tank. Beads produced in the 1L tank were similar in size to those produced in the 2L tank
with the small paddle, however, comparatively fewer beads were abnormally shaped (e.g.
peanut, dumbbell, tailed).
Bead Fabrication Procedure II determined how increasing or decreasing the
amount of PL solution in the processing protocol affects bead size. Beads with average
diameters of 320±63, 403±47, 807±120, and 896±79 µm were produced in the 6L tank
using 60 and 20 mL of PL solution and the 1L tank using 20 and 10 mL of PL solution
(Figure 2.2B), respectively. Beads produced in the 6L tank and the 1L tank, regardless of
how much PL solution was added to the process, showed no significant differences
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between conditions within the same vessel. Comparing beads produced in the different
vessels, the 6L60 beads were significantly different from both the 1L10 (p<0.001) and
the 1L20 (p<0.01) beads.
Lastly, in Bead Fabrication Procedure III, the concentration of the PVA solution
was varied to look at the changes in bead size and shape. The most notable difference in
beads produced in Bead Fabrication Procedure III is that as the PVA concentration
increased, the average bead diameter decreased (Figure 2.2C) from 864±168 to 628±33
µm and the different shapes (e.g. dumbbell, oval, tailed) were no longer present (i.e. the
beads were all round) after the PVA concentration rose above 0.25% (Figure 2.2D
images 2L20s, 2Lp1, 2Lp25, and 2Lp5).
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Figure 2.2 Average diameter measurements of beads produced in Bead Fabrication
Procedure I (A), II (B), and III (C) with representative images of PL beads (D; scale bar =
1000µm), * p<0.05, ** p<0.01, *** p<0.001. Beads produced by Bead Fabrication Procedure
I (6L20, 2L20B, 1L20, and 2L20s) demonstrate how vessel size and paddle size affect bead
size and shape. Beads produced in Bead Fabrication Procedure III demonstrate how beads
produced in each condition decrease in size as PVA concentration increases. As PVA
concentration increases shape of beads becomes more round. Beads made with 0.05% and
0.1% PVA concentration have varying shapes, e.g. oval, peanut, dumbbell, and tailed beads.
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Acellular Degradation Study
A bolus release of lactic acid was seen for all conditions through Day 14 and a
much slower release of lactic acid through Day 49 (Figure 2.3) during the degradation
study. Beads with the highest release of lactic acid were 2Lp5 beads followed by 2L20s
and 1L10 beads. Beads with the lowest release of lactic acid over the 49-day period were
6L20 beads. There was no correlation between the amount of lactic acid released and
processing method or size of the bead.

Figure 2.3. Lactic acid release for each condition over the 49-day degradation study
showing a bolus release of lactic acid within the first 14 days.
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Molecular Weight Analysis
The same as-received PL pellets were used to produce beads for all Bead
Fabrication Procedures. After processing, the molecular weight of the PL beads was not
different from the as-received PL pellets. The as-received PL and Day 0 beads had
similar average molecular weight (Mw) and polydispersity index (PD) values. All beads
produced by Bead Fabrication Procedure I showed a significant difference (p<0.0001)
from as-received PL after Day 21. At Day 49, 6L20 beads were significantly different
(p<0.0001) from 2L20s and 1L20 beads, while 2L20B beads were significantly different
(p<0.05) from both 6L20 and 1L20 breads. Significant differences (p<0.05) in PD were
only seen at Day 49 between 6L20 and 1L20 beads. For Day 21 and Day 49 time points,
beads produced in Bead Fabrication Procedure II were all significantly different
(p<0.0001), except for 6L60 beads (p<0.01) at Day 21. At Day 49, no significant
differences were seen when the amount of PL solution was increased in the 6L tank or
decreased in the 1L tank. Bead Fabrication Procedure III beads showed a significant
difference of p<0.0001 at both Day 21 and Day 49 for all bead types compared to asreceived PL.
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Figure 2.4 Comparisons of weight average molecular weight (A) and polydispersity index
(B) of beads produced in each Bead Fabrication Procedure as a function of immersion time
(* p<0.05, ** p<0.01, and *** p<0.0001).
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Thermal Analysis and Crystallinity Determination
Processing affected the glass transition temperature (Tg, Figure 2.5A),
crystallization temperature (Tc, Figure 2.5B), and melting temperature (Tm, Figure 2.6A)
of the beads. As beads degraded, Tg and Tm gradually increased to values closer to asreceived PL over the 49-day degradation period, while the Tc only increased through day
21 and then stabilized. The Tg of the as-received PL was significantly higher compared to
all conditions, regardless of the processing method. At Day 21 Tg differences between the
as-received PL were only seen in Bead Fabrication Procedure II with 1L10 beads
(p<0.05) and in Bead Fabrication Procedure III with 2Lp1 beads (p<0.01). No Tg
significant differences were seen between any bead types and the as-received PL at Day
49, however, significant differences, p<0.05, were seen at Day 49 in both Bead
Fabrication Procedure II between 6L60 and 6L20 beads and Bead Fabrication Procedure
III between 2L20s beads and 2Lp1 and 2Lp25 beads.
Crystallization temperatures (Figure 2.5B) were only compared across bead types,
as the as-received PL did not have a Tc. In Bead Fabrication Procedure II there were no
significant differences seen when the PL solution volume increased. In Bead Fabrication
Procedure III, as the PVA concentration was increased the Tc decreased. The only
significant difference was seen at Day 0, where 2L20s had a significantly higher Tc
compared to concentrations of 0.1% PVA and higher. The largest differences in Tc were
seen in Bead Fabrication Procedure I, where the vessel and paddle size changed between
conditions, indicating that this variable in processing is very important. At Day 0, 1L20
had the lowest Tc and 6L20 the highest. A significant difference, p<0.0001, was seen in
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6L20 and 2L20B compared to all other conditions, whereas, beads produced with the
smaller paddle (2L20s and 1L20) only showed a significant difference of p<0.01
compared to each other. As the beads degraded all conditions showed increased in Tc. By
Day 21, 6L20 was the only condition to have a Tc significantly higher than both 1L20
(p<0.01) and 2L20s (p<0.0001). At Day 49, the Tc had much less variation within each
condition of bead produced and thus there were significant differences seen based on
which paddle was used to process the beads with.
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Figure 2.5 Comparisons of glass transition (A) and crystallization temperatures (B) of beads
produced as a function of immersion time (* p<0.05, ** p<0.01, and *** p<0.0001).
Asterisks in a color other than black were used to differentiate between groups, e.g. in
Procedure I had a statistically higher Tg compared to all other conditions, indicated by
three black asterisks.
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Figure 2.6 Comparisons of melting temperatures (A) and crystallization percentage (B) of
beads produced in each Bead Fabrication Procedure as a function of immersion time
(Statistical significance indicated by: * p<0.05, ** p<0.01, and *** p<0.0001). Asterisks
indicating statistical significance using a color other than black were used to differentiate
between groups.
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The as-received PL had a significantly higher Tm compared to all conditions in
Bead Fabrication Procedure I, II, and III (Figure 2.6A), however, no significant
differences were seen between the conditions at Day 0 due to large standard deviations
for all conditions except the as-received PL. Comparing conditions from Bead
Fabrication Procedure I at Day 21, 2L20B had a significantly higher Tm compared to both
2L20s (p<0.01) and 1L20 (p<0.05). Comparing conditions from Bead Fabrication
Procedure III, at Day 21 2Lp5 had a significantly higher Tm compared to 2L20s
(p<0.0001) and both 2Lp1 and 2Lp25 (p<0.01) indicating that even though 2Lp5 beads
were produced in the highest concentration of PVA at 0.5%, a known plasticizer, the
plasticizer is no longer present in the polymer after 21 days as shown by the increase in
both Tg and Tm.
Lastly, percent crystallinity was compared based on bead fabrication procedure.
No differences were seen in beads produced in Bead Fabrication Procedure II, but
significant differences were seen in both Bead Fabrication Procedure I and III. The beads
with the highest percentage of crystallinity from Bead Fabrication Procedure I were the
2L20s beads (22.9%) which was significantly higher compared to 1L20 (20%, p<.01),
2L20B (14.4%, p<0.0001), and 6L20 (7.4%, p<0.0001) after processing. At Day 21 and
49, beads produced using the small paddle had crystallinity percentages that were
significantly higher (p<0.0001) than those produced using the large paddle, but no
significant differences were seen between conditions made with the same paddle. When
the PVA concentration was altered in Bead Fabrication Procedure III, the beads produced
had similar percentages of crystallinity because they were all produced in the same vessel
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with the same paddle. However, at Day 0 the 2Lp5 beads had the highest cyrstallinity
percentage of all beads (28.5%), which was significantly higher (p<0.01) than 2L20s
beads. At the end of the degradation study, 2L20s beads were 15.5% crystalline and were
significantly lower (p<0.01) compared to beads produced with a PVA concentration
higher than 0.1%.
In summary, the processing parameters that influence bead characteristics the
most are the ratio of paddle size to vessel size and PVA concentration; however, the one
material property not affected by processing is the molecular weight (Figure 2.7).
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Figure 2.7 Processing affects bead size, shape and thermal transitions, but not molecular
weight as seen in Bead Fabrication Procedure I (A) and III (B) comparing bead size,
molecular weights, and micrographs (scale bar = 1000 µm) of beads produced in each.
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Discussion
Fabrication of degradable polymer scaffolds for tissue engineering, not only for
therapeutic applications but also for diagnostic applications, remains highly challenging
[44]. Processing methodologies and techniques have been developed to produce scaffolds
with varying compositions, surface modifications, and properties to target the location
and use of the scaffold materials. Degradation is one of the major characteristics of these
tissue engineered scaffolds and systems [129], where the degradation process is
influenced by the size of the scaffold, the starting molecular weight of the material, and
the crystallinity. The majority of manuscripts detailing the use of polymeric tissue
engineered scaffolds report the as-received molecular weights; complete material
characterization after processing and sterilization generally is not conducted [49, 146,
147]. Characterization of the polymer post processing and post sterilization is crucial to
provide a better understanding of the likely in vitro and in vivo performance of a given
scaffold. Indeed subtle changes in material properties can cause radical changes in cell
behavior [130]. Understanding the relationship between processing and post-processing
material characteristics allow for tuning the production process to generate a scaffold
suitable for a specific application.
When producing scaffolds of designated shape and diameter, changes in
processing should not alter the final product. Production of the PL beads in Bead
Fabrication Procedure I demonstrate that processing changes i.e., paddle size and vessel
size (Figure 2.7A) caused notable differences in the diameter of the beads produced. The
beads produced in the 2L tank with the large paddle (2L20B) were on average 540 µm in

69

diameter. In contrast, when the large paddle was substituted with a small paddle (2L20s)
the beads produced had an average diameter of 864 µm. Thus, although the same
protocol was followed, the final materials produced were significantly different.
That observation suggested that other simple processing parameters routinely
reported in processing protocols [132], such as solvent type, solution volumes, and
polymer composition may also impact the final product. To assess this, Beads produced
in Bead Fabrication Procedure II addressed whether the PL solution volume affected bead
size. Bead diameters were not significantly different between beads produced in the 6L
tank or the 1L tank regardless of the PL solution volumes. Stir solution concentrations
were investigated by altering the PVA concentration. Increasing the concentration of the
PVA solution decreased both the diameter of the beads and the number of non-spherical
beads produced. While bead diameter measurements can be used to detect changes in
processing, the size of the beads also impact material properties including degradation.
Single emulsion methods used here were quite reproducible from batch to batch,
however, a large distribution of bead diameters within each batch occurred in many of the
conditions tested. Since degradation rate correlates to material mass, and therefore, bead
size (i.e. diameter), a high within-batch variability corresponds to a variety of degradation
profiles. This variability could be favorable for tissue-engineering applications, especially
where a bulk release of by-products could be used to develop a microenvironment that is
more representative of the breast cancer microenvironment. Bead size is a variable that
may be readily tuned when designing scaffold materials. Not only does the diameter of
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the bead determine its suitability in a given application, but it also impacts the
degradation profile of the system.
Although size and shape of a tissue engineering scaffolds are important, the
degradation profile is an additional property that requires careful consideration with
respect to the intended application. The mechanical properties of a tissue-engineering
scaffold change with the degradation profile. Practically, a scaffold should be treated
before and after processing to remove lower molecular weight species. PL is a material
that degrades by bulk degradation; thus, another bolus release of lactic acid will be
released as the material fully degrades. Hence the cell-material interactions will vary with
time and release of by-products. Some applications may require pre-degradation to ensure
accelerated rates and full degradation of the scaffold [148], while other applications like
use in a 3D in vitro model may need polylactide release at specific times to best represent
the breast environment at a specific time. As our results indicate, even small material and
processing changes affected the overall degradation profiles. Lactic acid measurements
from aliquots of the PBS solution containing immersed acellular beads gave an indication
of bead degradation. As the PL polymer chains in the beads were hydrolyzed into lactic
acid monomers, the amount of lactic acid measured in the PBS immersion solution
increased (Figure 2.3). With all bead types an initial bolus release of lactic acid within the
first 14 days was observed, then the lactic acid release slowed considerably. Longer
duration studies would enhance understanding of the lactic acid release profile and should
include evaluation of the cellular response.
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Polylactides, thicker than approximately 0.80mm [149], undergo bulk degradation
once implanted into the human body, where the molecular weight of the polymer starts to
decrease. However, the volume of the polymer generally does not decrease until the
molecular chains are reduced to a size where they can freely diffuse out of the polymer
matrix [150-152]. Regardless of the thickness of the device, the first by-products to
emerge will be those with the lower molecular weight [151]. As the PL beads degraded
and concurrently diffused lactic acid in the PBS solution, a corresponding decrease in
molecular weight of the beads was expected. Instead, here the beads produced
demonstrated an increase in Mn and Mw. This may in part indicate the removal of
impurities and lower molecular weight species from the as-received material, resulting in
an increase in molecular weight and a decrease in polydispersity index.
The molecular weight of a polymer influences how quickly the scaffold will
degrade when used in different applications. The as-received material, processing vessel
size, paddle type, and processing speed all influence the molecular weight of the beads;
hence, each parameter should be adjusted to obtain the targeted outcome. For example,
scaffolds used for injectable applications should have small diameters; thus, beads
produced by emulsion solvent methods could be produced with a large vessel and paddle
size and high spinning speeds. Another application may require beads with an accelerated
rate of degradation; in this case processing PL beads using a small vessel may be more
appropriate [148].
Crystallinity is another property of an absorbable polymeric scaffold that
influences degradation, mechanical stability, and cellular behavior. Crystalline surfaces in

72

general have higher surface energies compared to amorphous materials; surface energy
can impact protein absorption patterns and conformations, which stimulate specific
cellular behaviors [128, 130, 153]. The PL beads had a lower average Tg (Figure 2.4A)
than the as-received PL, likely due to the PVA and any remaining moisture in the beads
acting as a plasticizer within the beads. As the beads degraded, the PVA was released
from the beads and the Tg increased back to a temperature similar to the as-received PL.
The significant differences seen in Tg, Tc, Tm, and crystallinity overall for the PL beads
produced were caused by very tight standard deviations which caused the slightest
change in temperature to be significant from the last. For example, the range of
temperatures for Tm was 148-151˚C.
The decrease in crystallinity seen in the beads produced in the Bead Fabrication
Procedures can be explained by the polydispersity changes in the polymer chains over the
49-day study. In Bead Fabrication Procedure I for example, the Mn of the 1L20 and
2L20B beads decreased by almost 22 and 30%, respectively, while the Mw only decrease
by 8 and 21%, respectively. The chain lengths stayed relatively constant in the 1L20
beads and showed a slightly larger decrease in the 2L20B beads, while the number of
chains decreased at similar rates. This suggests that as a relatively high number of shorter
chains are removed, the longer chains do not have the opportunity to quickly rearrange,
and thus a decrease in crystallinity is seen, albeit a less pronounced decline in the 1L20
beads compared to the 2L20B beads. Because crystallinity affects the surface energy of
the material and thus cellular behavior, it is crucial to purposefully select processing
parameters that will guide cellular response to implanted materials.
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Processing materials is a challenge, as so many factors influence the
physicochemical and mechanical properties of a given material. Results from this study
showed that, of the variables studied in this research, the bead processing parameters of
vessel size/paddle area and PVA concentration have the largest influence on bead
diameters. While these are the main factors, they are not the sole factors. Paddle speed,
solvent and solution concentrations, as well as polymer molecular weight, crystallinity,
and polydispersity, all play a part in the resultant beads and their designated mechanical
and physiochemical properties. A small change in processing can cause drastic changes
in the final product, thus knowledge of how these parameters influence the outcome
characteristics is crucial and can help enormously in producing tissue-engineering
scaffolds that have tailored properties for their application.

Summary
While the focus of producing suitable degradable biomaterials for use in tissue
engineering applications is at the forefront of materials research, development of
methodologies and techniques to be used and the effects processing has on the bulk and
surface properties of the material have yet to be thoroughly explored and detailed. Here
we determined that both the vessel size/paddle size and PVA concentration have a
significant effect on both bead size and shape. Thus, these two processing variables
should be controlled regardless of the intended application. These observations highlight
how each handling and/or processing step affects absorbable systems, both their chemical
and physical properties and their function. Future investigations should assess the bulk
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properties of multiple scaffolding materials and define how processing parameters can be
modulated to generate tunable “platform” systems.
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CHAPTER THREE
Portions of results in this chapter were generated by an Institute for Biological Interfaces
of Engineering interdisciplinary team, including Clemson University undergraduate
student Devleena Kole, and were presented at the 2013 Annual Meeting and Exposition
of the Society For Biomaterials: McCave EJ, Kole D, Burg KJL: Development of a
Heterogeneous In Vitro Three-Dimensional Breast Tissue Model. In: Society For
Biomaterials 2014 Annual Meeting & Exposition: 2014 (Denver, CO; 2014) [3].
GENERATION OF THE STROMAL COMPONENT OF A 3D BREAST TISSUE
MODEL USING EXTRACELLULAR MATRIX MATERIALS

Introduction
The human breast is a complex tissue composed of a glandular structure (the
mammary gland) [7], consisting of a nipple, lobes, and ducts, surrounded by stromal
tissue, fibrous and fatty tissue. The mammary gland is a dynamic structural tissue that
changes, beginning with the formation of the lobule bud structure during neonatal
development, continuing with the development of alveoli or acini during adolescent
puberty, then full lobulo-alveolar development with child birth, followed by involution at
the end of lactation [8]. The stroma, i.e. the fatty and connective tissue, surrounds the
lobes of the glandular tissue [7]. The breast contains very little muscle and is mainly
composed of stroma, which defines the shape and size of the breast [7, 9, 11].
The stroma is not an inert tissue. The composition and organization of the ECM
and cellular components evolve with the developmental stages of the mammary gland
[13, 24]. Thus, the variations in epithelial-stromal interactions and ratios that occur
during the various stages of breast development influence the components of cellular
microenvironment (growth factors, hormones, and ECM) and also cell activities
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including gene expression accounting for the susceptibility or risk to develop breast
cancer [99, 106]. While research has focused on epithelial-stroma interactions and how
they influence the proliferation, the differentiation, and, at times, the quiescence of the
epithelial cells and their progenitors, there is still much that is unknown. In vitro model
systems have been developed, through the use of tissue engineering methods (reviewed in
[107]), to better understand the development and structure of the gland parenchyma and
how the stroma influences development and even breast cancer initiation and progression.
Tissue engineering, i.e. the construction of tissues using cells and biomaterial
“scaffolds” or “matrices” as foundational building blocks, has been of interest for many
years for mammary reconstruction following mastectomy or lumpectomy [154, 155], and
has been investigated more recently for use in building 3D mammary tissue models
[107]. The intricacies of mammary tissue have provided numerous challenges in tissue
engineering. The mammary gland is a complex tissue comprised of epithelial parenchyma
embedded in an array of stromal cells that regulate its proliferation, differentiation, and
survival [8]. The fibrous connective tissue of the stroma, also known as the ECM, is a 3D
network that surrounds the cells and is of two types. The first constitutes the basal
membrane (BM), which interacts directly with the epithelium and consists primarily of
globular collagen IV, laminin, entactin/nidogen, and heparan sulfate proteoglycans. The
second forms the interstitial matrix, which consists of fibrous collagen (usually Type I
and III) and fibronectin [25]. The latter contributes to the mechanical strength of the
tissue [25]. Luminal epithelial cells line the ducts and are surrounded by a layer of myoepithelial cells that attach to the BM [93], which acts as a mechanical barrier between the
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epithelial-lined ductal structure and the surrounding connective and fat tissue. The ECM,
largely through its dynamic chemical and mechanical characteristics, is able to regulate
cell shape, proliferation, polarity, differentiation, transcription, synthesis, and secretion
for a variety of cell types [106].
Epithelial cell monolayers have traditionally been used to study breast cancer, yet
two-dimensional (2D) cultures only partially reproduce the structure or the function of
the mammary epithelium in vivo [81]. Thus, 3D cultures have been developed to better
represent the in vivo environment. Much of breast biology and breast cancer research has
included mammary epithelial cells or breast cancer cells embedded in ECM component
mixtures such as collagen Type I, reconstituted basement membrane products (rBM, e.g.
Matrigel™), or a combination of the two, to mimic the breast ECM [79-81, 94].
Dhimolea and colleagues found that flexible Type I collagen matrices supported
polarized acini and branching ducts when human breast epithelial (MCF10A) cells and
human mammary fibroblasts obtained from reduction mammoplasties (RMF) cells were
suspended in the gels in co-culture [79]. Krause and colleagues co-cultured MCF10A and
RMF cells embedded in a Type I collagen gel, which resulted in the development of
branched ducts, but when rBM was added to the collagen in a 1:1 ratio, branching ducts
and alveoli were produced [81]. Dréau and coworkers [95] found that the behavior of 3D
cultures of normal murine mammary gland (NMuMG) cells, cultured either alone or in
combination with mouse mesenchymal stem cells (D1), were dependent on the “matrix”
or surrounding biomaterial environment consisting of agarose, collagen, or Matrigel™
alone or in combination. The number of acinar structures was significantly higher in
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cultures grown in combination matrices of Matrigel™ and collagen I when compared to
cultures grown in Matrigel™ or collagen I alone. No tubular structures were formed
when agarose was included in the matrix, regardless of the combination. These works
highlight the process of acinar and ductal formation, demonstrating how epithelial cells
react in different gel environments, highlighting the fact that the surrounding
microenvironment plays a particular role in normal ductal formation and overall
regulation of ductal branching and lobular formation in the breast.
The objective of this work was to develop a heterogeneous in vitro 3D breast
tissue model. This model will be used as a proof of concept of a modular research model
system. Gels of different compositions and concentrations, seeded with mammary
epithelial cells, were used to develop the stromal component of the 3D breast tissue
model. Three hydrogel matrices, Agarose, Collagen Type I, and Matrigel™, were
assessed for use as the 3D tissue model stromal component. Cell viability and generation
of acinar-like structures was assessed following seeding with MCF10A cells. The most
appropriate hydrogel was selected. This study, first determined the most suitable
component(s) for the base of the 3D model and second defined the optimal hydrogel
concentration for the 3D system.

Materials and Methods
Cell Culture and 3D Constructs
Normal breast epithelial cells (MCF10A; ATCC, Manassas, VA) were cultured in
Dulbecco’s Modified Eagle Medium (DMEM, Atlanta Biologicals®, Lawrenceville, GA)
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supplemented with 10% Fetal Bovine Serum (FBS; Corning, Manassas, VA), 1%
Fungizone (Life Technologies, Grand Island, NY), 5% antibiotic/antimycotic (Life
Technologies) and Clonetics® MEGM® SingleQuots® (Lonza, Walkersville, MD)
supplements including: 2.0 mL BPE, 0.5 mL hEGF, 0.5 mL hydrocortisone, 0.5 mL
insulin, and 0.5 mL GA-1000. While in 2D culture, medium was changed every 2-3 days.
Once cells were approximately 75% confluent, they were trypsinized (Corning) spun
down, and resuspended at 6x106 cells/mL. To generate the 3D culture systems three
hydrogel materials: agarose (Lonza,Rockland, ME), collagen Type I (BD Biosciences,
Bedford, MA), and Matrigel™ (BD Biosciences) at 1.6% (w/v), 1.6 mg/mL, and 1.6
mg/mL, respectively, were used either alone or in combination as the conditions for the
3D constructs based on previous work by Swamydas et al. [95]. An initial layer (150 µL)
of the 3D system components were plated in 8-well chamber slides (Nunc, Rochester,
NY) and gelled in an incubator (37°C, 5% CO2) for 30 minutes to provide a base layer in
the system to prevent cells from attaching to the bottom of the well. Then a top layer of
300 µL was mixed with 20 µL of cell suspension (6x106 cells/mL) and plated on top of
the base layer. Constructs were placed in the incubator and medium added after 24 hours.
Medium was changed every 3 days. MCF10A cells were grown for 10 days within each
system and evaluated for cell viability and acinar-like and ductal-like structure formation.
To determine the concentration of the base model 3D system, MCF10A cells
(1.2x105 cells/well) were mixed with collagen Type I and Matrigel™ (1:1 v/v) at 1.6, 2.4,
3.2, and 4.0 mg/mL concentrations, using the above method of a bi-layer design. Medium
was added 24 hours after seeding and changed every 3 days, harvesting the constructs at
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day 10. Repeating Live/Dead and histological analysis of the gels to determine the
optimal concentration.
Live/Dead Assay
Cell viability was assessed using a LIVE/DEAD® cell viability kit (Invitrogen,
Eugene, OR) according to the manufacture’s protocol. A Live/Dead assay solution using
a ratio of 2 mL of Dulbecco’s Phosphate Buffered Saline (PBS; Sigma, St. Louis, MO) to
1 µL of 4mM calcein-AM stock and 4 µL of 2 mM EthD-1 stock was prepared. After 30
min incubation with the Live/Dead assay solution the solution was removed and gels
were fixed in 4% paraformaldehyde (Sigma) for 30 minutes. Constructs were rinsed
twice with PBS to remove any remaining paraformaldehyde. A Zeiss Axiovert 40 (Carl
Zeiss MicroImaging, Gottingen, Germany) inverted fluorescent microscope was used to
capture representative fluorescent images of cells within the 3D constructs. Images were
analyzed using Image J (National Institutes of Health) cell count plug-in.
Cell Cluster Measurements
Phase contrast images of the 3D constructs containing cells were taken at the
same time as the Live/Dead assay. Images were captured on a Zeiss Axiovert 40 inverted
microscope. Using the outline tool in the Zeiss AxioVision software (Version 6.4, Carl
Zeiss) borders were drawn around the cell clusters and the corresponding area of the cell
clusters was calculated.

81

Histological Analysis
Histological 3D culture samples were fixed in 4% paraformaldehyde and frozen
sectioned. Hematoxylin and Eosin (H&E, Richard Allan Scientific, Thermo Fisher
Scientific, Kalamazoo, MI) staining was used to evaluate the acinar and ductal-like
structure formation within the 3D constructs. A semi-quantitative analysis on a scale of 03 with 0 representing clusters with 2 or fewer cells, 1 representing clusters with 2-5 cells,
2 representing 5 or more cells [156] with partial polarization, and 3 representing clusters
with 5 or more cells with full polarization (full acinar structure formation) was used to
evaluate acinar structure formation in different construct conditions and concentrations.
A similar scale was used to evaluate ductal-like structure formation.
Immunofluorescence was used to evaluate the expression of E-cadherin (e.g.
confirmation of acinar-like structures and polarization of these cells in the clusters) and
Ki-67 (i.e., cell proliferation). Slides were rehydrated using a series of rinses (2X each) in
distilled H2O (MilliQ, Darmstadt, Germany), PBS, and 0.2% Tween 20 (Bio-Rad,
Hercules, CA) in PBS. A 1:1 solution of 5N hydrochloric acid (HCl; Ricca Chemical
Company, Arlington, TX) and PBS was placed on the samples for 15 minutes to
permeabilize the cells. Slides were rinsed 2X with 0.02% Tween 20 and then blocked
using 10% goat serum (Sigma) for 30 minutes. The first primary antibody, E-cadherin
(1:1600 in 1% goat serum, Pierce™ Thermo Scientific, Rockford, IL), was placed on the
samples at incubated at room temperature (RT) for 2 hours. The primary antibody was
removed and the secondary antibody, Alexafluor® 594-conjugated AffiniPure F(ab’)2
Fragment Goat anti-rat IgG (H+L, 1:200; Jackson ImmunoResearch Laboratories, Inc.,
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West Grove, PA), was added to the samples and incubated overnight at 4°C. Alexafluor®
594 was removed and a second primary, Ki-67 (1:1000, Pierce™) was added for 2 hours
at RT. Alexafluor® 488 goat anti-rabbit IgG (H+L, 1:200; Life Technologies, Eugene,
OR) was incubated on the samples overnight at 4°C. Samples were rinsed twice with
PBS and ddH20. Slides were mounted with ProLong Gold® antifade reagent with DAPI
(Life Technologies). Slides were allowed to dry and imaged using a Zeiss Axiovert 40
inverted fluorescent microscope. E-cadherin was evaluated semi-quantitatively using a
scale of 0-3, 0 indicating no expression and 3 indicating expression within cell clusters
containing 5 or more cells. Single cells and cell clusters containing 4 or fewer cells were
excluded from the analysis. Expression of Ki-67 was evaluated by counting the number
of cells that were expressing the Ki-67 protein. A total cell count was taken in order to
determine the percentage of Ki-67 positive cells.
Statistical Analysis
JMP software (SAS Institute Inc., Cary, NC) was used to run a one-way Analysis
of Variance (ANOVA, α=0.05) to analyze differences comparing all pairs using post-hoc
Tukey-Kramer HSD for differences in 3D construct conditions as well as between 3D
construct component concentrations for cell viability, cell cluster measurements, and
histological analysis.

Results
To determine the most suitable stromal component(s) to use in the 3D breast
tissue model, Agarose, Collagen Type I, and Matrigel™ were used either alone or in
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combination and seeded with MCF 10A cells. This combination of hydrogel material and
cells formed the stromal component constructs. A series of analyses were used to
optimize the type of hydrogel material(s) and the concentration of those components to
use in the 3D breast tissue model starting with cell viability. Cell cluster measurements
and histological analyses were completed on those constructs not eliminated by cell
viability.

Figure 3.1 Optimization of the component(s) and concentration to be used for the 3D breast
tissue model stromal component.

Part I – Determination of Stromal Component(s)
Live/Dead Analysis
Live/Dead analyses indicated that differences in stromal conditions led to
alterations in cell viability and morphology. Conditions that decreased cell viability
below 75% included Agarose alone (A), Agarose/Collagen (AC), and Collagen alone (C).
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However, the effects of these stroma conditions on cell viability and morphology were
not significantly different from one another. The stromal component condition produced
from a 1:1:1 ratio of Agarose, Collagen, and Matrigel™ (ACM) had an average MCF10A
cell viability of 74.18±10.69%. All other stromal component conditions had a cell
viability over 75%, including Agarose/Matrigel™ (AM), Collagen/Matrigel™ (CM), and
Matrigel™ alone (M) with 85.3±6.1%, 88.0±7.9% and 93.1±4.4%, respectively. AM,
CM, and M conditions were not significantly different from each other, but were
significantly different from ACM, C, AC, and A stromal component conditions (Figure
3.2). The average for Agarose/Collagen/Matrigel (ACM) was below 75%, but could not
be excluded confidently as determined through statistical analysis. Cell viability for AM,
CM, and M conditions were not significantly different from each other, but CM and M
were significantly different (p<0.0001) from ACM, C, AC, and A stromal component
conditions. The ACM condition was statistically different from both AC and AM at
p<0.01.
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Figure 3.1 Average percentage of cell viability (** p<0.01, *** p<0.0001). Conditions with
cell viability less than 75% were excluded from further analysis.

Histological cell analyses indicated multiple cells clustered together in all
conditions, with larger cell clusters being present in M constructs. The only condition to
show cells spread across a distance, which indicates ductal-like structure formation, in the
cell viability assay occurred in CM constructs (Figure 3.3). Conditions that contained
Agarose had fewer cells in a single plane compared to conditions that did not contain
Agarose.
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Figure 3.3 Live/Dead microphotographs depict cell viability in each condition
(magnification = 50x, scale bars = 200µm); (A) Agarose condition – lowest cell viability,
(CM) Collagen/Matrigel™ condition showing the ductal-like structures, (M) Matrigel™
condition – highest cell viability. Cells were imaged in multiple planes within the constructs
to get a representative cell cluster count for cell viability.

After exclusion of conditions with a viability of 75% four stromal component
conditions, ACM, AM, CM, and M, were further analyzed for cell cluster measurements
and histological analysis to determine the most appropriate stromal components for the
model.
Cell Cluster Measurements
Cell cluster measurements were divided into categories of single cells/small
clusters (0-125 µm2), medium sized clusters (126-500 µm2), large clusters (500-2000
µm2), and extra-large clusters (>2000 µm2). These structures were confirmed using H&E
staining. The greatest number of cell clusters (n=4285) were found in M constructs, but
the cell clusters formed at the intersection of the top and bottom layers of the construct
leaving all the cell clusters in focus at once. All other construct conditions, AM, ACM,
and CM, had cells and clusters that were distributed throughout the 3D constructs. The
CM constructs (n=693) and AM constructs (n=477) had the largest percentage of clusters
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(Figure 3.4) that fell within the category of large clusters with 48.4±6.5% and 48.5±6.5%
respectively, which was significantly higher (p<0.01) than both ACM and M construct
conditions. The ACM constructs had the lowest percentage (18.9±2.6%) of large clusters.

Figure 3.4 Percentage of cell clusters by size in conditions with cell viability above 75%.

Histological Analysis
Histological sections of the constructs were stained with H&E to assess the
presence of acinar and ductal-like structures. Ductal-like structures were observed in CM
conditions. H&E staining also showed that cells and cell clusters were not distributed
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throughout M based constructs, where cells settled on the bottom layer of the gel
constructs.
Immunofluorescence staining was used to evaluate cell proliferation (Ki-67) and
acinar polarity (E-cadherin) in the stromal component constructs. Regardless of stromal
component conditions, low percentages of Ki-67 positive cells indicative of low cell
proliferation were measured (Table 3.1). ACM constructs had the lowest cell
proliferation after 10 days in culture with 0.40% and M constructs the highest with
1.25%. E cadherin staining was conducted on cell clusters with 5 or more cells, scored on
a scale of 0-3. M constructs had the highest semi-quantitative score and ACM with the
lowest (Table 3.1). Agarose containing constructs, ACM and AM, had very few cell
clusters containing 5 or more cells, 0 and 16 clusters respectively, whereas the Matrigel™
containing constructs had more cell clusters of 5 or more cells. Some M clusters
contained over 10 cells per cluster and many of the clusters were polarized with cell
nuclei oriented around the outer edge of the clusters with an open center (Figure 3.5).

Table 3.1 Histological analysis of the effects of stromal component conditions on both cell
proliferation and cell cluster polarity as determined by Ki-67 and, E-cadherin staining,
respectively.
Cond
ACM
AM
CM
M

Ki-67 Counts
#Cells # Pos % Pos

E-cadherin Scoring Categories
0
1
2
3

Total
Score

250

1

0.40%

0

0

0

0

0.0

473

4

0.85%

14

2

0

0

12.5

655

8

1.22%

15

12

6

0

72.7

1036

13

1.25%

15

20

10

5

110.0
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Figure 3.5 E-cadherin staining showing polarity of cell clusters for ACM, AM, CM, and M
(nuclei in blue and E-cadherin in red). Magnification = 100x, scale bars = 100 µm.

Part II – Determination of Stromal Component Concentration
From Part I of the study, constructs of Collagen/Matrigel™ were selected for the
stromal component of the 3D breast tissue model. Next, the concentration of the stromal
component must be determined. Initial concentrations of 1.6, 2.4, 3.2, and 4.0 mg/mL
were considered. Concentrations with cell viability below 75% were eliminated and then
cell cluster measurements and histological analysis were conducted to inform the
decision of the appropriate concentration for the 3D breast tissue model.
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Live/Dead Analysis
Cell viability based on the stromal component concentration was evaluated with a
Live/Dead analysis. Collagen/Matrigel™ constructs produced with concentrations of 4.0
mg/mL led to the lowest cell viability i.e., below 75% and significantly lower (p<0.0001)
than the cell viability observed in Collagen/Matrigel™ at concentrations of 1.6, 2.4, and
3.2 mg/mL, respectively. The 2.4mg/ml Collagen/Matrigel™ construct reliably (low
variability) produced led to the highest cell viability (78.3±3.4%, Figure 3.6).
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Figure 3.6 Cell viability within 3D construct produced from different concentrations,
ranging from 1.6-4.0 mg/mL of Collagen Type I and Matrigel™ in a 1:1 ratio.
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Cell Cluster Measurements
The 1.6 mg/mL concentration of Collagen and Matrigel™ had a significantly
higher (p<0.01) percentage of cell clusters in the 501-2000 µm2 range, with 66.2±8.2%
(n=935) of clusters falling within this range. A lower percentage of large area clusters
formed for 2.4 and 3.2 mg/mL constructs, 29.0±1.4% (n=1393) and 18.8±5.6% (n=165),
respectively.

Figure 3.7 Cell cluster measurements for remaining concentrations with cell viability above
75%.
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Histological Analysis
Hematoxylin and Eosin staining showed that Collagen/Matrigel™ constructs with
a concentration of 2.4 mg/mL had both acinar and ductal-like structures whereas only
acinar-like structures were observed in constructs generated using CM at 1.6 or 3.2
mg/mL concentrations (Figure 3.8). Of note, many of the cells and cell clusters were
found as a single layer at the intersection of the top and bottom layers of the construct in
the 1.6 mg/mL concentration. In contrast, the constructs generated with CM at 2.4 and
3.2 mg/mL concentrations had more uniformly distributed cells and cell clusters.
However, in the CM 2.4 mg/mL constructs the ductal-like structures mainly formed at the
intersection of the bottom and top layers. The construct generated from CM 3.2 mg/mL
concentration led to cell cluster formation uniformly throughout the construct.
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Figure 3.8 H&E staining of 1.6, 2.4, and 3.2 mg/mL stromal component concentration
constructs (top row: magnification = 50x, scale bars = 200 µm; bottom row: magnification =
200x, scale bars = 50 µm).

Immunofluorescence staining was used to evaluate cell proliferation (Ki-67) and
acinar polarity (E-cadherin) in the remaining CM constructs produced at concentrations
of 1.6, 2.4, and 3.2 mg/mL. Regardless of stromal component conditions, low
percentages of Ki-67 positive cells indicative of low cell proliferation were measured
(Table 3.2). CM constructs of 3.2 mg/mL concentration had the lowest cell proliferation
after 10 days in culture with 0.82% and 1.6 mg/mL concentration constructs the highest
with 1.18%. E cadherin staining was conducted on cell clusters with 5 or more cells,
scored on a scale of 0-3. Constructs produced from 3.2 mg/mL components had the
highest semi-quantitative E-cadherin score, 88.4, closely followed by the 2.4 mg/mL
concentration at 76.1, while the 1.6 mg/mL concentration had the lowest score at 40.4
(Table 3.2). Constructs of 1.6 mg/mL had many cell clusters that formed along the
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intersection of the bottom and top layers of the construct (Figure 3.9). These cell clusters
did not demonstrate as much polarization as the 2.4 and 3.2 mg/mL concentrations cell
clusters containing 5 or more cells. In the 2.4 and 3.2 mg/mL concentration constructs
many of the clusters were polarized with cell nuclei oriented around the outer edge of the
clusters with an open center (Figure 3.9).
Table 3.2 Histological analyses of stromal component concentrations
Ki-67 Counts
E-cadherin Scoring Categories
Conc
# Cells
# Pos
% Pos
0
1
2
3
844
10
1.18%
33
10
3
1
1.6
780
9
1.15%
12
33
1
0
2.4
736
6
0.82%
19
11
12
1
3.2

1.6

2.4

Total
Score

3.2

Figure 3.9 DAPI staining from Ki-67/E-cadherin staining showing polarity of cell clusters
found in 1.6, 2.4, and 3.2 mg/mL concentration constructs (magnification = 100x, scale bars
= 100 µm).

Based on consistency, a cell viabilty greater that 75%, cell cluster measurements
that indicate the formation of cell clusters containing 5 or more cells, and histological
analysis of the cell clusters constructs formed using CM at a concentration of 2.4 mg/mL
is optimal for use in our 3D breast tissue model.
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40.4
76.1
88.4

Table 3.3 An overview of why the 2.4 mg/mL Collagen/Matrigel™ concentration was
selected for the 3D breast model stromal component.

Collagen/Matrigel™
Concentration

1.6 mg/mL

2.4 mg/mL

Cell Viability

Cell viability above 75%

Highest cell viability
(78.35%) with lowest
variability

Cell Cluster
Measurement

Significantly higher
(p<0.01, 63.7%)
percentage of cell
clusters in the 501-2000
mm2 range

29% of cell clusters fell
in the 501-2000 mm2
range

Acinar Structure Acinar structures formed
mostly at the intersection
Formation between construct layers

Only concentration to
have both acinar and
duct-like structure
formation

3.2 mg/mL

Cell viability above 75%

14.9% of cell clusters fell
in the 501-2000 mm2
range

Acinar structure
formation found
uniformly throughout
constructs

Discussion
The objective of this study was to optimize the stromal component(s) and
concentration for the 3D model system to best represent the normal microenvironment of
the breast. The stromal components of Agarose, Collagen Type I, and Matrigel™ were
chosen based on their prevalent use in 3D model systems [79-81, 94, 95, 150]. All three
materials chosen have limitations and challenges. Agarose is stiffer than the other
materials and only allows limited cell movement and growth. Collagen is remodeled
quickly and alterations in the gel structure and stiffness are observed in short periods of
time. Lastly, Matrigel™ is a complex ECM with somewhat variable composition derived
from tumors, which may include components that adversely affect cell growth within the
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3D stromal constructs. Thus we tested different combinations of Agarose, Collagen Type
I, and Matrigel™ in varying ratios and densities to produce different constructs.
In producing the 3D constructs, we added a bottom layer of the component(s) to
prevent cells from settling out of the construct and attaching to the bottom of the 8-well
chamber slides. If the cells settled out of the constructs, then in Chapter 4, the polylactide
beads that are added to the 3D constructs would also settle out providing an environment
that was more 2D than 3D for the cells cultured. Also, in preliminary studies, if
constructs were produced without the bottom layer they would detach and begin floating
in 3-5 days. This is problematic because it affects the mechanics of the microenvironment
and the mechanical forces the cells sense in the constructs [157]. While a detached gel
model is successful in modeling breast cancer [45, 46, 67, 79], our model was intended to
stay anchored in the 8-well chamber slides. To prevent this from happening a thin bottom
layer was added to the constructs to ensure attachment of the constructs for 10 days.
Dhimolea and colleagues found that after 10 days in culture, MCF10A cells contraction
of collagen gels decreases and the risk of the gels floating reduces greatly [79].
Monitoring cells in 3D presented some unique challenges. For example,
Live/Dead analysis of the cells required longer incubation time as the dye solution had to
diffuse throughout the constructs before cells could be effectively stained. One of the key
technical limitations of the microscopic analyses of the 3D cell culture conditions is the
monitoring of 3D structures spanning multiple microscopy planes. Similar challenges are
inherently present in the histological analyses of those 3D structures. Approaches to
address those challenges have been reviewed [158]. Here, serial histological sections
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provided additional information regarding cell location and organization in the conditions
tested.
Based on the cell viability criterion (i.e., above 75%), observations in Part I of this
study led to the removal of constructs generated from A, C, and AC from further
consideration. As expected, constructs containing Agarose led to low cell viability partly
because they only allow limited movement and growth of the cells. Collagen I based
constructs also led to low cell viability (below 75%). Indeed, while Collagen Type I is
one of the main components of the breast, it has been shown that cell viability is reduced
in constructs made solely from Collagen Type I [159]. Matrigel™ containing constructs
performed as described previously in many of the assays conducted [95, 160]. Matrigel™
is used in many 3D cultures because of the cellular response to the material [94, 160,
161]. While the Matrigel™ used in the constructs tested here is growth factor reduced, it
is nevertheless an ECM secreted by tumor cells, with inherent variability in the
composition of ECM components and factors presents [161]. Here, Matrigel™ alone
based constructs were found to be a challenging 3D environment mostly due to the lack
of thickness the construct provides (Figure 3.5) that prevented incorporation of 300425µm diameter polylactide beads (see Chapter 4).
The remainder of the analyses were performed on constructs selected on the basis
of cell viability, all of them containing Matrigel™. Cell cluster measurements revealed
that AM and CM based constructs led to the formation of the highest percentage of cell
clusters with area measurements in the large range of 501-2000 µm2. While M based
constructs led to many more clusters than any other construct (4,285 vs. 425 to 700,
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respectively), it led to the lowest percentage of large-range cell clusters. In contrast with
other constructs, in the M based constructs, cells formed a compact cell layer facilitating
the microscopic monitoring of both single cell and cell clusters. In AM and CM based
constructs single cells and cell clusters were dispersed in multiple focal planes and
averaged between 10 and 50 cell clusters per stack of fields of view.
H&E staining of the ACM, AM, CM, and M based constructs confirmed that in M
based constructs the cells seeded onto the top of the bottom layer and grew at the
interface between the 2 layers of the constructs. In all other constructs cells dispersed
throughout. ACM based constructs had smaller cell clusters, likely due to the presence of
Agarose that form a stiffer matrix holding cells in place and preventing matrix
remodeling as mammalian epithelial cells typically do not express the enzyme (agarase)
to break down agarose [160]. Agarose molecules within the construct limit interactions
and remodeling of collagen and other matrix compounds present in Matrigel™ [160].
Agarose also by limiting cell interactions and signaling by ECM compounds prevented
cell proliferation as suggested by low Ki-67 staining. The most Ki-67 positive cells were
observed in M constructs and can be contributed to Matrigel™ composition that provides
a 3D microenvironment for cell growth and proliferation, but also acted as a 2D
substratum allowing cells to concentrate in limited area thereby increasing inter-cell
signaling resulting in both proliferation and acinar structure formation. This interpretation
is supported by the observations that in M based constructs cells also formed the most Ecadherin positive cell clusters compared to other constructs tested.
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Next, the optimal Collagen/Matrigel™ (CM) concentration to be used in
constructs was determined. Initial constructs with CM concentrations of 1.6 to 4.0
mg/mL were derived from previous work by Swamydas and colleagues [95]. The initial
constructs using a CM concentration of 1.6 mg/mL was selected based on the stiffness of
the material and its ability to incorporate polylactide beads without breaking apart or not
covering the beads completely as it settled while gelling. CM constructs with
concentrations greater than 4.0 mg/mL are significantly more stiff [162]. However, such
stiffness is significantly higher than those measured in normal breast tissues and thus
were excluded from the present study. Three criteria for the stromal component
concentration of the constructs were used to determine the optimal constructs: (1) cell
viability within the constructs, (2) cell formation of acinar and ductal-like structures, and
(3) proper polarization of the formed structures.
Live/Dead assays demonstrated that the cell viability significantly decreased in
CM-based construct generated with 4.0 mg/mL compared to CM based constructs made
with either 1.6, 2.4 or 3.2 mg/mL. The observed decrease in cell viability likely has
multiple causes including possibly the consequence of a decreased nutrient diffusion but
more likely the absence of appropriate microenvironment cues [92].
As the concentration of CM increased in the constructs tested, a decrease in the
size and number of clusters was observed. However, in the 1.6 mg/mL CM derived
constructs, cells settled to the bottom of the top layer producing a dense layer of cells at
the interface between the two layers of the construct. In those conditions, larger cell
clusters formed at that location whereas fewer cell clusters were present throughout the
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rest of the construct. In the CM constructs derived from 2.4 and 3.2 mg/mL
concentrations, cell clusters were smaller, but more dispersed throughout the top layer of
the construct. Additionally, in the 2.4 mg/mL CM derived constructs, ductal-like
structures were observed mostly at the interface between the bottom and top layers (as
seen in Figure 3.8). Some ductal-like structures had cell nuclei that oriented around an
open middle that carried over a distance greater than 3-4 cells. In both H&E and
fluorescent histological sections, these structures were shaped like commas, where at
least one end was tapering while either the center had more space or the opposite end was
rounded out similar to a terminal end bud.
The histological analysis conducted confirmed the cell viability and cell cluster
measurement results. Ki-67 expression was not expected to be prevalent by day 10 within
the constructs as most cells in clusters would be in the process of differentiating or if they
were located at the center of a cluster, they may be in the process of apoptosis. Single
cells that were isolated would not be proliferating unless they had the right cues from
nearby cells and cell clusters. E-cadherin expression should only be observed in cell
clusters that are in the process of becoming polarized or differentiating. Results showed
that E-cadherin expression increased as the concentration of Collagen and Matrigel™
increased. One explanation might be that in order for cell polarization and differentiation
within the cell clusters the cells must be in a stiffer environment or provided signals from
adjoining cells through cell-cell junctions.
Basecd on the data gathered in the present study, the optimal 3D matrix
(construct) for modeling breast tissue can be generated using a ratio 1:1 of Collagen I and
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Matrigel™ at a concentration of 2.4 mg/mL. This CM derived construct provided
MCF10A cells a microenvironment compatible with cell survival, proliferation and
differentiation into organized acinar and ductal-like structures.

Summary
Optimal MCF10A cell growth occurs in 3D constructs derived from combined
collagen I and Matrigel™, Therefore, these components will serve as the stromal matrix
of the heterogeneous 3D breast tissue models (see Chapter below). The next studies
further our understanding of how combinations of matrix components and polylactide
microspheres modulate cell viability. Additionally, normal and cancerous cell behavior is
evaluated in a heterogeneous breast tissue model that incorporates polylactide beads in
CM-based constructs.
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CHAPTER FOUR

A COMPOSITE 3D BREAST MODEL TO DETERMINE THE EFFECTS OF
HETEROGENEITY ON NORMAL AND CANCEROUS BREAST EPITHELIAL
CELLS

Introduction
Much research using breast tissue models has been conducted to understand how
cells become cancerous in the mammary gland, propagate, and eventually metastasize in
the body. While this research has provided a better understanding of the underlying
mechanisms associated with normal mammary gland function and breast cancer, our
understanding of the extracellular matrix (ECM)-cell interactions during normal breast
tissue and malignant development remains unclear. Model systems currently in use
include clinical and in vivo models, two-dimensional (2D) in vitro models, and threedimensional (3D) in vitro culture models. In recent years, 3D model systems have been
developed for numerous normal tissues and pathologic conditions. Ranging from the use
of tissue tumor explants to cell lines in homo or heterotypic cultures, 3D in vitro culture
systems provide information on the role of mesenchymal cells, the matrix composition,
and density in the formation of acinus- and duct-like structures. However, the need for
reliable, versatile, and reproducible 3D in vitro model systems that allow the modulation
of the ECM properties remains.
In the normal breast, cellular and ECM components change with development
over time. In breast cancer, changes in the microenvironment are indicated through
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increased cell populations as well as changes in the ECM. The tumor microenvironment
is a heterogeneous environment that is most notably characterized by an increase in
fibroblast and myofibroblast activity, increased angiogenesis, increased infiltration of
inflammatory cells, and remodeling of the extracellular matrix adjacent to the cancerous
cell [28]. Without the influence and inclusion of these cell types and structural
components in current 3D models, it is not possible to completely understand how
polarity affects tumor initiation, progression, and metastasis.
Normal human and murine mammary epithelial cell culture models have been
established to uncover the key components of initiation and maintenance of cell
differentiation. Those components include both the mammary and stroma cells and the
proteins of the surrounding ECM [69]. In these models the correlation between cell shape
and growth and differentiation [45, 46, 66], the role the ECM plays to influence cell
phenotype [67, 69, 79, 80], and the interaction between epithelial and stromal cells [13,
25, 81] have been investigated. In most of these 3D culture systems, matrix materials
(e.g., collagen, reconstituted basement membrane) allow the formation and maintenance
of morphology and functions mimicking those observed in vivo [69]. In particular, these
materials support the generation of polarized luminal ductal and acinar structures.
However, the use of these matrix materials is challenging, in part because of composition
inconsistency as well as variability between lots, and makes the interpretations of
observations made in those system more difficult [74].
Cancer models have significantly enhanced our understanding of carcinoma
biology in four areas: the formation and maintenance of a hollow glandular lumen and its
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disruption by cancer genes, the regulation of apical-basal polarity in normal and
cancerous epithelium, the discovery that cell-cell and cell-ECM adhesion pathways
interfere with the phenotypic expression during the tumorigenic progression, and the
emerging importance of ECM tensional force driving 3D tissue architecture and
homeostasis [74]. While these four areas are of great importance in understanding tumor
formation and cancer progression, others have also used 3D models to evaluate the
cytotoxicity and toxicology of cancer drugs [82-84]. While these models help to further
our understanding of breast cancer and its progression, they have yet to investigate the
effects of heterogeneity on normal and breast cancer cells.
Overall, current 3D models have allowed insight into the development and
function of normal mammary epithelial tissue, tumor formation and cancer progression,
as well as evaluation of effective therapeutic agents in cancer treatment. However, there
are limitations as to what cellular and matrix components are used, what these models
can accomplish, and how well they represent the true in vivo breast conditions.
Furthermore, standardization of such culture systems may generate a reliable and
reproducible model to test and monitor breast cancer treatments. Thus, a new modular 3D
breast tissue model will be developed. The 3D breast tissue model system will be
customizable to answer specific questions about the normal mammary microenvironment
and its influence in cancer progression.
The development of a composite 3D breast tissue model will allow for
determination of the effects of heterogeneity on normal mammary epithelial and
cancerous epithelial cells. The mechanical stiffness of the 3D model system, generated
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with or without beads embedded in the hydrogel, will be evaluated at the macro- and
micro-mechanical level using an Instron mechanical tester and an atomic force
microscope (AFM), respectively. MCF10A and MCF7 cell viability, proliferation, and
function will also be evaluated in these 3D model systems and the effects of stiffness (i.e.
inclusion of the beads) determined.

Materials and Methods
Cell Culture and 3D Breast Model Systems
Normal breast epithelial cells (MCF10A; ATCC, Manassas, VA) were cultured in
Dulbecco’s Modified Eagle Medium (DMEM, Atlanta Biologicals®, Lawrenceville, GA)
supplemented with 10% Fetal Bovine Serum (FBS; Corning, Manassas, VA), 1%
Fungizone (Life Technologies, Grand Island, NY), 5% antibiotic/antimycotic (Life
Technologies) and Clonetics® MEGM® SingleQuots® (Lonza, Walkersville, MD)
supplements including: 2.0 mL BPE, 0.5 mL hEGF, 0.5 mL hydrocortisone, 0.5 mL
insulin, and 0.5 mL GA-1000. MCF7 cells (ATCC) were cultured in DMEM
supplemented with 10% FBS, 1% Fungizone, 5% antibiotic/antimycotic. While in 2D
culture, medium was changed every 2-3 days. Once cells were approximately 75%
confluent, they were trypsinized (Corning) spun down, and resuspended at 6x106
cells/mL. To make the 3D breast model systems Collagen Type I (BD Biosciences,
Bedford, MA) and Matrigel™ (BD Biosciences) at 2.4 mg/mL were used in a ratio of 1:1
as the stromal component for the 3D models based on previous work by Swamydas et al.
[95]. An initial layer (150 µL) of the 3D system components were plated in 8-well
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chamber slides (Nunc, Rochester, NY) and gelled in an incubator (37°C, 5% CO2) for 30
minutes to provide a base layer in the system. Then a top layer of 300 µL was pipetted
into a 1.5 mL microcentrifuge tube either without cells (control gels) or with 20 µL of
MCF10A or MCF7 cell suspension (model gels) and incubated for 24 minutes. The
microcentrifuge tubes were removed from the incubator and 17 mg of beads were added
to half of the model gels containing no cells, MCF10A cells, or MCF7 cells. The beads
were mixed into the gels using 1000 µL pipette tips that were modified to have a wider
opening, pipetting the beads and gel mixture to mix thoroughly. The model gel contents
were then transferred to the 8-well chamber slides and plated on top of the base layer.
Gels were placed in the incubator and respective cell medium added after 24 hours.
Medium was changed every 3 days. All 3D models were grown for 10 days then
evaluated for cell viability, acinar- and ductal-like structure formation and measurements,
and macro- and micro-mechanical changes, as well as histological analysis of cell
proliferation, cell-cell adhesion, cell-ECM adhesion, and migration markers.
Live/Dead Assay
Cell viability was assessed using a LIVE/DEAD® cell viability kit (Invitrogen,
Eugene, OR) according to the manufacture’s protocol. A Live/Dead assay solution using
a ratio of 2 mL of Dulbecco’s Phosphate Buffered Saline (PBS; Sigma, St. Louis, MO) to
1 µL of 4mM calcein AM stock and 4 µL of 2 mM EthD-1 stock was prepared. After a
30-minute incubation with the Live/Dead assay solution and 10-minute incubation with
Hoechst (Invitrogen) the solution was removed and gels were fixed in 4%
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paraformaldehyde (Sigma) for 30 minutes. Gels were rinsed twice with PBS to remove
any remaining paraformaldehyde. A Zeiss Axiovert 40 (Carl Zeiss MicroImaging,
Gottingen, Germany) inverted fluorescent microscope was used to capture representative
fluorescent microphotographs of cells within the 3D constructs. Microphotographs were
analyzed using Image J (National Institutes of Health).
Cell Cluster Measurements
Phase contrast microphotographs of the 3D constructs containing cells were taken
at the same time as the Live/Dead assay. Microphotographs were captured on a Zeiss
Axiovert 40 inverted microscope. Using the outline tool in the Zeiss AxioVision software
(Version 6.4, Carl Zeiss) borders were drawn around the cell clusters and the
corresponding area of the cell clusters was calculated.
Macro- and Micro- Mechanical Analysis
Macro-mechanical analysis of the 3D breast models was conducted using an
Instron mechanical tester (Instron, Norwood, MA). Acellular model systems were
produced as stated above in 8-well chamber slides. The chamber slides were then placed
on a platform (made in house, using acrylic, to fit over the chuck) on the Instron machine.
A 50 N load cell (Instron) and a circular compression platen (diameter = 6 mm) was used
to determine how the inclusion of beads within the model changes the mechanical
properties. The compression platen was lowered into the sample at 3mm/min until the
Instron registered a compressive load of 0.05 N, indicating full surface contact with the
models. After contact, the compression platen continued lowering into the samples at 3
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mm/min until a strain of 25% was reached based on the average initial thickness of the
model gels. Bluehill 2 software (Instron) was used to calculate the 3-15% chord modulus
of the gels.
Micro-mechanical analysis of the 3D models was conducted using an atomic
force microscope (AFM). Acellular model systems were produced in a similar fashion
above, but plated into custom made molds representing an 8-well chamber slide that was
2 mm thick so that the AFM tip could be lowered into the model systems without
interference. An MDF-3D-BIO™ AFM (Asylum Research, Santa Barbara, CA) with
spherical AFM tips (5 mm radii, spring constant 0.08 N/m; NanoandMore, Lady's Island,
SC) was used. Each sample was tested at four points. The elastic modulus was calculated
by fitting a Hertz model, as defined in Lance et.al. [162].
Histological Analysis
Histological 3D culture samples were fixed in 4% paraformaldehyde and frozen
sectioned. Hematoxylin and Eosin (H&E, Richard Allan Scientific, Thermo Fisher
Scientific, Kalamazoo, MI) staining was used to evaluate the acinar-like and ductal-like
structure formation within the 3D constructs. A semi-quantitative analysis on a scale of 03 was used to evaluate acinar structure formation with cell clusters containing at least 5
cells [18] in different construct conditions and concentrations. A semi-quantitative
analysis on a scale of 0-3 and reported with a score between 0 and 300, with 0
representing clusters with 2 or fewer cells, 1 representing clusters with 2-5 cells, 2
representing 5 or more cells with partial polarization, and 3 representing clusters with 5
or more cells with full polarization (full acinar structure formation) was used to evaluate
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acinar structure formation in different construct conditions and concentrations [163]. A
similar scale was used to evaluate ductal-like structure formation.
Immunofluorescence was used to determine the expression of E-cadherin (i.e. the
presence of acinar-like structures and polarization of these cells in the clusters), c-Met
(migration), Integrinß1 (cell-ECM adhesion), and Ki-67 (cell proliferation). Frozen
section from 3D cultures for each condition tested were first rehydrated using a series of
rinses (twice each) in distilled H2O (MilliQ, Darmstadt, Germany), PBS, and 0.2%
Tween 20 (Bio-Rad, Hercules, CA) in PBS. Then sections were incubated 15 minutes in
1:1 solution of 5N hydrochloric acid (HCl; Ricca Chemical Company, Arlington, TX)
and PBS to permeabilize cells. After rinsing twice with 0.02% Tween 20 and then
blocking using 10% goat serum (Sigma) for 30 minutes, slides were incubated at room
temperature (RT) for 2 hours with E-cadherin (1:1600 in 1% goat serum, Pierce™
Thermo Scientific, Rockford, IL). Following rinsing step, slides were incubated overnight
at 4°C with Alexafluor® 594-conjugated AffiniPure F(ab’)2 Fragment Goat anti-rat IgG
(H+L, 1:200; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). Next, after
a rinsing step, samples were incubated at RT for 2 hours with either Ki-67 (1:1000,
Pierce™), c-Met (1:1000, Pierce ™), or Integrinß1 (1:1000, Pierce™). After a
subsequent rinsing step, slides were incubated overnight at 4°C with. Alexafluor® 488
goat anti-rabbit IgG (H+L, 1:200; Life Technologies, Eugene, OR). After rinses in PBS
and ddH20, samples were mounted in ProLong Gold® antifade reagent with DAPI (Life
Technologies). Slides were allowed to dry and imaged using a Zeiss Axiovert 40 inverted
fluorescent microscope. E-cadherin and Integrinß1 expressions were evaluated semi-
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quantitatively using the following 0-3 scale with 0 indicating no expression and 3
indicating positive expression, within cell clusters containing 5 or more cells. Single cells
and cell clusters containing 4 or fewer cells were excluded from the analysis. Expression
of Ki-67 and c-Met was evaluated based on expression in single cells.
Statistical Analysis
JMP software (SAS Institute Inc., Cary, NC) was used to run a one-way Analysis
of Variance (ANOVA, α=0.05) to analyze differences comparing all pairs using post-hoc
Tukey-Kramer HSD for cell viability, cell cluster measurements, mechanical properties,
and histological analyses.

Results
The objective of the study was to investigate whether increased heterogeneity
generated by the inclusion of polylactide beads in Collagen/Matrigel™ matrices, within
the 3D models, affected both normal and cancerous mammary epithelial cells.
Live/Dead Analysis
In CM matrix containing or not polylactide beads, MCF10A or MCF7 cells were
seeded and cell viabilities were determined. MCF10A cells showed a significantly higher
cell viability compared to MCF 7 cells in either CM matrix or CM matrix + polylactide
beads (p<0.0001, Figure 4.1). In CM matrix, the cell viability of MCF10A cells was
62.1±20.1%, while the percentage of viable MCF7 cells was 50.1±19.5%. When beads
were incorporated into the CM matrix, the MCF10A cell viability increased to
69.1±18.9% while the MCF7 cell viability decreased to 38.3±20.1%. Thus, the addition
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of polylactide beads significantly decreased MCF7 cells viability (p<0.05, Figure 4.1).
When MCF10A cells were seeded onto CM matrix containing polylactide beads, the cells
attached and grew on the beads (Figure 4.1B), whereas MCF7 cells in similar conditions
did not. The coverage of the polylactide beads embedded in the CM matrix by MCF10A
differed. Nevertheless, MCF10A cells completely coated many of the smaller beads
(~200-250 µm Figure 4.1B). As most of the beads were lost during the sectioning
process, no histological analysis was performed.
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Figure 4.1 (A) Comparison of cell viability in the model systems produced with and without
polylactide beads; * p<0.05, *** p<0.0001. (B) Fluorescent image of a 3D Hoechst stained
Collagen/Matrigel™ gel embedded with polylactide beads. Arrow points to a polylactide
bead surrounded by MCF10A cells; scale bar = 200 µm. (C) Section of an MCF10A model
containing beads; nuclei of cells stained with DAPI. Scale bar = 100 µm.
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Figure 4.2 Phase contrast microphotographs of the model systems containing MCF10A (left
column) and MCF7 cells (right column) with (bottom row) and without (top row)
polylactide beads (magnification = 200x, scale bars = 50 µm). In all models without beads,
single cells and acinar structures formed throughout (black arrows) while ductal-like
structures (orange arrow) formed mostly in models with MCF10A cells.

Throughout the different planes of the CM matrix + beads many different
structures formed. Using phase microscopy, 3D cell structures formed were evaluated. In
CM matrices throughout the matrix, MCF10A cells were present either as single cells,
acinar structures, or ductal-like structures (Figure 4.2, upper left). Many of the ductal like
structures spanned multiple planes and seemed to orient directionally (not shown) within
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the gels. In the CM matrix + beads, cells were concentrated mostly in the areas between
the beads. Consequently, MCF10A cells were densely present in the CM matrix and used
the beads as a 2D surface proliferating across them (Figure 4.1B). This contrasted with
MCF7 cells that did not adhere to the beads but rather formed larger cell clusters (Figure
4.2, lower left).
Cell Cluster Measurements
Cell clusters were categorized as single cells/small clusters (0-125 µm2), medium
sized clusters (126-500 µm2), large clusters (500-2000 µm2), and extra-large clusters
(>2000 µm2). Seeding of MCF7 cells onto CM matrix embedded with or without beads
led to the formation of MCF7 cell clusters with surface areas of 1821 and 1442 µm2,
respectively. In contrast, in similar conditions, MCF10A cell clusters had surface areas of
631 and 910 µm2, respectively.
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Figure 4.3 Percentage of cell clusters that fell within the specified cluster measurement
ranges of single cells/small clusters (0-125 µm2), medium sized clusters (126-500 µm2), large
clusters (500-2000 µm2), and extra-large clusters (>2000 µm2).

Macro- and Micro-mechanical Testing
Mechanical testing was conducted on acellular model systems with and without
beads. Instron testing was used to determine if incorporation of polylactide beads
influenced the macro-mechanical properties of the model systems. No significant
differences were observed in the mechanical properties of the models when comparing
models without beads to models containing beads. Determined by Instron mechanical

116

testing the 3% chord modulus of the models was 66.2 ±128.2 Pa (n=12) and 37.3±68.9 Pa
(n=8) for models without and with beads, respectively. AFM, used to determine the
micro-mechanical properties of the model systems, indicated that inclusion of beads did
not affect the micro-mechanical properties of the systems. The modulus was determined
to be 3.04±0.37 Pa and 2.84±0.99 Pa for the CM matrix without (n=4) and with
polylactide beads (n=4), respectively.
Histological Analysis
MCF10A cells formed acinar and ductal-like structures as shown by H&E
staining, regardless of the inclusion of beads, within the CM matrix. The number of
structures formed was semi-quantified. MCF10A cells seeded in CM matrix containing
beads had the highest acinar structure whereas as MCF10A developed less acinar
structures when seeded in CM matrix (no beads) (score of 16.5 and 13.1, n≥6). MCF7
cells in similar conditions led to acinar structure scores of 14.4, and 13.1 (n=6)
respectively. Ductal-like structure quantification of H&E stained samples also indicated
that MCF10A cells seeded in CM matrix with beads led to the highest number of ductlike structure (16.5 vs. 11.7 in CM matrix without beads). MCF7 cells also led to ductlike structures more so in CM matrix containing beads (12.6 vs. 9.7, respectively). While
these observations have a high variability (no significant differences was observed
between cells or conditions for score for acinar and ductal structures), the inclusion of
polylactide beads in the CM matrix tends to affect the number of acinar and ductal-like
structures.
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Furthermore, the expression of Ki-67, E-cadherin, Integrinß1, and c-Met were
investigated to assess cell proliferation, cell-cell attachment, cell-ECM attachment, and
migration. The number of Ki-67 positive cells a marker of cell proliferation, was between
0.9 and 1.9% regardless of cell or condition tested. More proliferation was observed with
MCF10A cells (1.9% and 1.7% for CM matrix with and without beads, respectively)
compared to MCF7 cells in similar conditions (1.4% and 0.9% in CM matrix with and
without beads, respectively). E-cadherin was analyzed in cell clusters containing 5 or
more cells. CM matrix containing beads led to higher E-cadherin expression, 107 and 83
for MCF10A and MCF7 cells, respectively. In CM matrix (no beads) E-cadherin
expression was lower (81 and 71 for MCF10A and MCF7 cells, respectively). No
significant difference was observed between the conditions tested regardless of the
embedding of beads or the cells tested. Nevertheless, these observations strongly suggest
that increasing the heterogeneity of the CM matrix by the addition of polylactide beads
promote acinar structure formation especially by MCF10A cells. The expression of
integrin ß1 and c-Met was inconclusive possibly because of limitations in the fluorescent
filters used.
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Figure 4.4 E-cadherin staining of model systems. First column includes nuclei stained using
DAPI. Second column, same sections stained with E-cadherin primary antibody. Third
column, combined images overlaying the DAPI stained nuclei and the E-cadherin images.
Magnification = 100x, scale bars = 100 µm.
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Discussion
Criteria for to a optimized breast tissue 3D model included the ability to easily
and quickly change the stromal components to mimic different stages in breast
development and breast cancer progression. Further, knowing that the breast cancer
environment is heterogeneous, different materials and/or cell types were incorporated
within the 3D model. The rationale associated with the incorporation of polylactide
microspheres in the 3D model was two-fold. First, the polylactide beads are much stiffer
[164] compared to the hydrogel stromal components composed of Collagen TypeI/Matrigel™ [162], Second, as the beads degrade they release lactic acid into the
surrounding microenvironment helping mimic an acidic microenvironment normal in
breast cancer. While lactic acid release was not a parameter studied in the present set of
experiments designed to develop an heterogeneous 3D environment, lactic acid release
profiles likely would be similar to that presented in Chapter 2. The latter demonstrates
that polylactide beads can be used in multiple facets to study different effects.
During the formation of the 3D matrix, a bi-layer approach was used to prevent
the polylactide beads from settling out of the gels to the bottom of the wells. To get the
beads to stay suspended throughout the top layer of the constructs, the
Collagen/Matrigel™ components were incubated for 24 minutes and then beads were
mixed into the pre-gelled matrix. Since the gels were “pre-gelled” prior to adding the
beads, when the beads were mixed in the gel separated into chucks. After the beads are
mixed in, the chunks of pre-gelled components intermix within the non-gelled
components limiting the space where the beads can fall through the matrix, and thus
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keeping them suspended within our top layer. This method of mixing the beads into the
gel needs to be optimized further as differences in incubators and mixing methods
influence how well the pre-gelled phase keeps the beads in suspension.
In 3D CM matrix embedded with beads, the MCF10A cells are close enough to
the beads to sense the increased stiffness leading to cell migration and attachment to the
beads. In contrast, MCF7 cells did not attach to the beads in similar conditions. This is
most likely due to the anchorage dependence of MCF10A a behavior that is decreased or
lost in MCF7 cells.
Cell viability and cell cluster were used to ensure that the CM derived constructs
generated consistently mimicked observed made earlier (see Chapter 3). Inclusion of the
beads in the CM matrix did not seem to affect the cell viability. In fact an increased the
MCF10A cell viability as the beads provided additional surface for cells to adhere and
proliferate. Further, cell cluster observations made in the CM matrices embedded with
polylactide indicated that the pre-gelling process did not affect cell viability or how cells
clustered together. However, the double mixing step may have promoted the migration of
cells out of the CM matrix resulting in fewer clusters of cells as compared to our previous
observations where the top layer was plated and gelled without the intermediate “pregelling” step before adding beads (See Chapter 3).
Mechanical testing of the CM matrix with or without embedded polylactide
beads was conducted. However, due to the properties of the CM matrices, they could not
be removed from their plastic wells for mechanical testing. Thus, the CM matrices with
or without embedded beads were tested within the vessel wells. During the testing, the
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beads cut through the CM matrix due to the stiffness differential between the beads and
CM matrix and the pockets of liquid within the gels. To improve the accuracy of
measurements of the stiffness, an improved method of generating the CM matrix ± beads
should be implemented. The steps associated with the generation of CM matrix ± beads
also limited micro-mechanical testing methods. Normally when conducting AFM, gels
are tested in an unconfined manner, but due to the properties of the gels only confined
tests could be run. Further, the beads used in the CM matrix were on average 300 µm in
diameter, so the CM matrix had to be at least 500 µm thick to ensure that the beads were
suspended in the matrix. At this thickness, it was not possible to image through the
matrix while taking measurements. This made it impossible to determine exactly where
measurements were being taking within the matrix. To make more definitive conclusions
about how the incorporation of the beads affected the stiffness of the microenvironment
detected by the cells, more measurements at specific locations within the 3D
microenvironment should be undertaken.
The formation of cell clusters within the 3D conditions tested either acinus- or
duct-like structures was demonstrated using H&E staining and DAPI nuclear staining
MCF10A cells in the 3D condition tested formed cell clusters and cell clusters with 5 or
more cells started to form a polarized structure with hollow center. In contrast, when
MCF7 cells were cultured in those 3D conditions clustered cells rarely formed polarized
structures. Indeed, some of the MCF7 cell clusters had over 20 cells but no organized
structure. Further, MCF10A cells cultured in 3D CM matrix with beads led to clustered
cells expressing the greatest amount of E-cadherin suggesting proper polarity of acinar
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structures. While E-cadherin expression as seen in MCF7 cell clusters generated in
similar 3D culture conditions, the expression was not as localized between the cells
contrasting with the observation made in MCF10A cell clusters.
The embedding of beads to increase matrix heterogeneity led to increased cell
density in the matrix areas between the beads. These increased cell densities were
associated with the formation of larger clusters. This could be in part due to increased
signaling between cells through increased growth factor concentrations and/or direct cellto-cell contacts. Additionally, this could also be explained in part by the variation in the
mechano-transduction generated within the 3D CM matrix by the addition of beads.
Indeed, beads have a higher mechanical stiffness compared to Collagen and Matrigel™
and, thus the cells may be responding to this localized stiffness increase. Further research
should be conducted to confirm the importance of mechano-transduction in the cell
behavior.

Summary
A tunable 3D breast tissue model was generated that incorporate polylactide
beads to assess the effects of matrix heterogeneity on the behavior of both normal
mammary epithelial and cancerous epithelial cells. Further work should focus on refining
the process in which beads are suspended in the Collagen/Matrigel™ matrix and on the
optimization of the number of cells to be seeded in the 3D model. Additional validation
of the heterogeneous 3D CM matrix + bead environment as breast tissue matrix is
required.
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CHAPTER FIVE
Results in this chapter were generated by an Institute for Biological Interfaces of
Engineering interdisciplinary team and co-written with Clemson University doctoral
student Jordon Gilmore, and were presented at the 2014 Northeastern Biomedical
Engineering Conference McCave EJ, Gilmore JA, Burg TC, Burg KJL: Evaluation of an
Introductory Research Program for Minority Student in an Interdisciplinary Tissue
Engineering Lab. In: 40th Annual Northeast Bioengienering Conference (NEBEC):
2014; Boston, MA: IEEE; 2014. [4] and the 2014 American Society for Engineering
Education Annual Meeting and Exposition McCave EJ, Gilmore JA, Burg KJL:
Engineering and Science Student Preparedness for Research: Exploring the
Connections Between Student Identity and Readiness for Research. In: 121st
American Society for Engineering Education Annual Conference & Exposition.
Indianapolis, IN; 2014[5].
MINORITY, UNDERGRADUATE STUDENT’S DEVELOPMENT OF A
RESEARCH IDENTITY

Introduction
The increasingly technical global economy and rapidly changing national
demographics have presented the US with a critical workforce shortage in the educational
areas of Science, Technology, Engineering, and Mathematics (STEM) [165]. As the
country attempts to maintain its leadership position in research, development, and
innovation, studies reported in the literature have made clear that US production of
STEM graduates needs improvement. Employment in STEM fields grew by 23%
between 1994 and 2003, compared to only 17% for non-STEM fields; nonetheless, the
US is now struggling to meet the rapidly increasing demand for STEM workers [166].
The continued need to remain globally competitive and the fact that 39% of people in the
US under 18 are persons of color (U.S. Census 2000) underlie the urgent need for
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colleges and universities to improve their efforts to graduate minority students in STEM
disciplines [167].
Along with an increased interest in undergraduate degree attainment, there is
significant interest in increasing the number of graduate degrees awarded in STEM,
particularly to underrepresented minority students [168]. STEM education researchers
have commonly defined underrepresented minorities (URMs) as African American,
Hispanic/Latino, or Native people, including Native American, Alaska Native, Native
Hawaiian, and Pacific Island individuals [168]. The drive to increase the number of
graduate degree recipients is directly relevant to research and innovation goals and
national economic interest [168]. One of the strategies employed for increasing the
number of URM students in STEM has been the introduction and promotion of
undergraduate research programs. Both federal and private agencies have committed to
investing significant funding into these programs, as they have been reported to increase
student intention of enrolling in graduate or professional schools [169, 170]. The National
Science Foundation (NSF), through the Emerging Frontiers in Research and Innovation
(EFRI) program is one of these program examples. The NSF has awarded supplemental
funding for Research Experience and Mentoring (EFRI-REM) outreach programs with a
focus on developing research in STEM disciplines. The REM program provides a
training program for researchers and supports the national priority to attract and retain a
diverse STEM population.
Many researchers have explored potential causes for minority student
underrepresentation in the STEM disciplines. Issues such as preparedness deficiencies,
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stereotype threats, familial or societal expectations, or low esteem have been presented as
potential reasons for low interest, aspiration, admission, retention, and persistence in
STEM of ethnic minority students [171-178]. Diminished pursuit of graduate studies for
URM students were thought to be largely related to financial hardship post baccalaureate;
however, further research has shown that URMs in STEM also may not see graduate or
professional schools as significantly beneficial to career aspirations and interest [179].
Undergraduate research programs have been shown to be effective in fostering the
interest, skills, and aspirations that may develop into pursuit of graduate / professional
school and potential research and innovation careers [169, 170]. The concept of
“communities of practice” described by Wenger supports the idea that participation in
different communities and experiences affects participant identity development [180].
The National Science Board members, in their report “Moving Forward to Improve
Engineering Education”, propose participation in research experiences, specifically in the
freshman and sophomore years, as a desirable means to engage URM students in the
community of STEM [181]. These experiences aim at introducing students to STEM and
broadening their education while improving retention. One aspect that has been
highlighted by undergraduate research experts is identity development within the context
of STEM [169]. Attention to identity has increased, specifically within the sciences
[182], as work continues toward increasing the STEM population and workforce.
Investigators have suggested that participation in an undergraduate research program
results in domain identity related to the area of participation [183]. It is this identity
development process that fosters feelings of preparedness for future research and creation
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of a research identity integrated with a student’s STEM domain-specific identity.
Domain-specific identity, comprising three dimensions of student beliefs - interest,
performance/competence, and recognition, has been used to observe math, physics, and
general sciences identities [184-189].
It has been suggested that engineering research is advanced by an increasingly
diverse population of STEM researchers aiming to complete interdisciplinary research
objectives. Diversity of thought and perspective is a prerequisite to addressing the
world’s complex problems. There is a significant need for training and development of
diverse populations to answer evolving research questions. To develop researchers one
must understand how their identity, which is based on a researcher’s belief about his/her
performance, competence, recognition by others, and interest, influences their feelings of
preparedness for research experiences. It is our assertion that students that feel more
prepared for research experiences are more likely to participate in future research
experiences.
Our study focused specifically on a research training opportunity funded by the
National Science Foundation (NSF) Emerging Frontiers in Research and Innovation
(EFRI) program. We hosted an undergraduate research program to introduce
underrepresented, early-stage undergraduates to research using our tissue-engineering
laboratory as the backdrop. The program was designed as a first step toward full
engagement in undergraduate research, i.e., to lower the perceptual barriers to
participation, provide tools, and promote confidence to pursue rigorous research. We
assessed how URM student participation in an introductory, interdisciplinary tissue
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engineering research experience prepared the students for future research endeavors in
their own majors. Student experiences highlighted in this study pertain to their
participation in an NSF-EFRI Research Experience and Mentoring (REM) program
during the academic year and subsequent research or professional experiences the
following summer. These research or professional experiences included Research
Experience for Undergraduates (REU) programs, cooperative education (co-op)
experiences, institutionally-funded research programs, and other summer employment
opportunities. The purpose of this study was to understand how a student’s perception of
preparedness is influenced by the student’s science and engineering identity, based on
their participation in interdisciplinary research.

Methods
Clemson University (CU) and the University of North Carolina at Charlotte
(UNCC) receive NSF:EFRI funds that allow CU engineering researchers and UNCC
biology researchers to work together to build and analyze breast cancer benchtop tissue
test systems. The NSF distributed a competitive call for supplemental funding proposals
to funded EFRI grantees, termed Research Experience and Mentoring; the goal of the
opportunity was to further the progress in EFRI topic areas while broadening
participation of underrepresented groups in STEM fields [190]. CU and UNCC
successfully competed and were awarded REM funding for the 2012-2013 academic
year. The objective of the CU-UNCC NSF:EFRI-REM program was to introduce URM
undergraduate students, especially those at an early transition point in their academic
career, to a positive introductory research experience that would inspire confidence and
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create credentials for future research opportunities. Students with no prior research
experience were specifically recruited. Each student participated in 1 semester of the
NSF:EFRI-REM program, either in the fall or spring, and each had the opportunity to
apply to participate in a 10-week REU program encompassing experiences at both
universities. All REM participants were encouraged to apply for other REU programs
across the nation, other summer research experiences, or co-operative education
experiences.
During the school year, URM students were recruited through CU and UNCCsupported offices with focus on underrepresented student recruitment and retention in
STEM. Students were encouraged to apply for the REM opportunities and were selected
based on their interest in the program, their ability to communicate how this experience
might influence them, and their academic progress (including performance in STEM
classes). The principal investigators, graduate student and staff mentors reviewed
applications, and the undergraduate students, termed by NSF the Research Participants
(RPs), were invited to participate in the REM program. Each semester, the REM program
began with a Research Studio lasting approximately 8 hours before students began the
laboratory experience. The Research Studio began with a pre-survey regarding research
experiences and then included an introduction of tissue test systems and overall EFRI
project goals, completion of laboratory safety training, an introduction to research ethics,
technical writing, and basic laboratory practices, participation in a team building exercise,
discussion of the projects to which each student would be exposed, and discussion of the
expectations for and of RPs. Once RPs completed the Research Studio, each RP was
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paired with a graduate student mentor and the mentor’s project. After completion of the
Research Studio, each student was required to spend 3 hours on lab/research-related
activities each week during the semester. Weekly professional development exercises
introduced the RPs to a variety of research-related skills and topics. Students ended the
semester with a rapid fire podium presentation and poster presentation at Networking
Day, a day where all students, graduate student mentors, faculty mentors, and external
support mentors gathered to discuss research activities and outcomes of the REM
program. A research experience post-survey was given, following the 15-week semester,
to assess the student experience.
The joint EFRI:REU began in late May for a 10-week period and included two
RPs from CU and two RPs from UNCC. The first 5 weeks were spent in the engineering
laboratories at Clemson University, and the second 5 weeks in cancer biology
laboratories at the University of North Carolina at Charlotte. Each REU weekday
consisted of approximately 8 hours of lab/research-related activities. All EFRI:REU RPs
gave poster presentations overviewing their research at the end of the REU and all
EFRI:REU students were invited to apply to participate in/present at the NSF and
American Association for the Advancement of Science-sponsored Emerging Researchers
National Conference in STEM in Spring 2014.
Each academic semester, eight RPs participated in the REM program, four at each
university. The demographics of the population were determined by information
submitted in the REM applications, including gender, ethnicity, college level, major (with
concentration), and minor. Of the 16 RPs in the REM program, three were male and
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thirteen female. Students self-indicated their ethnicity on the application as: Hispanic or
Latino (regardless of race), American Indian or Alaska Native, Asian American, Black or
African American, White, or Native Hawaiian or Other Pacific Islander. The population
included two Hispanic or Latino students, thirteen Black or African American students,
and one Asian American student. RPs included thirteen sophomores, one freshman, and
two juniors. Clemson University RPs were students seeking either engineering or science
degrees while University of North Carolina at Charlotte RPs were students pursuing
science degrees. Out of the 16 participants, six were obtaining engineering degrees in
industrial engineering, computer engineering, environmental engineering, and chemical
engineering, while two had yet to declare an area of focus and were still in the general
engineering program. The other 10 students were pursuing science degrees; specifically,
chemistry (1) and biology (9). Of the 16 students that participated in the REM program,
two from each university were selected to participate in the summer REU program. All of
the REU participants were female and three of the four were science majors. The REU
RPs, all females, identified their ethnicities as Asian American (1), Hispanic/Latino (1),
and Black or African American (2).
The REM program pre- and post-survey (Table 5.1) was administered to CU
students only and was used to assess how the REM program influenced students’ feelings
of preparedness for future research programs and to assess skills gained through the
program. Pre- and post-surveys included: participant demographics (i.e. name,
educational aspirations, major), research preparedness items (Q1-Q5, Table 5.1), research
skills assessment items (Q6-Q10, Table 5.1), and short answer questions pertaining to
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laboratory practices and attributes. Items Q1-Q5 were evaluated on a Likert-type scale,
with 1 indicating strong disagreement and 5 indicating strong agreement. Questions Q6Q10 were answered as yes/no and evaluated in binary format, where yes = 1, no = 0. An
Analysis of Variance (α=0.05) was used to analyze pre- to post- response as a whole as
well as with respect to academic term.

Table 5.1 Pre- and Post-Preparedness Survey Items
Research Survey Items
Item #

Research Preparedness Items

Q1

I feel prepared to participate in a research program at the college level

Q2

Research is an important part of my undergraduate education

Q3

Continuing research as a graduate student would be beneficial to me and my career
goals

Q4

I feel comfortable speaking about or presenting scientific research in an academic setting

Q5

I am familiar with ways to find research opportunities
Research Skills Assessment Items

Q6

Have you ever applied to participate in a research program at the college level (other
than to this program)?

Q7

Have you ever participated in a research program at the college level?

Q8

Have you ever used scientific journals as part of a research project?

Q9

Have you ever given a research presentation (oral or poster)?

Q10

Have you ever attended or participated in a research conference or meeting?

An identity survey, given to REM participants from both CU and UNCC, was
used in order to assess identity development after participation in the REM program.
Former REM RPs were given an identity pre-survey in May before they started their
summer activities. Eleven of the 16 participants completed the pre-survey. Students that
completed the pre-survey were given a follow-up identity post-survey the first week of
the fall semester following the various summer activities. Ten post-surveys were
completed; five by science majors and five by engineering majors. The summer
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experiences of these 10 RPs included REU (4), co-operative education experience (2),
summer research experience (2), and non-research related activities (2). The identity
survey questions were adapted from the Sustainability and Gender in Engineering (SaGE)
survey [184-186, 188, 189]. Questions for engineering and research identity were adapted
from these valid and reliable survey items with the help of experts in engineering
education research. The survey items were divided into three identities; science,
engineering, and scientific research. The same questions were asked to investigate each
identity, substituting the word science, engineering, or scientific research in each item.
Each question was evaluated on a Likert-type scale, the far left of the scale anchored as
“Strongly Disagree” (1.0) and the far right of the scale anchored as “Strongly Agree”
(7.0). Questions in the survey pertaining to preparation were categorized based on the
type of future experience, and included research, non-research, and graduate research
questions. Statistical analysis of the data was conducted using Analysis of Variance
(ANOVA, α=0.05) to determine statistical differences between majors, for both presurvey and post-survey responses, and within majors (pre- to post-response).

Results and Discussion
REM Program Survey
The REM survey results indicated an overall positive increase in student survey
responses pertaining to preparedness in research and its influence on future research
activities. The results suggest the students felt more prepared to participate in research and
felt more comfortable with some of the tasks (e.g. presenting research) required when
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completing research activities. Significant increases were seen in two of the responses
from pre- to post-survey, specifically “I feel prepared to participate in a research program
at the college level” and “I am familiar with ways to find research opportunities” (Figure
5.1A), with p-values of 0.0172 and 0.0075, respectively. Further, a significant increase
(p=0.0089, Figure 5.1B) was seen in response to the question “Have you ever used
scientific journals as part of a research project”.
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Figure 5.1. REM research program survey results. Asterisk indicates significant differences
between pre- and post-survey items at p<0.05.
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The NSF:EFRI–REM program resulted in a significant increase in students’
feeling of preparation for future research experiences. By introducing students early in
their career to research activities, we begin to give them the tools necessary to succeed in
future research endeavors. Teaching skills that will be used in both academic and research
settings allows students to gain confidence in themselves and their abilities to succeed in
similar situations, thus preparing them for STEM careers.
Identity Survey
Results from pre- and post- identity surveys suggest that science and engineering
identities are related to each other, as well as to the development of research identity. The
analyses shown below in Tables 5.2, 5.3, and 5.4 compare survey item responses for
science majors versus those of engineering majors. For example, the first line of Table
5.2 indicates that pre-survey responses for science majors yielded a mean (µ) response of
6.80, while engineering majors had a mean response of 7.0. These responses were related
to the question, “To what extent do you disagree or agree with the following statement? I
am interested in learning more about science.” The difference in science majors’ and
engineering majors’ pre-responses yielded a non-significant p-value of 0.3466 after
ANOVA testing. Similarly, post-responses also had a non-significant difference
(p=0.1720) with means of 7.0 and 6.4 for science and engineering, respectively. Analyses
completed comparing pre- to post-responses within majors were conducted but are not
included in table format. Only two of the survey items were significant; descriptions of
these items are included below.

135

Table 5.2: Self-Reported Interest Items Comparing Science and Engineering Majors.
Symbols µ and σ represent the mean and standard deviation of the population, respectively.
P-Values highlighted indicate significant differences between majors.
Pre-Summer Experience
Sci.
Survey Item

Μ

Eng.
σ

µ

Post-Summer Experience
Sci.

P-Value
Σ

Eng.

P-Value

µ

σ

µ

σ

To what extent do you disagree or agree with the following statements?
I am interested in learning more
about science

6.80

0.45

7.00

0.00

0.3466

7.00

0.00

6.40

0.89

0.1720

I enjoy learning science

7.00

0.00

6.60

0.55

0.1411

6.80

0.45

6.60

0.55

0.5447

To what extent do you disagree or agree with the following statements?
I am interested in learning more
about engineering

5.00

1.73

7.00

0.00

0.0325

5.20

1.64

6.80

0.45

0.0688

I enjoy learning engineering

4.40

0.89

6.80

0.45

0.0007

5.20

0.84

6.80

0.45

0.0055

To what extent do you disagree or agree with the following statements?
I am interested in learning more
about scientific research

6.60

0.55

6.40

0.89

0.6811

6.75

0.50

6.40

0.89

0.5097

I enjoy learning scientific
research

6.60

0.55

6.40

0.89

0.6811

6.60

0.55

6.40

0.89

0.6811

Two questions addressed the aspect of domain-specific interest. The questions “I
am more interested in learning more about …” and “I enjoy learning …” revealed
significant differences between the science and engineering majors when the topic was
engineering, for both the pre-survey and post-survey responses (Table 5.2). While the
science and engineering majors’ means for both the pre-survey and post-survey are nearly
equal for science and scientific research identity items, the engineering identity items
reveal a significant difference. Engineering students identified much more interest in
engineering topics as compared to the science students.
Questions were posed about RP competence in the three areas of science,
engineering, and research. While the survey items addressed competence, performance
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was not included in this analysis as there were no grades assigned to student research
outcomes. Regarding competence (Table 5.3), it was found that science students felt
significantly less confident in their ability to understand science outside the classroom
after their summer experience. This could be, in part, because more in-depth research and
summer experiences broadened the students’ perspectives to what is required to
understand science and conduct scientific endeavors outside the classroom.
The other area of significance of note within competence from Table 5.3 is in the
differences of “understanding engineering”, “understanding concepts studied in
engineering”, and “being able to overcome limitations and setback/obstacles in
engineering”. Significant differences were seen by science students in all of these
categories except “I am confident that I can understand engineering in the laboratory”.
The results may be explained, in part, by the fact that three of the five science majors
who completed the surveys participated in the joint summer EFRI:REU program. The
summer EFRI:REU incorporated an engineering component and thus many of the science
majors were exposed to engineering problems. The engineering students were
significantly more confident in every one of these categories after their summer
experiences. This result was expected, as all but one of the engineering RPs that
completed the survey were involved in summer research that focused on some aspect of
engineering, most of them in areas of their own majors. These RPs gained experience and
knowledge in their specific engineering areas and thus would have strengthened identity
in the area of competence. The engineering question that did not result in significant
differences when comparing majors both pre- and post- summer experience was
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“Engineering makes me nervous”. However, the science students, when comparing their
pre- to post-summer experience responses with respect to science, did indicate
significantly less (p = 0.0046, data not shown in table format) nervousness post-summer.
One of the major foci for this study was the development of feelings of
preparedness for future research opportunities. Results shown in Table 5.3 below indicate
that both engineering and science majors are relatively confident in their level of
preparedness for future research. This is signified by means above 6.0 for nearly every
preparedness item. There was no significant difference between engineering and science
majors in terms of preparedness, suggesting the program helped to develop confidence in
research preparedness across the spectrum of represented majors. The mean confidence
level of science majors with respect to preparedness items was also slightly higher
(though not significant), again indicating that perceived research outcomes may be more
closely related to the skillset students identify with science.
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Table 5.3: Self-Reported Competence Items Comparing Science and Engineering Majors.
Symbols µ and σ represent the mean and standard deviation of the population, respectively.
P-Values highlighted indicate significant differences between majors.
Pre-Summer Experience
Sci.
Survey Item

Μ

Eng.
σ

µ

Post-Summer Experience
Sci.

P-Value
σ

Eng.

P-Value

µ

σ

µ

σ

To what extent do you disagree or agree with the following statements?
I am confident that I can
understand science in class

6.40

0.55

6.20

0.84

0.6666

6.80

0.45

6.80

0.45

1.0000

I am confident that I can
understand science in the
laboratory

6.20

0.45

6.20

0.84

1.0000

6.60

0.55

6.20

1.10

0.4860

I am confident that I can
understand science outside of
class

6.40

0.55

5.20

0.84

0.0278

6.60

0.55

6.40

0.89

0.6811

I understand concepts I have
studied in science

6.60

0.55

5.80

0.84

0.1114

6.80

0.45

6.60

0.55

0.5447

Science makes me nervous

4.20

1.79

3.20

2.28

0.4626

3.20

1.48

3.40

2.07

0.8651

I can overcome limitations in
science

5.60

0.89

5.75

1.50

0.8565

6.20

0.84

6.40

0.55

0.6666

I can overcome
setbacks/obstacles in science

5.60

0.89

6.00

1.00

0.5237

6.40

0.55

6.40

0.55

1.0000

To what extent do you disagree or agree with the following statements?
I am confident that I can
understand engineering in class

4.40

0.55

6.40

0.55

0.0004

4.80

1.48

6.40

0.89

0.0727

5.20

1.30

6.40

0.55

0.0943

5.20

1.64

6.00

1.00

0.3796

4.40

0.89

6.00

0.00

0.0039

4.60

1.52

6.40

0.89

0.0516

I understand concepts I have
studied in engineering

4.40

0.89

6.40

0.55

0.0027

4.40

1.82

6.20

0.84

0.0790

Engineering makes me nervous

4.60

0.89

3.60

2.30

0.3917

3.00

1.22

3.00

1.41

1.0000

I can overcome limitations in
engineering

4.00

0.71

6.00

1.00

0.0065

4.20

0.45

6.40

0.55

0.0001

I can overcome
setbacks/obstacles in
engineering

4.00

0.71

6.20

1.10

0.0054

4.60

0.89

6.40

0.55

0.0050

6.60

0.55

6.20

0.84

0.3972

I am confident that I can
understand engineering in the
laboratory
I am confident that I can
understand engineering outside
of class

To what extent do you disagree or agree with the following statements?
I am confident that I can
understand scientific research in
class

6.40

0.55

5.80

0.45
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0.0943

I am confident that I can
understand scientific research in
the laboratory
I am confident that I can
understand scientific research
outside of class

6.40

0.55

6.00

0.00

0.1411

6.60

0.55

6.20

0.84

0.3972

6.00

0.71

5.60

0.55

0.3466

6.40

0.55

6.00

1.00

0.4554

I understand concepts I have
studied in scientific research

6.20

0.45

5.80

1.10

0.4714

6.60

0.55

5.80

0.84

0.1114

Scientific research makes me
nervous

4.80

1.30

4.00

2.00

0.4751

3.40

1.52

3.40

1.82

1.0000

I can overcome limitations in
scientific research

5.80

0.45

6.00

1.22

0.7404

6.20

0.84

6.40

0.55

0.6666

I can overcome
setbacks/obstacles in scientific
research

5.80

0.45

6.40

0.55

0.0943

6.40

0.55

6.40

0.55

1.0000

To what extent do you disagree or agree with the following statements? I feel prepared to participate in...
Academic research program
(e.g. REU, research experience)
offered during the summer

6.40

0.55

6.00

0.71

0.3466

6.80

0.45

6.40

0.89

0.3972

Academic research programs
offered during the academic
year

6.40

0.55

6.20

0.45

0.5447

6.80

0.45

6.60

0.55

0.5447

Non-academic research
program (e.g. scientific or
engineering based co-operative
education experience or
internship) offered during the
summer

6.20

0.45

6.40

0.55

0.5447

6.60

0.55

6.40

0.89

0.6811

Non-academic research
programs offered during the
academic year

6.20

0.45

6.20

0.45

1.0000

6.40

0.55

6.20

0.84

0.6666

Continued research at the
graduate level

6.40

0.55

5.75

0.96

0.2381

6.40

0.55

5.80

1.10

0.3052

The third aspect of identity, recognition, reveals some of the stark differences
between science students and engineering students with respect to how they and others
recognize them in the communities of practice of science, engineering, and research.
Recognition plays a crucial role in how people see themselves fitting into a Community
of Practice and a lack of recognition has been shown to deter students from pursuing
certain career paths [191].
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Before the summer experience, science students reported significantly higher
(p=0.0039) recognition from their mentor(s) as compared to engineering students,
whereas in every other aspect of science identity (i.e. recognition of self and recognition
by parents, friends, advisor(s), and faculty), there were no significant differences by
major in either the pre- or post-summer experience items. Engineering identity of science
majors was significantly lower (Table 5.4) compared to the engineering majors both preand post-summer experience, except for recognition by their mentor(s) in the pre-survey.
The higher recognition by mentor(s) of the science students in this category could be due
to the fact that two of the five science students who completed the surveys participated in
the engineering REM program instead of the science REM program, thus their mentor(s)
were of engineering backgrounds instead of biology. The last significant difference of
note was between majors evaluating the survey item “Others ask me for help in scientific
research”. The science student responses, in the pre-survey, reveal significantly higher
(p=0.0438) recognition with respect to others asking their help compared to engineering
majors. This difference is most likely influenced by the coursework completed by each
student. Many of the engineering students, at this point in their degree progress, have just
begun to enroll in science-related classes, whereas science degree-seeking students
enrolled in general science classes immediately upon matriculation as they are required to
take many more science classes compared to engineering students. Further, engineering
students are less likely to take a biology class compared to science students, as most
engineering degrees require many more physics classes and physics is not, at this point,
classified as a general science class for engineering majors.
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Table 5.4: Self-Reported Recognition Items Comparing Science and Engineering Majors.
Symbols µ and σ represent the mean and standard deviation of the population, respectively.
P-Values highlighted indicate significant differences between majors.
Pre-Summer Experience
Sci.
Survey Item

Μ

Eng.
σ

µ

σ

P-Value

Post-Summer Experience
Sci.

Eng.

µ

σ

µ

σ

P-Value

To what extent do you disagree or agree with the following statements?
I see myself as a science
person

6.60

0.55

5.80

1.10

0.1823

7.00

0.00

5.60

2.19

0.1909

My parents see me as a science
person

6.60

0.55

5.80

1.64

0.3319

6.80

0.45

5.60

2.07

0.2415

My friends see me as a science
person

6.80

0.45

5.40

1.34

0.0578

7.00

0.00

5.40

2.07

0.1228

My faculty advisor sees me as a
science person

6.20

1.30

5.40

0.89

0.2907

6.80

0.45

4.75

2.06

0.0641

My mentor(s) see me as a
science person

6.60

0.55

5.00

0.71

0.0039

6.80

0.45

5.40

2.07

0.1783

My professor(s) see me as a
science person

6.00

1.22

4.80

0.45

0.0736

7.00

0.00

5.20

2.05

0.0851

Others ask me for help in
science

6.00

0.71

5.20

1.48

0.3080

6.40

0.89

6.40

0.89

1.0000

To what extent do you disagree or agree with the following statements?
I see myself as an engineering
person

3.80

1.64

6.60

0.55

0.0068

4.20

1.64

6.60

0.55

0.0147

My parents see me as an
engineering person

2.80

1.10

6.40

0.55

0.0002

3.80

1.30

6.40

0.55

0.0034

My friends see me as an
engineering person

2.75

1.50

6.20

0.84

0.0031

3.60

1.52

6.40

0.55

0.0047

My faculty advisor sees me as
an engineering person

2.40

1.14

5.80

0.45

0.0003

3.40

1.34

6.40

0.55

0.0017

My mentor(s) see me as an
engineering person

3.80

2.17

5.80

0.45

0.078

4.00

1.58

6.40

0.55

0.0125

My professor(s) see me as an
engineering person

3.20

1.64

5.40

0.55

0.0218

3.40

1.34

6.20

0.84

0.0042

Others ask me for help in
engineering

3.00

1.22

6.00

1.00

0.0028

2.20

1.30

5.80

1.64

0.005

To what extent do you disagree or agree with the following statements?
I see myself as a scientific
research person

5.80

0.45

5.40

1.52

0.5871

6.60

0.55

5.20

2.05

0.1783

My parents see me as a
scientific research person

6.20

0.45

5.20

1.48

0.1869

6.00

0.71

5.40

1.95

0.5358

My friends see me as a
scientific research person

6.40

0.55

5.20

1.48

0.1281

6.60

0.55

5.20

1.92

0.1562
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My faculty advisor sees me as a
scientific research person

6.00

0.00

5.20

1.30

0.2073

6.20

0.45

5.00

2.12

0.2509

My mentor(s) see me as a
scientific research person

6.20

0.45

5.20

1.30

0.1434

6.60

0.55

5.20

2.05

0.1783

My professor(s) see me as a
scientific researcher

5.80

0.45

4.80

1.30

0.1434

5.80

1.30

5.40

2.07

0.7245

Others ask me for help in
scientific research

5.00

1.00

3.00

1.58

0.0438

5.60

0.55

5.00

1.87

0.5108

One of the major outcomes of this analysis was the indication that science RPs did
not identify as engineers, either before or after participation in various summer
experiences. This result was consistent across all explored aspects of identity: interest,
competence, and recognition. This result was also statistically significant across most
survey items concerning engineering identity, with science RPs reporting statistically
lower means than those of their engineering RP counterparts. For the RPs surveyed, this
result suggests a distinction between science and engineering for students majoring in
science. When comparing science major responses with regard to science identity to
corresponding engineering identity items, a significantly higher mean response (statistics
not shown in table) can be seen for science responses. This further supports the assertion
that these science RPs have very strong viewpoints on the components of science identity
and its distinction from engineering identity components.
In contrast to these results, engineering RPs indicated comparable levels of
science identity as reported by their science RP colleagues. It can be seen across each
measured component of identity that engineering student and science student responses to
science-focused identity items resulted in non-significant differences in most cases. It is
our assertion that these results indicate an intersectionality of science identity and
engineering identity for engineering students. These students do not see the two fields of
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study as inherently different as do the science students. This idea is supported by the
work of Godwin and coworkers, in which both science and physics identities were shown
to support or contribute to the development of engineering identity [186]. These results
suggest that for these engineering students, the components contributing to a strong
science identity are the same as, or necessary for the development of, the components of
their engineering identities.
These contrasting results are interesting, considering the implications derived
from the research identity items explored in this study. For the most part, research
identity items yielded non-significant differences between science and engineering
majors for both pre- and post-survey results. However, closer examination of the mean
values of these items reveal that, although not significant, science majors consistently
reported slightly higher responses than engineering majors with respect to research
identity items. Because these results are not statistically significant and because of the
limited sample size, one cannot definitively conclude science majors report higher
research identity than engineering majors. However, the consistency of the responses
across all areas of identity suggests that science identity may be more closely linked to
research identity for these students. Interestingly, the lack of significant difference also
suggests that engineering students also readily identify with components of research. Two
explanations may clarify this result. First, engineering students may identify with
research through some set of components common to both engineering and science
identity. This explanation supports the previous assertion there is significant
intersectionality between the science and engineering identities of engineering students.
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Second, engineering students may identify with research through their identification with
science. This idea supports the previous statement that the most direct link to research
identity may be through a strong science identity, but science and engineering identities
are indeed separate. Figure 5.2 below illustrates these two potential explanations.

Figure 5.2 Potential explanations for research identity data. 1) Significant intersectionality
between engineering and science identities, with science identity being most directly linked
to research identity. 2) Engineering and science identity are distinctly different, but
connected. Science identity is most directly linked to research identity.

It is also important to note some outcomes of this work not specifically related to
the analysis. Science student post-survey results indicated a significantly higher response
to the item, “I see myself as a research person” when compared to pre-survey results.
This result indicates a significant growth in the self-recognition component of research
identity for this group of students. It was the goal of this work to improve research
identity development in these students; therefore, this result was a positive outcome of
the study. Corresponding engineering student results for this item indicate comparable
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pre- and post-results without a statistically significant difference. This result reinforces
the previous assertion that students of both majors more closely associate research with
science at this stage in their academic development. It is our hypothesis that the differing
natures of summer experiences for the engineering students responding to this survey
may have played a role in research identity indication. We also hypothesize that students
overwhelmingly consider research to be an academic exercise; therefore, students
participating in more industry-focused experiences may not have associated their specific
summer activities with research.
The results suggest that engineering students identify less with research, as
compared to science students, and subsequently feel less prepared to conduct research;
however, participation in an interdisciplinary experience increases their indication of
academic research preparedness. The results show, for the population studied, that
participation in a research program, such as REM and summer REUs, increases URM
student research identity which, in turn, could help increase diversity of the research
population.

Limitations and Future Directions
While this work is a good starting point to better understand minority
undergraduate students’ perceptions of science, engineering and research identity and
preparedness to conduct research, it is evident that the programs, and therefore the
surveys, were limited by the small sample size. While this study was intended to assess
how students participating in the program identify within science, engineering, and
research, further, in depth work assessing engineering and research identity is necessary
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to better understand how federally-funded and related programs impact students and the
future of STEM fields. Some limitations of the study related to the identity survey items
include the adaptation of items and missing data. The survey items have been validated
and proven reliable for science and math identity through the SaGE study [189]. Further,
missing data responses were dealt with by deleting entire responses for missing pre- or
post- results. As for the REM program survey, each student’s perception of the questions
may have skewed their response to the questions and thus the results of the survey items.
Future work in this area of study should focus on capturing a larger, more
representative population of undergraduate researchers. A longitudinal study would be
insightful to follow up this work in order to see how the identities of science, math,
engineering, and research change and morph over time with each RP’s experiences and
beyond, as he/she becomes part of the STEM community. Future work comparing
research experiences of URMs to those of non-URM students would add insight
regarding the relationship between ethnicity, gender, or experience level and research
identity, or regarding the influence of cultural differences (e.g. between English speaking
countries, other Western countries, and Eastern European or Asian or African countries)
on identity development. Further work must be conducted to establish the validity and
reliability of research identity survey items. Based on current literature, science, math,
and physics identities factor into the development of engineering identity [186]. Future
research may explore the relationship of these already validated identities with research
identity, or may explore the connection of engineering identity to research identity. This
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could be done through interviews to better understand student perceptions of research
identity and their feelings of preparedness for research.

Summary
The overall motivation for this work is to increase the number of
underrepresented minority students pursuing STEM careers which may lead to the
fulfillment of research and innovation goals for the United States in years to come. It is
our position that participation in undergraduate research programs fosters the
development of research identity in both science and engineering students and will allow
students to feel more prepared to pursue further research opportunities. The program
highlighted in this work combined “hands-on” experience with faculty and graduate
student mentoring to develop this research identity. Interest, competence, and recognition
are critical factors in the development of any type of identity. Survey tools used in this
study sought to explore the effect of participation in this program on those factors in
identity development. Results showed that science students and engineering students may
see their respective areas of study in different lights than their counterparts, but also they
see research and its connection to their established academic identities as different.
Science majors seemed to identify highly with only science, while engineering students
identified with both science and engineering identity items. Science identity seemed to be
the most direct link to the development of research identity in these students. Based on
the results from this study, we consider these programs to be a positive and impactful
experience for underrepresented minority students interested in research careers.
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CHAPTER SIX
CONCLUSIONS
The overarching objective of this work had two components; the first was
technical work focused on developing a 3D in vitro breast tissue model and the second, to
understand how undergraduate students in Science, Technology, Engineering, and
Mathematics (STEM) disciplines who participate in research develop a research identity.
In Chapter 2, it was determined that processing parameters affect the final material
properties of polylactide beads. Both the vessel size/paddle size and PVA concentration
have a definitive effect on bead size and shape. These are two processing variables that
can and should be controlled for the intended application. In choosing beads for the 3D
breast tissue model, beads with a diameter of 250-325 mm were selected because 1) the
larger the beads have more mass and anything over 400 mm would not suspend in the
model and 2) the smaller beads have a more uniform shape providing a more consistent
model.
Collagen/Matrigel™ of 2.4 mg/ml was chosen to represent the stromal component
of the 3D breast tissue model based on their performance reported in Chapter 3. This
combination provided a MCF10A cell viability above 75%, production of both acinar and
ductal-like structures and cell cluster measurements consistent with a cluster of 5 or more
cells providing the most representative model of the normal breast tissue.
To produce a heterogeneous 3D breast tissue model, polylactide beads were
suspended in the 2.4 mg/ml Collagen/Matrigel™ system. Cell viability, cell cluster
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measurements, macro and micro mechanical properties, histological analysis of cell
proliferation, cell-cell adhesion, and acinar and ductile-like structure formation were
analyzed to assess the feasibility of producing a model system to look at the influence of
heterogeneity on normal and cancerous mammary epithelial cells. This work
demonstrates that a heterogenous 3D breast tissue model can be produced incorporating
degradable, synthetic materials. Further, inclusion of these materials affected acinar and
ductile-like structure formation, for example, cancerous epithelial cells formed larger
clusters of disorganized cells, which is more consistent with a breast cancer environment.
The overall motivation for the educational component of this work is to increase
the number of underrepresented minority students pursuing STEM careers. This work
suggests that participation in undergraduate research programs foster the development of
research identity in both science and engineering students during their first two years of
undergraduate study. The students felt more prepared to pursue further research
opportunities after this initial experience. During the program, students received
mentoring from faculty and graduate students aiding in their development of a research
identity. These conclusions are drawn from the results of a survey tool designed to assess,
interest, competence, and recognition, three critical factors in the development of
engineering, science, and research identity. One difference that was found between
engineering and science students was that the science majors seemed to identify highly
with only science, while engineering students identified with both science and
engineering identity items. Correlations revealed that science identity was connected to
the development of research identity in these students. Based on the results from this
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study, we consider these programs to be a positive and impactful experience for
underrepresented minority students interested in research careers.
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CHAPTER SEVEN
RECOMMENDATIONS FOR FUTURE WORK
1.

Monitoring of 3D structures for this study was challenging. Use of an inverted
fluorescent microscope works well for histological sections but when imaging full
3D gels, in the future the use of a confocal microscope is recommended. This will
allow the capture through multiple microphotographs of the 3 dimensions of the
acinar and ductal-like structure formation.

2.

Some specific histological staining could be conducted on whole constructs
allowing analysis of full structures instead of sectioning the structures. However,
this approach is limited to few stains beside specific immunohistochemistry using
fluorescent probes. Although, this may allow more accurate cell cluster counts
and measurements and provide a more comprehensive understanding of cell
viability and cell organization with H&E stains and routine stain, serial sections
remains the standard with efforts to develop computer software approaches
allowing section compilation and 3D rendering.

3.

In the studies conducted constructs were seeded with approximately 120,000 cells
per well, While these numbers were based on values found in the literature, using
a ratio of cells to a specific volume or area in the matrix could provide a better
model. Whether increasing the number of cells seeded in the 3D construct would
facilitate both physical and chemical cell interactions and potentially promote the
generation of breast like structures remains to be investigated.
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4.

In the process to form the heterogeneous 3D breast CM matrices, the suspension
of polylactide beads in the Collagen/Matrigel™ was challenging. In the future, a
gelation method that decreases the amount if time, e.g. crosslinking of the matrix
materials, would prevent the polylactide beads from settling out of the matrix and
provide a more uniform distribution of the beads throughout the construct. In
addition, mechanical testing and histological analyses were affected by the need
for specific vessels to contain the 3D constructs and the difficulties sectioning 3D
matrix containing beads. By changing the consistency of the model constructs,
more accurate mechanical testing could occur. Future research should address
those limitations.

5.

Polylactide beads were incorporated into the 3D CM matrices to provide both
heterogeneity and an acidic environment normal within the breast tumor
microenvironment. Polylactide beads release lactic acid into the surrounding
matrix as they degrade; however, pH change in the matrix surrounding the beads
was not evaluated. Further work should explore the effects of pre-degrading the
beads, the pH changes that occur due to bead degradation, and the effects of the
acidic environment within heterogeneous 3D CM matrices.

6.

The 3D breast tissue model produced here needs to be validated to ensure the
model system represents the desired select aspects of the normal breast
environment, but also can be tuned to represent the different environments seen in
breast cancer disease progression. Currently the model has been developed to
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represent aspects of the normal mammary epithelial environment, however,
further benchmarking must be done to ensure it is truly representative.
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Appendix A
Polylactide (PL) Bead Processing – 1L Beaker
Equipment Required
• 1L Beaker
•

Plastic tubing for transferring beads to rinse bottles

•

IKA Works overhead stirrer with paddle stir rod

•

Syringe (glass not required) with 16 gauge needle

•

Orbital shaker

•

Glass flasks with ceramic insert and filter paper for drying beads with house air

Working Solutions
• 10% (w/v) PL Solution: 2g PL pellets in 20 mL dichloromethane (Mallinckrodt
#4879). Leave overnight on orbital shaker at 150 rpm for pellets to go into
solution. This particular concentration was optimized for Cargill amorphous
PLLA pellets, so it may differ from the most desirable concentration for the
particular batch you are using. Two vials of this solution have been used to
successfully make one batch of beads.
•

0.3% (w/v) PVA Solution: 3g PVA (MW of 13-23k – Aldrich #36-317-0) in 1000
mL distilled water. Stir on low heat until PVA dissolves in water. Cool to room
temperature before using to process beads.

•

2% (v/v) Isopropanol Solution: 20 mL Isopropanol (VWR #VW5520-3) in 980
mL distilled water. Be sure to have 3 bottles of this solution prepared before
beginning.

Procedure
1. Beaker set-up. Place 1 L beaker on stir platform.
2. Set stirring conditions. Add 150 mL of 0.3% PVA solution to beaker. Make the
solution 0.05% by adding an additional 750 mL of distilled water to the beaker.
Position stir rod on overhead stirrer in center of beaker so that the stir rod sits at
the 300 mL mark on the beaker. Stir at 200 rpm for 5 minutes to ensure thorough
mixing.
3. Attach needle to syringe. Remove plunger from syringe. Pour 20 mL of PL
solution into syringe quickly but carefully. Avoid pouring the solution down the
side of the syringe – try to pour down the center. Solution on the sides, near the
top of the syringe, will cause it to seize in a short time making bead production
extremely stressful on your thumb, hand, and wrist. After emptying contents into
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syringe, insert plunger. While maintaining slight pressure, turn the syringe over
and let the air bubbles in the solution float to the top. Remove the air bubbles
from the syringe by applying gently pressure. Be sure to have a paper towel handy
to avoid squirting PL solution all over the hood.
4. Submerge needle of syringe at a 45° angle near (but not in) the stirring vortex at
the center of the beaker. Try to apply consistent pressure to syringe and dispense
entire contents of syringe into the stirring PVA solution.
5. Stir beads in the solution at 300 rpm for 90 minutes. These settings should only be
used as a guide. Ultimately, the decision is up to you to determine if your beads
appear to be small enough. Lowering the speed below this range will cause the
beads to increase in size while increasing the speed will produce beads of smaller
size.
6. Turn the overhead stirrer OFF. Allow beads to settle in beaker. Using the house
vacuum and “bioreactor” bottle top remove the 0.05% PVA solution from the
beaker leaving approximately 200 mL.
7. Add 400 mL of 2% Isopropanol solution. Turn overhead stirrer ON, and stir again
in the 175-200 rpm range for 5-10 minutes.
8. Turn the overhead stirrer OFF. Allow beads to settle on bottom of beaker. Again
using the house vacuum, remove the remaining solution.
9. Move beads to a 250 mL pyrex bottle by pouring the beads into bottle from
beaker. You may need to use a squirt bottle full of Isopropanol solution to help
move beads from beaker to bottle.
10. Add 50 mL of fresh 2% Isopropanol solution to 250 mL pyrex bottle.
11. Place bottle on orbital shaker overnight (24 hours) at 150 rpm.
12. Place ceramic insert into top of glass flask. Insert 3” filter paper into ceramic
insert. Remove the beads from the bottle that was on the orbital shaker, and place
them on the filter paper. Turn the house air on low flow to slowly dry the beads.
Remove the beads from the filter paper and store them in 20 mL glass scintillation
vials under vacuum.
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Appendix B
Immunofluorescence Staining
	
  

Objective: Use immunofluorescence staining to assess expression of primary and
secondary antibodies on fixed, frozen sections embedded in OCT.
Materials:
• 0.2% tween PBS
• 10% goat serum in PBS
• 1% goat serum in PBS
• 1:1600 rat anti-Ecadherin in 1% goat serum
• 1:200 goat anti-rat Alexa 594 (spun down @ 1000 rpm for 1 min)
• 1:1000 rabbit anti-Ki67, 1:1000 rabbit anti-CD29, or 1:1000 rabbit anti-met in 1%
goat serum
• 1:200 goat anti-rabbit Alexa 488 (spun down @ 1000 rpm for 1 min)
• ddH2O
• PBS
• Pap pen
• Paper towels
• Waste container
• Sectioned samples, embedded in OCT
Protocol:
1. Draw around each slide using a pap pen to contain rinses to slide
2. Rinse twice with ~1 mL ddH2O per slide for 2 minutes to remove OCT. Pour
ddH2O into waste container.
3. Rinse once with ~1 mL PBS per slide for 2 minutes. Empty into waste container.
4. Add ~1 mL 1:1 HCl:PBS to each slide for 30 minutes. Empty into waste
container.
5. Rinse twice with 0.2% tween PBS for 2 minutes. Empty into waste container
6. Block with 10% goat serum for 45 minutes at room temperature (RT).
7. Add rat anti-Ecadherin primary antibody solution for 2 hours at RT.
8. Rinse with 0.2% tween PBS for 2 minutes. Empty slide(s) in waste.
9. Add goat anti-rat 594 secondary antibody. Leave overnight in fridge, protected
from light.
10. Rinse once with PBS for 2 minutes. Empty slide(s) into waste.
11. Add second primary antibody (e.g. rabbit anti-Ki67) for 2 hours at RT. Protect
from light.
12. Rinse with PBS for 2 minutes. Empty slide(s).
13. Add second secondary antibody, goat anti-rabbit-alexa 488. Leave overnight in
fridge, protected from light.
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14. Rinse twice with ddH20 for 2 minutes. Empty slide(s).
15. Mount coverslip with Prolong Gold Antifade Reagent + DAPI and store away
from light.
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